incivo is used to treat adults with hepatitis c infection . it is used in adults to treat chronic hepatis b infection in adults who are at least 1865 years old . its active substances are peginterferon alfa - 2b , ribavirin and telaprevir . these are medicines known as ns3 - 4a protease inhibitors . the nns 3 - 5a proteace inhibitor is a type of protein that is essential for the hepa c virus to multiply . inciva is used together with peg interferon - alfated and rib avirine to treat heparin . what incivi is used for inciVO is used on its own to treat adult patients with chronic hpatiti c infections . patients with 
do not take incivo - if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). - when taking peginterferon alfa or ribavirin , please carefully read the package leaflets of their contraindications ( e . g . pregnancy precautions ) carefully read all the information contained in the leaflets that come with inciva . when taking inciVO with peg interferonalfa and rib avirn , take special care with accvo when taking the following medicines , which may cause severe side effects . 56 stop taking the medicine alfuzosin if any of these apply to you , tell your doctor immediately . symptoms of an enlarged prostate may occur after taking alpha - 1 - adrenaleceptor antagonists ( such as ami
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will prescribe the appropriate dose regimen for you based on your condition and body weight . the recommended dose regimen is 3 to 6 tablets twice a day . this means taking 2 to 8 tablets twice daily . take the tablets twice weekly , once in the morning and once in evening , at about the same time each day , for up to 6 weeks . for both hepatitis c virus infection and human immunodeficiency virus infection , efavirenz , the recommended dosage regimen is based upon your body weight and your child ' s weight , and should take incivo for as long as your child is able to tolerate the recommended daily doses . children 3 to 8 years of age and older the recommended dosing
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get rash , especially an itchy skin rash ( see section 2 ). the rash may get worse over time . other symptoms may also be related to the rrash . in case of a severe skin reaction , contact your doctor immediately . it is important that you tell your doctor if a skin r / rash develops . tell your physician immediately if your rash is severe . the doctor may want to monitor you more closely . any signs of other symptoms that may be associated with a rash include fever , tiredness , swelling of the face , and swelling of lymph glands , a wide - spread rash with peeling skin , fever . flu - like symptoms , painful skin skin . these may be signs of rash
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle after exp . the expiration date refers to the last day of that month . incivo tablets should be stored in the bottle and should be used within six months after first opening of the bottle . keep the bottle tightly closed in order to protect from moisture . this medicine does not require any special temperature storage conditions . throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incivo contains - the active substance is telaprevir . each tablet of inciVO contains 375 mg of tel aprev . - other ingredients are tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrously , sodium lauryl sulphate , croscarmellose sodium , and sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , the talc , titanium dioxide ( e171 ), iron oxide yellow ( er ) what if inciva looks like and contents of the pack film , capsule - shaped tablets with " tmc " debossed on one side . the tablet is 20 mm long and 4 
what zinbryta is zinbeta contains the active substance daclizumab beta , a monoclonal antibody . what zbrytar is used for zin Brytta can be used in adults to treat multiple sclerosis ( ms ) in adults who are not able to respond to therapy , or who have failed to respond adequately to one or more mms treatments . it is used when other treatments have not worked or have not helped to stop inflammation . how zinbyta works mc is a condition where the protective sheath around the nerves in the central nervous system ( brain and spinal cord ) loses its protective layer ( called myelin ) and keeps it at a low level . this loss of myelian is called demyelinate . in relapsing md
do not take zinbryta - if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine listed in section 6 . - have liver problems . warnings and precautions talk to your doctor before taking zinberytta and if any of these apply to you : - you have any other autoimmune disorders . do not use any other medicines , herbal supplements or any medicines or supplements you take at the same time . this is because some people may get liver side effects from taking these medicines . you should tell your doctor if they are taking , have recently taken or might take any other medicine . talk to you doctor before you take zbrytes if : you have depression in the past you have or have had , a severe infection such as pneumonia or tuberculosis ( tb
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much zinbryta to inject the recommended dose of zinbecco - zin is 150 mg . your doctor will do a blood test to check how well your liver is working before giving you zin Brytta . the usual dose is 40 mg / kg body weight . if your doctor decides that you should have this blood test , your doctor may decide that you can have a test before you start injecting zin brryte yourself zin bryto is given under the skin ( subcutaneously ) in the thigh , stomach , or back of the upper arm . instructions for injecting the zinkta are given at the end of section 7 . before injecting your first
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : tell your doctor or pharmacist straight away if you notice any of the following serious side effects during your treatment : serious side reactions liver problems common ( may affect up to 1 in 10 people ) unexplained nausea ( feeling sick ) or vomiting ( being sick ), stomach pain increased tiredness loss of appetite ( anorexia ) your skin turns yellow dark ( tea - coloured ) urine 41 uncommon ( may effect up to1 in 100 people ). severe inflammation of the liver may lead to death . tell your physician immediately if any of these affect you . you may need medical attention . if your liver is not working properly , your doctor may decide to reduce your dose or stop your treatment temporarily or permanently . liver problems may occur with this product . very
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled syringe in original package in order to protect from light . you should use a new ssyre / pen within one hour of a fridge . zinberyte s / pens may be stored at temperatures up to 30 for a single period of up to three months . once you have removed zin bryta from the refrigerator for more than 30 days , the product must be used within 30 days or discarded . for children , adolescents and adults , zin Brytt
what zinbryta contains - the active substance is daclizumab beta . each pre - filled syringe contains 150 mg daclizuab beta in 1 ml solution . - each pre- filled pen contains 150 micrograms daclizab beta in 1 millilitre solution - one pre  filled pen provides 150 microliters dacizumabeta . 1 -the other ingredients are : sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 under ' zinbetta contain sodium '). what zbrytoa looks like and contents of the pack zin bryta is a colourless to slightly yellow solution for injection in a pre – filled pen with an attached needle .
wilzin belongs to a group of medicines known as metabolism products . wilszin is used to treat willson ' s disease , a rare inherited defect in copper excretion in the liver , the eyes and the brain . this causes liver damage and neurological disorders in which the medicine passes through the intestine and its further accumulation in the body . it is used in adults to treat patients with wILson  s diseases . you should have been given this treatment by your doctor .
do not use wilzin if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilszin . if this applies to you , do not take wILzin and tell your doctor . warnings and precautions talk to your doctor before taking wlzin wifzin is used during initial therapy if signs and symptoms indicate that you have willson ' s disease and you are currently taking another anti - copper agent , penicillamine . you should not take more wwil Zin for the initial treatment , but should continue to take other anti  copper agents . your doctor may decide to reduce the dose of peniciillamine if your symptoms do not improve after the treatment has stopped . blood and urine monitoring will be performed regularly to monitor for signs that you are having insufficient treatment ( such as copper excess ) and /
what wilzin contains the different dose regimens are available in different strengths and strengths . the strengths are 25 mg and 50 mg . each dose is taken with or without food . take one tablet of 1 mg of wilszin 50 mg twice a day for 2 weeks . if you take more wILzin than you should if your doctor prescribes you 25 mg twice daily , take 1 tablet of ' willzin 50mg ' or 2 tablets of 1 mg of the medicine , taken with food , for 25 mg , you take 1 mg wlzin 50 micrograms twice - day , taking 2 tablets . when you take wulzin 25 mg you will take 1 dose of , or 2 doses of : 25 microgram , 1 to 6 microgram and 1 microgram of the active substance . you should take a single dose
like all medicines , wilzin can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( affects more than 1 user in 10 ) common ( effect affects 1 to 10 users in 100 ) uncommon ( affect 1 to 1 user per 10 , 000 ) rare ( affect less than 1 patient in 10 000 ,000 ) very rare ( effect impacts less than1 user in 1 , 10 . 000 ). not known ( frequency cannot be estimated from the available data ): wilszin intake may cause gastric irritation . in some patients , treatment may be stopped and changes in blood tests may show an increase in some liver and pancreatic enzymes and a decrease in blood red and white cells . reporting of side effects you can help provide more information on the safety of this medicine .
keep out of the reach and sight of children . do not use wilzin after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . store below 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains - the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg of Zin acetate dihydrate ). each capsule contains 50 mg of gold ( equivalent  to 167 .84 mg of zirconium ade dihydrate and magnesium stearate . the capsule shell contains gelatin , titanium dioxide ( e171 ), and brilliant blue fcf ( wmf ). wlzin 25 mg hard capsules are printed with the company logo and the company symbol in black ink . printing ink contains black iron oxide ( i ) and shellac . what a wilszin looks like and contents of the pack wILzin 25 g hard capsule - willzin 50 mg hard hard capsule is printed with " gmf " in black on the capsule
what biktarvy is biktarivy contains the active substance bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor . what bikittarvies is used for emtricitabine , is an antiregular medicine known only as a nucleoside reverse transcriptasse inhibitor ( nrti ) tenofovir alafenamide , also known as : an anti retroviral medication known as " a nuclear nucleogram reverse transcriptor ( trtis ) biktegranvir is used to treat the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection . biktedti reduces the amount of hiv in your body . this will improve your immune system and reduce the risk of developing illnesses
do not take biktarvy - if you are allergic to bictegravir , emtricitabine , or tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). - take the following medicines : - with rifampicin , which is used to treat some bacterial infections such as tuberculosis - saint john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . if any of these apply to you , do not use biktarivy and tell your doctor . warnings and precautions talk to your doctor or pharmacist before taking biktegy : liver problems talk to you doctor if your child has liver disease , including hepatitis . liver disease includes
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . do not take antacids to prevent stomach ulcers , heartburn or acid reflux caused by the use of aluminium , magnesium hydroxide mineral supplements , vitamins , calcium , iron , and water for injections ( see section 2 under ' what biktarvy contains '). if your doctor has prescribed these medicines , they may not be suitable for you : if the medicine is not suitable for your condition . if he / she decides that biktariy is not recommended for you on dialysis . biktabvy may be used in patients not on diatic use . patients not receiving biktay who are not on a dialytic use should not take bik tarty 
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects may occur immediately : inflammation or infection . in some patients with advanced hiv infection , opportunistic infections ( infections that occur in people with a weak immune system ), symptoms of inflammation from previous infections may occur soon after hiv treatment is started . it is thought that these symptoms are due to an improvement in the body ' s immune response , which helps to fight infections that may have been present with no obvious symptoms . autoimmune disorders , when the immune system attacks healthy body tissue , may also occur after you start taking medicines for hiv in addition to biktarvy .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the seal and carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from light and moisture . keep the container tightly closed .
what biktarvy contains - the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktarivy tablet contains bicentegrar sodium equivalent to 50 mg bictégravir and 200 mg emetricit abine / tenoffovir fumarate equivalent to 25 mg tenovir altafèneamide - each tablet contains tablet core microcrystalline cellulose , and croscarmellose sodium , magnesium stearate . - film - coating polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , the talc , iron oxide red ( i ) and iron oxide black ( encoding for " gsi ").
novonorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your panceras does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . novonourm is used to control type 2 diabetics in adults as an add - on to diet and exercise : treatment is usually started if diet , exercise and weight reduction alone have not been able to control ( or lower ) your blood glucose . it is important that novonorgm is taken in combination with metformin , another medicine for diabetes . your doctor will prescribe novonerm if you have type 2 disease .
do not take novonorm : - if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). - in case you have type 1 diabetes . - when you start taking novonarm , the acid level in your blood may increase ( diabetic ketoacidosis ). warnings and precautions talk to your doctor or pharmacist before taking novoorm ( if your doctor has told you that you have a severe liver disease ). do not start taking gemfibrozil ( a medicine used to lower increased fat levels in the blood ). 47 - have liver problems . do not use novonorgm if : you have moderate liver disease do not give novonom - you have had a severely liver disease or you have kidney problems - novonlorm is not recommended if any of these apply to
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 0 . 5 mg before each main meal . swallow the tablets with a glass of water immediately before or up to 30 minutes before each major meal , preferably at least 4 hours before each meal ; preferably within 30 minutes after each main meals . your doctor may increase your dose to 16 mg after each major meals , as needed . if your blood sugar is too low , it can become too high , leading to a hypo . you should continue to take novonorm for as long as your diabetes continues to get worse . continue your treatment as long you are learning how to use it . for information on how to switch from one day to the next , see the box at the end of this leaflet .
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of hypogliescaemia is ( may affect up to 1 in 10 people ). it is a hypo in section 2 . the hypoglates are generally mild / moderate but may occasionally develop into hypoglemic unconsciousness or coma . allergy allergy is very rare ( may effect up to1 in 10 , 000 people ) and usually occurs suddenly . symptoms may include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . anaphylactic reaction is essentially an early warning for all patients . other side effects are listed below . if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting
what novonorm contains - the active substance is repaglinide . - other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , and poloxamer . the tablets also contain iron oxide yellow ( e172 ) only in the 1 mg tablets and iron oxide red ( 0 . 2 mg tablets ) not all pack sizes may be marketed . what novovonorme looks like and contents of the pack novonorgm tablets are round , convex tablets with " 0. 5 " on one side and " 1 " on the other side . they are marked with " 2 " on either side and plain on the opposite side , respectively 
what pumarix is pumarice is a vaccine for use in adults aged 18 years and older to prevent pandemic flu ( influenza ). pandemie flu is essentially a type of influenza that happens at intervals that vary from less than 10 years to many decades . it spreads rapidly around the world . the signs of pandelic flu are similar to those of ordinary flu but may be more serious . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarize may not fully protect all persons who are vaccinated .
pumarix should not be given : - if you have previously had a sudden life - potentially life threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the ingredients of the vaccine ( including egg and chicken protein , ovalbumin , formaldehyde , sodium deoxycholate ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if any of these apply to you , tell your doctor or nurse immediately . however , in a pandemic situation , it may be appropriate for you to go home and receive medical treatment . in case of an allergy reaction , you should not receive pumaris . warnings and precautions 33 talk to your doctor , pharmacist or nurse before having this vaccine if 33 you have had any allergic reaction other than a
pumarix is intended for use in adults aged 18 and over . it should only be given by healthcare professionals trained in administering pumarx with a similar h5n1 as03 - like vaccine to adults aged 17 years and older . your doctor will decide if you should receive pumarice if the vaccine is suitable for you . pumarize is intended to be given to infants from 3 - 9 years of age and young children from 3 months to 17 years of health . you should not receive pumariix if your child has not been properly vaccinated . if he / she is injecting puMarix , it is given as an injection into a muscle , usually in the upper arm . should you have any further questions on the use of this vaccine , ask your doctor , pharmacist or nurse .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may cause dangerously low blood pressure . in case of shock , you may need emergency treatment . other side effects include : very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles or joint pain common ( might affect up to 1 in every 10 people ) redness and swelling where the injecting is given fever sweating shivering diarrhoea feeling sick uncommon ( may effect up to1 in every 100 people ). not known ( frequency cannot be estimated from the available data ) low blood sugar ( hypoglycaemia ) high blood sugar . reporting of side effects 23 if you get any side effects talk to your doctor or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects
keep this vaccine out of the sight and reach of children . do not use the vaccine after the expiry date which is stated on the carton and the sachet after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . once the vaccine has been dissolved in water for injections , the contents should be used immediately . if not used immediately the vaccine can be stored for up to 24 hours below 30 .
what pumarix contains the active substance is split influenza virus , inactivated , containing antigen * equivalent to : a / inactivation , of strain : pre 8 - ibcdc - 6 , with a concentration of 0 . 5 ml haemagglutinin . the vaccine contains a substance called ' adjuvant ' as03 . this adjuvanted is a mixture of squalene , and dl - 1 - tocopherol , polysorbate 80 and water for adjutants . what pumariix looks like and contents of the pack the suspension for injection contains sodium chloride , disodium hydrogen phosphate / potassium dihydrogen phosphat , potassium chloride and water to be injected . it is supplied in a vial 
somakit toc is a radiopharmaceutical product that contains the active substance edotreotide . the powder contains a small amount of a nuclear medicine called gallium ( 68ga ) chloride , which is similar to the radioactivity produced by your own body . this procedure involves the use of gallium ( 6ga and 68Ga ). edeotreotrotide is injected into a vein or other body areas . it is used in a medical imaging procedure called positron emission tomography ( pet ). this medical procedure allows you to get images of the abnormal cells and tumours , and to help your disease . if you are given som akit tc , the nuclear medicine doctor will discuss with you the rationale of the procedure with the radiopharmaceutician . your doctor and the nuclear
do not use somakit toc - if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). if allergic reaction occurs ( see section 4 , " what you need to know before you use so somamakit ") warnings and precautions talk to your doctor before using somma kit toc ( see also section 4 for further information ). talk to a doctor before you are given som - you have kidney or liver problems . - your liver does not work properly if your doctor thinks you may have renal or hepatic disease . children and adolescents ( under 18 years of age ) do not give this medicine to children and teenagers under 18 because of the risk of dehydration during the examination . other medical conditions that affect the body such as cushing syndrome ( inflammation ) or other medical
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakit toc will only be used in specially controlled areas . it will only ever be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this product and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide on the quantity of som akit tc to be used , and on the storage conditions necessary . two 100 mbq ( megabecquerel ) the quantity to be administered is two 200 ml megabequerell . administration of so somat toc and conduct of the procedure after radiolabelling , somamakit can be administered by intravenous injection ( a single injection ). after the injection , the doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ) to somakit toc . symptoms may include warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may include stinging at the injection site , ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects get a quick look at the package leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : do not store above 25 oc . do not freeze . radiolabelling will be performed after the first administration . somakit toc must not be used after the expiry date which is stated on the label after exp . hospital staff will ensure that the product is stored correctly and not stored above 25oc for a single period of maximum 4 months . store below 25  do not use if you notice any visible sign of deterioration or if radioactive products are disposed of in accordANCE with national regulations on radioactivity .
what somakit toc contains - the active substance is edotreotide . each vial of powder contains 40 micrograms of edeotreotroline . - other ingredients are : 10 - phenanthroline , gentisic acid , and mannitol ( e421 ), formic acid . sodium hydroxide and water for injections are included in the pack . the content of the vial is coloured with sodium and , after radiolabelling , the solution is clear . it contains hydrochloric acid ( a substance present in radiopharmaceutical preparation ). what sommakit tc looks like and contents of the pack somamakit forc is supplied as a glass vial with black flip - off cap . this is a white powder in a clear
afinitor is an anticancer medicine containing the active substance everolimus . everolim helps to control the tumour and slow down the growth and spread of cancer cells . afinitour is used to treat hormone receptor - positive advanced breast cancer in postmenopausal women , when other treatments ( including non - steroidal aromatase inhibitors ) have not helped to stop the disease under control . it is used in combination with a medicine called exemestane ( a steroids aromatease inhibitor ) and hormonal anticancancer therapy in adults with advanced tumours and neuroendocrine tumours that have spread beyond the stomach and bowels and into the bloodstream .
you must not be given afinitor if you are not sure . before cancer treatment your doctor will tell you if the effect of afinitour is too strong or too weak . you must also tell your doctor if any of the following apply to you : you are allergic to everolimus , sirolimus / temsiroli Mus or any of other ingredients of this medicine ( listed in section 6 ). if this applies to you ( or you are unsure ), tell your healthcare professional . if , after you have been given afinior , tell your pharmacist if ( or they may be allergic ) to any of these ingredients . warnings and precautions talk to your doctor before you are given afinitorior : if your liver is working properly if vous have any disease which affects your liver . your doctor may prescribe a different dose of afinitor
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 10 mg once a day . you should swallow the tablet whole with a glass of water . do not chew the tablet . if your doctor thinks you may have taken too much afinitor , talk to your doctor immediately . patients with liver problems may need a lower dose of afiniter ( 5 mg / 5 mg or 7 . 5 mg twice a morning ). your doctor may reduce your dose if necessary to reduce your daily dose , or if certain side effects may occur . your doctor will tell you how long you should continue treatment with afinitour . stop taking afinitur if a child swallows some tablets , do not take any more . talk to a doctor immediately for advice . taking
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and seek medical help immediately if you have any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin , with a red rash or raised bumps . the following side effects may happen while taking afinior : very common ( may affect more than 1 in 10 people ): increased temperature ( with chills ( signs of infection ) fever , coughing , difficulty breathing , wheezing . inflammation of the lung ( pneumonitis ) common ( might affect up to 1 in every 10 people in your family ) - coughing up blood , shivering - diarrhoea , vomiting , nausea , constipation ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 25 . open the blister before taking the tablets . this medicine does not require any special temperature storage conditions . tampering is not allowed . please return the tablets to the pharmacist . return the used tablet to the pharmacy . these measures will help to protect the tablets from moisture .
what afinitor contains the active substance is everolimus . afiniteur 2 . 5 mg film - coated tablets each tablet contains 2 , 5 mg of everoli Mus . Afinitor 5 mg films - embedded tablets each tablette contains 5 mg or more of everollimus - afinitour 10 mg film coated tablets - attached tablets each pill contains 10 mg of Everolimus the other ingredients are butylhydroxytoluene ( e321 ), magnesium stearate , lactose monohydrate , hypromellose , and crospovidone ( containing lactoses anhydrous ). what afinior looks like and contents of the pack afiniter 2 : 5 mg tablets are white to slightly yellowish , round , with " nvr " marked on one side . they are marked with " 5 " on one face 
what laventair ellipta is laventaire ellippa contains two active substances umeclidinium bromide and vilanterol . these belong to a group of medicines called bronchodilators . what laVENTair ellpte is used for laventAIR elliрta can be used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties that slowly get worse over time . in copd the muscles around the airways tighten . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary airways . as a result , your breathing difficulties will get worse .
do not use laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , do not using this medicine and tell your doctor immediately . warnings and precautions talk to your doctor or pharmacist before using laventaire ellippa : - patients with asthma . lavent air ellimpta should not be used if : you have asthma - you have heart problems or high blood pressure - your doctor may want to monitor you more closely - or you have an eye problem called narrow - angle glaucoma - have an enlarged prostate , difficulty passing urine or a blockage in your bladder - suffer from epilepsy - has thyroid gland problems - diabetes - had severe liver problems immediate breathing difficulties
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . use laventair ellipta regularly it is very important that you use laVENTair elipta every day , as instructed by your doctor to do so . this will help to keep you free of symptoms throughout the day and night . if laventAir ellippa is used to relieve a sudden attack of breathlessness or wheezing , you should use a quick - acting reliever inhaler ( such as salbutamol ). if your doctor has prescribed
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions you should have one or more of the following symptoms while using laventair ellipta . stop using lavenair ipt , and contact your doctor immediately . uncommon side effects ( may affect up to 1 in 100 people ) skin rash ( hives ) or redness rare side effects (1 may affect 1 in 1 , 000 people !) swelling , sometimes of the face or mouth ( angioedema ). becoming very wheezy and coughing or having difficulty in breathing or feeling weak or light headed ( which may lead to collapse ). if you get any of these effects : stop using this medicine and see a doctor immediately as they could be serious . very rare side effect ( may effect up to1 in 10 , 500 people ). swelling mainly of the faces and mouth
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microgram of umecilidinium brmide ) and 22 microgram ( mg of vilantarate )- the other ingredients are trifenatate , lactose monohydrate ( see section 2 under ' laventaire ellippa contains lactoses ') and magnesium stearate ( see end of section 2 for further information on ingredients of laventa ellipinta ). what laVENTair elept consists of an inhalations powder . the ellipepte inhaler contains a light grey plastic body with a red mouthpiece
tremfya contains the active substance guselkumab , a monoclonal antibody . this medicine contains the key active substance called il - 23 , which is used to treat psoriasis in adults with moderate to severe " plaque p soriaticsis ". this is an inflammatory condition that affects the skin and nails . tremefyaims to improve the condition of the skin around the nails and reduce the appearance of nails , and to reduce symptoms such as scaling , shed , flaking , itching , pain and burning .
do not use tremfya - if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using tre.fye . - you have an active infection . warnings and precautions talk to your doctor or nurse before using this medicine . you should not be given active tuberculosis warnings , precautions and measures before you are given treefyan : - tell your healthcare provider if : you have or have ever had an infection , including an infection that you have ever been diagnosed with tubercuossis . it is important that you tell your caregiver that you are having tubercularosus . tubercleosists must be checked regularly for signs or symptoms of an infection before you
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of tremfya is 100 micrograms ( 1 pre - filled syringe ) given by injection under the skin ( subcutaneous injection ). the recommended starting dose is 4 to 8 microgram / kg given once a month . your doctor will decide how many treatments you need . if your doctor decides that you need more tretfyan than you should tresfy , you may inject trempfyo yourself or your caregiver may inject it yourself . you or your carer should contact your doctor for advice if they have any questions . for more information , see the box at the end of this leaflet . do not shake treefye vigorously as this may affect
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical attention : serious allergic reaction - difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , with a red rash or raised bumps other side effects include : tell your nurse or pharmacist if they notice any side effects not listed in this leaflet . some side effects may be serious common ( may affect up to 1 in 10 people ) upper respiratory infections common ( might affect upto 1 in 100 people ). headache , joint pain , diarrhoea , vomiting , nausea , abdominal pain . reporting of side effects 23 if your child gets any side effect , talk to your doctor or pharmacist or nurse 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . this medicine should not be used if the solution is cloudy or contains flakes or large particles . after first opening of the refrigerator , the pre- filled siringe must be used within 30 days or discarded . you must use this medicinal product only if it is clearly visible or if there are particles in it . any unused medicine must be discarded after first use .
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusedlkumbab in 1 ml solution . - other ingredients are histidine , histamine monohydrochloride monohydrate , polysorbate 80 , sucrose , water for injections . what hemfYa looks like and contents of the pack solution for injection : trempfyan is a clear , colourless solution , supplied in a carton pack containing one single - dose glass sYringe or in  a multipack containing 2 ( 3 packs of 1 single  dose pre – filled  ssyres ). not all pack sizes may be marketed .
the active substance in trepulmix is treprostinil . treprastinkil belongs to a group of medicines called prostacyclins . prostacins are hormones that help to control blood pressure by relaxing blood vessels . by doing so , prostacycles prevent blood from clotting . the active ingredient in TREpulmix inoperable chronic thromboembolic pulmonary hypertension ( cteph ) is a hormone produced by the body . it is produced by a process called ' csh '. it can be used to treat persistent or recurrent ctesephe , either before or after surgical treatment , or by requiring exercise capacity ( the ability to deal with symptoms of the disease ). inoperabil thrombolic ptepeph ( p
do not take trepulmix - if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). - have a disease called " pulmonary veno - convulsionary disease ". this is a disorder that occurs when the blood vessels in the lungs become swollen , leading to a higher pressure in the blood vessel between the heart and the arteries . - suffer from severe liver disease . talk to your doctor if any of these apply to you . warnings and precautions talk to you doctor or pharmacist before taking tre Pulmix : - you have had a heart problem or have had one in the last six months . you have severe changes in heart rate severe coronary heart disease , including unstable angina a chest defect or a faulty heart valve . your doctor may want to
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how trepulmix is given your doctor will give you tre Pulmix as a continuous subcutaneous infusion under the skin ( intravenously ) through a small tube ( cannula ) in your abdomen or thigh . your doctor may give you your dose of trepepulmix in a portable pump . you can use your treprostinil at any time of the day , or either on a regular or semi - routine basis . the pump will push the medicine through the infusion line to make sure that you do not receive accidental overdose . usual doses are 1 to 2 . 5 mg / kg given every other week . this will give your body a chance to deliver 2 , 5 or 10
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people widening of blood vessels pain at the infusion site reaction at the site of infusion bleeding or bruising at the at the location of the inffusion headaches nausea diarrhoea jaw pain common - may affect up to 1 in every 10 people dizziness , light - headedness or fainting at rest or low blood pressure skin rashes muscle pain ( myalgia ) joint pain ( arthralgi ) swelling of feet , ankles , numbness / tingling at the place of infusing trepulmix . uncommon - might affect upto 1 in 100 people swelling of ankles or limbs ( rhinitis ) pain at site of the needle bru
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . a trepulmix vial may be stored at room temperature ( up to 30 ) for continuous subcutaneous infusion in , or a single reserve ( syringe ) of undiluted tre Pulmix may be kept at room temp ( upto 30 ). this medicinal product may be administered within 72 hours . this medicine must not be used if it is noticed that it is damaged , has discolouration or other signs of deterioration . any unused medicine must be discarded .
what trepulmix contains - the active substance is treprostinil . trepelmix 1 mg : each vial contains 1 mg of tre prostinate ( as sodium salt ). - each 10 mg vial provides 10 mg of either trepst inil ( as salt ) or treulmix 2 . 5 mg , each 2 , 5 mg viall contains 2  . 4 mg of the active ingredient , trepropstinningil ( sodium salt in the form of 10 mg / 25 mg ) per vial . the active ingredients are treperstinkil ( in sodium salt and water ). the other ingredients are water for injections . what repulmix looks like and contents of the pack tre Pulmix 1mg tablets are white to off - white tablets marked with " pfizer " on one
thorinane contains the active substance enoxaparin sodium , which is a low molecular weight heparin ( lmwh ). thrinanane is used to : 1 - prevent existing blood clots from forming , and 2 - stop blood coagulations from re - forming in your blood . thourinana is used : to - help prevent blood clumps in your body . to help prevent new blood  clotting in your life . you must keep using thoinan if you : - have a reduced chance of blood - get rid of blood in your own blood , or you may have blood oc - need to have an operation , have an acute illness or have unstable angina ( an abnormal heart rhythm ), or have had 
do not use thorinane - if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . - you may also be allergic to any of these other low molecular weight heparins ( such as nadroparin , tinzaparin or dalteparin ). - have had a reaction to hepin that caused a severe drop in the number of your clotting cells ( platelets ). this reaction may be a sign of heperin - in - use thrombocytopenia . talk to your doctor if any of this happens to you . warnings and precautions talk to
like other similar medicines ( medicines to prevent blood clotting ), thorinane can cause bleeding . it is important that you tell your doctor immediately if you experience any bleeding event that does not stop by itself or if there is evidence of excessive bleeding ( exceptional weakness , tiredness , paleness ), dizziness . if your headache has unexplained swelling , contact your doctor or nearest hospital immediately . your doctor may decide to keep you under closer observation or change your medicine . stop taking thourinana and contact your physician immediately : if : you have had a severe allergic reaction ( difficulty breathing , swelling of the lips , mouth , throat or eyes ), blockage of a blood vessel which could lead to a bleeding , such as cramping pain , diarrhoea , nausea or vomiting , stomach pain .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store below 25 . after dilution the solution should be used within 8 hours . this medicine must be used immediately after thorinane has been dissolved . use the thrinanae pre - filled syringes as instructed by your doctor .
what thorinane contains - the active substance is enoxaparin sodium . each ml of solution contains 100 micrograms of enocaparIN sodium , corresponding to a concentration of 0 . 2 microgram / mL . - each pre - filled syringe contains either 0
senstend contains two active substances called lidocaine and prilocaine . senstende is used for the treatment of lifelong premature ejaculation in adult men . the active substances in senstenD work together by blocking two different receptors in the head of the penis to increase ejculation .
do not use senstend - if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using senstende . allergy or sensitivity to other local anaesthetics senstendon is not approved for use in children and adolescents . it is used in children of all ages who are not able to use amide - type local anestheses . if your child has a genetic disease or other condition that affects your red blood cells ( glucose , which can cause phosphate deficiency , anaemia or methaemoglobinaemia ) or to other types of medicine sensitivities ( sensitivity ) should be avoided . children and teenagers with severe liver problems should not use this medicine in
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 3 sprays ( 3 spray containers ) per spray . 1 spray ( 3 ml ) will be injected into the head of your penis . this dose is given as 3 spray ( 24 sprays ) in the morning and 3 spray in the evening . after 24 hours , the pump will be removed from the spray container and the pump mechanism is removed . if the valve is not in contact with eyes , nose , mouth and ears , senstend should be sprayed into the pump . senstende should be used as soon as possible after it is removed from its sprinkling . use in children and adolescents the pump can be used in children aged 1 year and above . it should only be used on the
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : common ( may affect up to 1 in 10 people ) inability to develop or maintain an erection feeling of burning in the penis uncommon ( may effect up to1 in 100 people ). headache local irritation of the throat or irritation of a part of the skin redness of failure to ejaculate during sexual intercourse abnormal orgasm tingling of the peni pain or discomfort in the legis itching of the sex drive or tearing of the pad of the hand or soles of the foot . if you experience any of these , stop taking senstend and tell your doctor straight away . not known ( frequency cannot be estimated from the available data ) feeling of discomfort in or around the penisse pain or irritation in the inner lining of the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store below 25 . throw away the container 12 weeks after first opening . keep the metal container tightly closed in order to protect from light and moisture . never puncture or burn it . you must throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 micrograms lidocanine and 50 microgram prilacaine - each spray delivers 50 microlitres with 7 . 5 mg lidocabine and 2 . 4 mg prilicaine  . - one spray container of 6 . 6 mL delivers 20 microlitre . one spray containers of 5 m carries 12 microgram per spray . what senstentd looks like and contents of the pack senstendon is a clear , colourless to light yellow cutaneous spray , solution in an aluminium spray container with metering valve . it is available in packs of 1 spray container 6 , 5 - spray containers .
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults melamineoma that has not been fully removed after complete resection in adults ( treatment with surgery called adjuvant therapy ) advanced non - small cell lung cancer ( lung cancer that has come back or has spread to other organs ) it is used to : treat advanced kidney cancer in adults advanced renal cell carcinoma ( advanced kidney tumor ) if you have had , or are unsure , previous therapies including an autologous stem - cell transplant ( ovulation ) or if a transplant has been unsuccessful . treat advanced cancer of the head and neck in adults advance urothelial carcinoma ( uroshelial cancer ). treat bladder and urinary tract cancer in adult patients nivolumab , a monoclonal
do not use opdivo - if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using oppdivo and during treatment : - contact your doctor if : you have problems with your heart such as a change in the rhythm or rhythm of the heartbeat , or an abnormal heart rhythm . your lungs may get blocked up and this may cause breathing difficulties or cough . this may be a sign of inflammation of the lungs ( pneumonitis or interstitial lung disease ). - you have diarrhoea ( watery , loose or soft stools ) and any symptoms of inflammation or of the digestive systems ( colitis ), such as stomach pain or discomfort . - your doctor may want to monitor you closely 
the recommended dose of opdivo in adults is 240 mg given as 2 separate injections of 480 mg / kg each , given once a week for 4 weeks . opectinib is used for oppdivo when combined with ipilimumab for the treatment of skin cancer . the recommended dosage of apdivon in adults , adolescents and children aged 1 year and above is based on the dose of one tablet of nivolumab per kilogram of your body weight , taken once - every 4 weeks ( based upon the recommended starting dose ). the recommended recommended starting dosage of the obdivo 240 micrograms ( mg ) or 2 480 microgram ( mg or 4 tablets ) of pdivdivo with a single tablet of the same tablet . in children and adolescents , ii
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . opdivo may be stored at room temperature ( up to 25 ) for up to 48 hours . from a microbiological point of view , the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains - the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nivivolum . - each 40 mL vial contains 4 mg of 100 mg of 10 mml , 240 mg of 24 mg of the active ingredient , including nitrate dihydrate . the other ingredients are sodium citrate dihydrogen ( e331 ), sodium chloride ( see section 2 " oppdivo contain sodium "). - other ingredients of opmd are mannitol ( е421 ), pentetic acid , polysorbate 80 , sodium hydroxide , hydrochloric acid and water for injections . what if you use obdivo for injection or for injection , please see section " pdivd
clopidogrel tad contains clopizid and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). clodogrell t ad is taken by adults to prevent blood cluts ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosesis , and atherathrombotic events ( such as stroke , heart attack , or death ). you have been prescribed cloclopidegrel to help prevent blood
do not take clopidogrel tad 30 if you are allergic to clopizide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking clonogrell ttade . if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . in case you suffer from severe liver disease , your doctor may want to reduce your dose of clodogrela t d . warnings and precautions if any of these apply to you before you take a dose of the tepidogral , you should tell your dentist that you have a risk of bleeding such a legal condition that puts you at risk of internal bleeding ( such as an stomach ulcer ). also tell your healthcare professional if your doctor suspect
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel tad per day to be taken orally with or without food , and at the same time each day . if your doctor has told vous that you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogresl - t d ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one 7 - day course of treatment of one 75 - mg tablet , or two 75 % tablet doses of cropidogral .
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in some cases , red pinpoint diamonds and a feeling of confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the spine . this may be the signs of an allergic reaction . tell your doctor if your skin starts to peel . very common side effects ( may affect more than 1 in 10 people ): diarrho
what clopidogrel tad contains the active substance is clopizid . each film - coated tablet contains 75 mg of clodogrell ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( 233 ), yellow iron oxide and talc and macrogol 3000 in the film . what  Clopidogral tard looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 , 14 and 28 film - coated devices are available . not all pack sizes may be marketed .
tacforius contains the active substance tacrolimus . it is an immunosuppressant . following your organ transplant ( e . g . liver , kidney ), your body ' s immune system will try to reject the new organ . tacforus is used to control your body'  s response to the transplanted organ : tacforitus is also used to prevent rejection of the transplant of the liver ; it works in the same way as any previous treatment you took during your transplantation .
do not use tacforius - if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). - are allergic or to siroli Mus . - have been given any macrolide - antibiotic ( e . excipients , e. g , anhydrous , such as erythromycin , clarithromycin or josamycin ). warnings and precautions tacrolivimus immediate release capsules ( i . depreciated , or e in accordance with local recommendations , tacrolimimus immediate - release capsule ( if e deprezed , deprésesed , for epsilate , tocni ) or tacforitus prolonged - released capsules do not contain tacrolim . tacfor
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . this medicine should only be prescribed to you by a doctor experienced in the treatment of transplant patients . your doctor will prescribe the same tacforius medicine every time you collect your prescription . if your transplant recipient responds to a different tacforlimus medicine , your doctor may prescribe another medicine . make sure that you use this medication exactly as described in this leaflet . do not use this product if the wrong medicine is used to prevent the rejection of your transplanted organ . the dose you take depends on your body weight . how much tacforinus you will take . usual doses the usual dose is 0 . 10 mg / kg body weight taken on the day of transplantation . doses may be given on days 0 to 30 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . infections may occur during treatment with tacforius . severe effects may occur , including allergic and anaphylactic reactions . benign and malignant tumours may occur following tacforinus treatment . cases of pure red cell aplasia ( a very severe reduction in red blood cell counts ), agranulocytosis (  a severely lowered number of white blood cells ), haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ), febrile neutropenia ( an increase in the number of a type of whiteblood cells that fight infection ). these events may include : a lack of sufficient number of cells , which may cause haemorrhoids ( stevens - johnson syndrome , toxic epidermal n
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . discard all the prolonged - release hard capsules 1 month after opening the aluminium wrapping . this will prevent from re - sucking the capsules .
what tacforius contains - the active substance is tacrolimus . tacforus 0 . 5 mg : each capsule contains 0 5 mg of tacrolivimus ( as monohydrate ). tacforitus 1 mg ; each capsule releases 1 mg of stratimus ( AS monohydrate). tac forius 3 mg , each capsule release releases 3 mg of dehydration of tacrolulimus( as monohydrat ). - tacforinus 5 mg, each cartridge releases 5 mg tacrolimmus ( As monohydrate). - capsule content hypromellose 2910 ( ethylcellulose , lactose , magnesium stearate . what tac foreadsorbent contains : capsule shell tacforea 0. 5 ml : 1 mg contains hyproli Mus ( as monohydrate ) - each
clopidogrel zentiva contains clopizid and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). clodogrell zentivea is taken by adults to prevent blood cluts ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosesis , and atherathrombotic events ( such as stroke , heart attack , or death ). you have been prescribed cloclopidegrel
do not take clopidogrel zentiva - if you are allergic ( hypersensitive ) to clopizid or any of the other ingredients of this medicine ( listed in section 6 ). -if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - If you suffer from severe liver disease . before you take a dose of clodogrell zentivea , tell your doctor and do not taking clodegrel or any other precautions . do not use clodinogreil zenivia : if any of these apply to you . you should tell your dentist that you have an increased risk of bleeding sucha if your doctor determines that you may have - or have , or have ever suffered , a medicinal condition that puts you at risk of internal bleeding (
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if your doctor has told vous that you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral  Zentiva ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 mg tablet , taken or injected at the hospital . you should take clopdogrell zentivea for as long as your physician continues
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in some cases , red pinpoint diamonds and a feeling of confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the spine . this may be the signs of an allergic reaction . liver problems may be associated with yellowing or yellowing in the skin or the whites of your eyes ( oedema ), yellowing under the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . clopidogrel zentiva should be stored in a refrigerator ( 2 8 ). do not freeze . aluminium blisters : do not store above 30 . store in the original package in order to protect from light . when clopdogrell zentivea is stored in all aluminium cartons , it does not require any special storage conditions . this medicine does not need any special temperature storage conditions or if there are any visible sign of deterioration . only a trained healthcare professional knows how to store clotter and handle it correctly . these measures will help to protect the environment .
what clopidogrel zentiva contains the active substance is clopizid . each tablet contains 75 mg of clopinogrell ( as hydrogen sulphate ). the other ingredients are ( see section 2 ' clodogrela zentivea contains lactose ' and ' liquid clone zenta contains hydrogenated castor oil '): mannitol ( e421 ) hydrogenated castingor oil ( see ' take special care with clottosis ' below ), microcrystalline cellulose ( 6000 ), macrogol 6000 ( low - substituted hydroxypropylcellulose ), lactoses monohydrate ( milk sugar ), hypromellose ( е464 ), triacetin ( containing red iron oxide ( 233 ), titanium dioxide (  e
yttriga is a radioactive medicine . it is used in combination with another medicine to deliver tiny radiation doses . the treatment is intended for patients who have not previously been treated with radiolabelled medicinal product .
do not use yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yytrige ( listed in section 6 ). - when you are pregnant or think you may be pregnant . warnings and precautions talk to your doctor or pharmacist before using yettrigga . yittrigriga is not a radioactive medicine . it is used in combination with another medicinal product . radiopharmaceuticals will not be used in conjunction with yattrig . the use of radioactive material is the responsibility of the user and should be disposed of in accordance with national regulations for radioactive medicinal products . children and adolescents yantriga should not be given to children under 2 years of age and under 16 years of body weight . other medicines and yintrigan tell your doctor if
your doctor will determine the appropriateness of the treatment . method of administration yttriga should only be used by healthcare professionals trained in radiolabelling of medicinal products . the doctor will decide on specific diseases and the dose to be administered . if you are given more yytrig , than you should if a patient is given too much yettrigga , there is no risk of overdose . your doctor or nurse will give you appropriate treatment if necessary .
like all medicines , yttriga can cause side effects , although not everybody gets them . if any of the side effects get serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist . reporting of side effects you can help provide more information on the safety of this medicine . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects, you can provide more details on the reporting of possible side effects by reporting any side effect .
yttriga will be stored under the responsibility of the specialist in appropriate premises . storage of radioactive substances will be in accordance with national regulations . the following information is intended for the specialist only . keep this medicine out of the sight and reach of children . any unused product or waste material should be disposed of in accordANCE with local regulations , if necessary .
what yttriga contains - the active substance is chloride . 1 ml sterile solution for injection contains 1 g of hydrochloric acid . - each vial contains 3 mmol yew ( 0 . 5 mg / mL solution ). what Yttrigga looks like and contents of the pack yytrig consists of a v - shaped bottom and a colourless type i glass vial containing 10 mml of solution . each carton contains a flat bottom sealed with a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciama is given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . when ciaba is combined with a drug called ciplatin for the initial treatment of patients with advanced stage of lung cancer , it can be prescribed to you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy , but it can also be prescribed ciabria as a treatment for patients with advancing stage of long - term patients with certain type of lung carcinoma whose disease has progressed after other initial chemotherapy has been used .
do not use ciambra - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciama ( listed in section 6 ). - when you are breast - feeding . warnings and precautions talk to your doctor or pharmacist before using treatment with ciambaa . - you have recently received or are about to receive a vaccine against yellow fever . before you receive ciabria , tell your doctor if : - your doctor determines that you have problems with your kidneys . your doctor may decide to give you ciaba by infusion . during each infusion you will have samples of your blood taken to evaluate if your kidney and liver function are working properly and to check that you are getting enough blood cells to receive the medicine . you may not be given ciamara if these tests are too low 
the dose of ciambra is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your area , and your doctor will use this body surface area to workout the right dose for you . this dose may be adjusted , or treatment may be delayed depending on your blood cell counts and on your general condition . a hospital pharmacist , nurse or doctor will have mixed the ciaba powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution for injection before it is given to you , in a vein . the infusion will last approximately 10 minutes . when using ciabria in combination with cisplatin : the doctor or hospital pharmacist will work out your dose of your height , weight and the dose you need based on your height or weight . you will
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following : 52 fever or infection ( common ): if your doctor gets a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if caught early , chest pain ( common common ), or a fast heart rate ( uncommon ). if it is not treated , pain , redness , swelling or sores in your mouth ( very common common). allergic reaction : - skin rash ( common with burning or prickling sensation ) or fever ( common in patients with skin reactions ).
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . you may store the infusion solution of pemetrexed for up to 24 hours at 2 , 8 , 15 or 25 . if the reconstituted solution is not used immediately , the inffusion solution should be used immediately after reconstitution . once reconstitution of the infuzation solution , use immediately or store in the refrigerator . this product is stable for upto 24 hours when stored at 2 to 8  15  25 , if refrigerated . any unused solution must be discarded .
what ciambra contains - the active substance is pemetrexed . ciama 100 mg : each vial contains 100 milligrams of pemetrexxed ( as pemetreixed disodium hemipentahydrate ). ciamma 500 mg - each viall contains 500 milligramms of Pemetrexeed ( as Pemetreix hemimahydrate). after reconstitution , the solution contains 25 mg / ml of pemeterxede . further dilution by a healthcare provider is required prior to administration . the other ingredients are mannitol ( e421 ), hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( for further phe adjustment ). see section 2 " ciabria contains sodium ". what ciembra looks like and contents of
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ) that are used to prevent certain infections from entering your blood . immunogam can help to increase levels of human hepatitis b immunoglobuins , and immunoglobularin g ( igg ) in your blood or plasma of screened patients . you should not be given immunogam if you are not sure . how immunogam works immunogam reduces the amount of hepatis - b virus in haemodialysed patients , particularly in the first few days of vaccination . using immunogam with a hepa bvirus carrier may provide an immune response . it may result in the development of measurable hepathis a antibodies to b antibodies . vaccination is a means of continuous prevention for patients who are infected with heparin b
you must not be given immunogam if you have ever had an allergic reaction to human immunoglobulins or other blood products . if this applies to you , tell your doctor immediately . you have an iga deficiency . an allergic response may occur when you are given iga containing products , or when you have been told by your doctor that you are not able to receive immunogam in the following doses : children and adolescents ( below 18 years of age ) who are treated with immunogam may experience adverse reactions such as chills , headache , fever , vomiting , allergic reactions ( nausea , arthralgia ), joint pain , low blood pressure , and moderate low back pain . your doctor may decide to make antibodies against hepatitis b immunoglobuulin regularly . it is strongly recommended that you receive human hepatis -
immunogam is intended for vaccination against hepatitis b virus only . as the first vaccine dose will be administered , human hepatis - b immunoglobulin will be injected at a temperature not above 25oc . administration prevention of hep b : the recommended dose is 500 micrograms per day for 24 to 72 hours . in case of hpb in haemodialysed patients : a dose of 500 microgramms per dose for 2 days is recommended . seroconversion after vaccination against the hepes b is carried by a hepulis  b vaccine carrier . the hpatiti b immuneglobuline administration and serocónversion following vaccination instructions are provided with each package of immunogam . if you are given more immunogam than you should immunogam should be administered at : temperature 20
like all medicines , immunogam can cause side effects , although not everybody gets them . the following undesirable effects have been observed during clinical trials with immunogam : very common ( affects more than 1 user in 10 ) common ( effect affects 1 to 10 users in 100 ) uncommon ( affect 1 to 8 users in 10 000 ) rare ( affect less than 1 patient in 10 10 , 000 ). very rare ( effect effect affect less then 1 user per 10 . 000 ), although undesirable effects may occur , some undesirable effects were observed during the clinical trials . immunogam is injected into the muscle ( intramuscularly ). uncommon ( effect affected 1 to10 users in 1 , 1000 ) in 7 - day period nausea , fatigue , induration , swelling , and / or vomiting . not known ( frequency cannot be estimated from the available data ) effects observed in clinical trials during
keep immunogam out of the sight and reach of children . do not use immunogam after the expiry date which is stated on the carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vially in the outer carton in order to protect from light . from a microbiological point of view , immunogam should not be used if the solution is cloudy or has deposits or if it is coloured or coloured . medicines should not been disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . immunogam 1 . 5 ml solution for injection contains 5 mg of human plasma protein , corresponding to a concentration of 96 iu / mL . - other ingredients are polysorbate 80 . what immuno Gam looks like and contents of the pack immunogam is a solution for injecting in a glass vial . it is essentially a colourless to pale yellow liquid . each pack contains 1 vial of solution .
remicade contains the active substance infliximab . infloximabe is a monoclonal antibody a type of protein that attaches to a specific target in the body called tnf ( tumour necrosis factor ) ( ttf ). rericade belongs to  a group of medicines called ' t nf blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis psoriatic arthritis ankylosing spondylitis ( bechterew 's disease ) ppsorbidasis . remade is also used to control the activity of tmf alpha in adults , adolescents and children aged 6 years and older who suffer from crohn '
do not use remicade - if you are allergic to infliximab or any of the other ingredients of remade ( listed in section 6 ). - are allergic ( hypersensitive ) to proteins that come from mice . - have tuberculosis ( tb ) or another serious infection such as pneumonia or sepsis . warnings and precautions talk to your doctor before using rericade and if any of these apply to you . you must tell your doctor if : you have heart failure , or have had to stop relicade before . your doctor may want to monitor you more closely . do not take reMICade without your doctor' s advice . take special care with reminiade do not stop taking remikade until you have checked with your doctor or pharmacist before taking
rheumatoid arthritis the usual dose is 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), ppsorasis , ulcerative colitis and crohn 's disease the usual starting dose is 5 mg for each kg of your body weight each day . your doctor will decide the dose you need . how remicade is given remade will be given to you by your doctor or nurse . you will be hydrated and will be administered rericade by infusion . the medicine will be prepared and given as an infusion ( drip ) ( over 2 hours ) into one of your veins , usually in your arm . after the third treatment , you will receive relicade over approximately 4 -
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however some patients may experience serious side effects and may require treatment . side effects may also occur after your treatment with remicade has stopped . tell your doctor straight away if you notice any of the following : signs of an allergic reaction such as swelling of your face , lips , mouth or throat which may cause difficulty in swallowing or breathing , skin rash ( hives ), swelling of the hands , feet or ankles . these reactions may be serious or life - threatening . an allergic response is possible within 2 hours of your injection . more signs of allergic side effects that may occur up to 12 hours after your injection include pain in the muscles , fever , chills , muscle pain , and muscle pain when you first start taking rema
remicade will be stored by the health professionals at the hospital or clinic . keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and the carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . you may store remade outside of refrigerated storage up to a maximum of 25 for a single period of up to six months . reMICade is stable for infusion and is stable at room temperature for up to 3 hours at 2 8 and for upto 28 days at room temperatures . this may require an additional 24 hours at 25 after removal from refrigeration . your doctor will determine the correct storage conditions for you . in the event of unopened product , the product should be discarded 
what remicade contains - the active substance is infliximab . each vial contains 100 mg of infloximabe . after preparation each ml contains 10 mg of of influimabat . - other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate and dibasic salt phosphatade . what retinade looks like and contents of the pack relicade is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white . it is a white to off - white cake or cake . one pack of rericade has 1 , 2 , 3 , 4 , or 5 vials . not all pack sizes may be marketed .
rasagiline mylan is used to treat parkinson ' s disease in adults . it can be used together with or without levodopa ( another medicine that is used in parkinsons ' disease ). with parkinSON 's disease , there is a loss of cells that produce dopamine in the brain . dopam is  a chemical in the body involved in movement control . rasagagilina mylan helps to increase and sustain levels of dopa in the human brain , enabling it to work better .
do not take rasagiline mylan - if you are allergic to rasagisline or any of the other ingredients of this medicine ( listed in section 6 ). - in case you have severe liver problems . - are taking any of these medicines : - rasagaline mylan may be used as monoamine oxidase ( mao ) inhibitors ( for treatment of depression or parkinson ' s disease ). this may be taken as medicinal or natural products ( e . excipients ) such as st . jen 's wort , pethidine ( a strong pain killer ). you must wait at least 14 days before rasagagilina mylan treatment is stopped unless your doctor tells you to stop treatment with mao inhibitors or pethamine . warnings and precautions talk to your doctor or pharmacist before taking
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 1 tablet of 1 mg taken by mouth once daily . rasagiline mylan can be taken with or without food . if your doctor has prescribed rasagaline myLAN , he or she may give you another dose immediately . keep the rasagin mylan carton in order to protect it from light . take rasagide mylan at about the same time each day and keep it at room temperature all the time . you should swallow the rasageline myla tablet whole with water . do not chew , crush or split the tablet before swallowing . after taking rasagile mylan , do not open the vial . wait until the next dose is due . once the vially has been opened , discard the rasagam
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects were reported more often when placebo was given orally ( frequency not known ). the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( effect affects 1 to 10 users in 100 ) uncommon ( affect affects less than 1 to 1 , 000 ) very rare ( affect less than 10 users per 10 ,000 ) not known ( frequency cannot be estimated from the available data ). very common abnormal movements ( dyskinesia ) headache common abdominal pain fall allergy fever flu ( influenza ) feeling of being unwell neck pain chest pain ( angina pectoris ) dizziness - feeling of general discomfort - headache - diarrhoea - vomiting - nausea - stomach pain ( indigestion
what rasagiline mylan contains - the active substance is rasagisline tartrate . each tablet contains 1 mg rasagilide . - - other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize meal starch ( maize ), talc , stearic acid ( see section 2 ). what rasagitline myla looks like and contents of the pack rasagive mylan tablets are 11 . 5 mg tablets , 6 mg tablets in perforated , round , biconvex tablets . they are marked with ' m ' on one side and ' 1 ' off the other side . the tablets are available in blister packs of 7 , 10 , 28 , 30 , 100 and 112 tablets in each blister pack . not all pack sizes may be marketed 
do not use hulio - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). - you have a severe infection , including tuberculosis ( see " warnings and precautions "). it is important that you tell your doctor if any of these apply to you . - signs and symptoms of infections , such as fever , wounds , feeling tired , dental problems . you have moderate or severe heart failure . it is possible that you have had or have , or might have - had a serious heart condition ( see also " warning and precautionary measures "). warnings : talk to your doctor or pharmacist before using hULio and if the patient experiences allergic reaction ( see section 4 ). allergic reactions have symptoms such as chest tightness , wheezing
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . polyarticular juvenile idiopathic arthritis in adults ( 2 to 17 years of age ): if your child is 10 to 30 kg , your doctor may prescribe a different dose . hulio 20 mg / 30 mg is used in children and adolescents from 2 to17 years of height . for children and teenagers from 2 months to 30kg , hULio 40 mg . not applicable in children enthesitis - related arthritis in children ( 6 to 17 months of age and older ) if their child is 15 kg to less than 30 kg the doctor may recommend a lower dose , but this may be more convenient for them . in children from 6 to to 17 year of age the doctor will prescribe the right dose
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require urgent medical treatment . side effects may occur at least up to 4 months after the last hulio injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash or hives swollen face , hands or feet trouble breathing or swallowing , pale complexion , dizziness , persistent fever , or bruising or bleeding . signs and symptoms of infection include fever ; feeling sick ; cough ; rash ; itching ; pain in the joints ; joint pain ; muscle pain . uncommon : may affect up to 1 in 100 people loss of appetite ; weight loss ; loss of weight ; increased body weight .
what hulio contains - the active substance is adalimumab . - each vial contains monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections . what helio looks like and contents of the pack hULio 40 mg solution for injection in vial : each ml of solution contains 40 mg of aad limumumabe in 0 . 8 mL of solution , which is clear to slightly opalescent and has a rubber stopper . the vial is labelled with ' hlia 40mg ' and the company logo on the vially . pack sizes : 1 vial and 2 vials : pack of 1 vially and
yellox contains bromfenac , a member of a class of medicines called non - steroidal anti - inflammation drugs ( nsaids ) that reduce inflammation . yyx is used to reduce eye inflammation after cataract surgery in adults .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using yyx if : you have asthma , skin allergy , or intense inflammation in your nose you are taking other nsaids . nns aids include acetylsalicylic acid , ibuprofen , ketoprofened , diclofec . you should not use this medicine together with topical steroids ( cortisone ) because it may increase the risk of unwanted side effects . your doctor may want to monitor you more closely if any of these apply to you . talk to a doctor or go to yox : if your doctor determines that you have bleeding problems .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop of yellox in your eye ( s ) once a day in the morning . use in the evening . do not put in any other eye ( other eye ss ). use within 2 hours after the last dose , and the drops will be re - used the next day , if your cataract surgery is planned . method of administration yellowx is for oral use . it is for use in adults only . you should wash your hands after using the eye drops . remove the bottle cap . hold the bottle tightly closed . press the bottle down and hold the cap on the bottle . make sure that your thumb and fingers are not touching the cap , as shown in pictures below . tilt your head back . pull down your lower
what yellox contains - the active substance is bromfenac . each ml of solution contains brom Fenac ( as sodium sesquihydrate ). each syringe contains 33 mg brom Fenac -the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , and tyloxapol . - povidone ( k30 ), disodium edetate and sodium hydroxide to maintain acidity levels . what Yellox looks like and contents of the pack yyelloux is a clear yellow liquid ( solution ) supplied in a 5 mL glass vial with a screw cap .
dzuveo contains the active substance sufentanil . it belongs to a group of strong painkillers called opioids . sufenteanil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo - if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). - have a serious lung or breathing problem . warnings and precautions talk to your doctor or pharmacist before taking dzveo and during treatment if : you have any condition that affects your breathing ( such as asthma , wheezing or shortness of breath ), as dZveo may affect your breathing . you need to stop treatment and your doctor may decide to interrupt treatment , or may have to stop . your doctor might decide to temporarily or permanently stop dzoneo if any of these apply to you . if your doctor determines that you have , during or after treatment : - you have had a head injury or brain tumour . talk to a doctor or nurse before taking this medicine
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the single - dose administration device should be connected to the internet connection . this medicine should not be used in combination with any other strong painkillers such as sufentanil . how much to take the recommended dose is 30 mg . to take one sublingual tablet , use the disposable single  dose applicator . if the applicators is not connected to dzuveo , it should be taken under the tongue only . after use , the tablets dissolve under the skin and the tablets dissolve under the lingual tongue . you can take the tablet at any time of the day or with or without pain relief . your tongue should be opened and dragged back to the tablet . for 10 minutes after you have taken the tablet you should
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need medical attention : - severe breathing problems , such as slow and shallow breathing . if any of these side effects occur , contact your doctor immediately . very common side effects ( may affect more than 1 in 10 people ): nausea ( feeling sick ), vomiting ( being sick ) and feeling hot . common side effect ( may effect up to 1 in10 people ), inability or difficulty sleeping . not known ( frequency cannot be estimated from the available data ) - inability to sleep - feeling tired - being sick ( vomiting ), being sick and feeling warm . uncommon side effects may affect up to1 in 10 persons : inability and difficulty sleeping ( insomnia ), feeling weak or generally unwell . reporting
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . light and oxygen should be injected in the product . store in the original package in order to protect from light and moisture . keep this medicinal product out of sight and light . it does not need any special temperature storage conditions or if there are any visible signs of deterioration . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg of sufenil ( as citrate ). - other ingredients are mannitol ( e421 ), dicalcium phosphate , hypromellose ( 6000 ), croscarmellose sodium , indigo carmine ( k25 ), and stearic acid ( s ) and magnesium steerate . what  Dzuvee looks like and contents of the pack dzzuvea is a white to off - white tablet with round edges and marked " 3 " on one side . dziveo is supplied in a single - dose applicator ( labelled [ sublingual tablet ]). the applicators contains one sufenteanil 30 mg tablet in 5 ml or
erleada is a cancer medicine that contains the active substance apalutamide . it is used to treat adult men with prostate cancer that has spread to other parts of the body or cannot be removed by surgical treatments . sensitive prostate cancer has spread within the body and cannot be eliminated by surgical treatment . the active ingredient in erleda is testosterone - resistant prostate cancer . er leada blocks the activity of androgens in the prostate , allowing the body to produce its own protection against androgènes . apalutaMIDe stops prostate cancer cells from growing and multiplying .
do not take erleada if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking erleda . if any of these apply to you ( or you are not sure ), talk to your doctor . warnings and precautions talk to you doctor , pharmacist or nurse before taking this medicine . you should tell your healthcare professional if : you are pregnant or think you may be pregnant ( see pregnancy , breast - feeding and contraception section ). you are breast – feeding . do not breast  - feed while taking this medicinal . this medicine is not recommended during treatment with this medicine and you are at high risk of having seizures . your doctor will tell you if and when you may need to take any medicines to prevent blood clots ( e 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg twice a day for up to 60 days . your doctor will tell you the dose to take . take erleada every day for as long as your body needs it . this medicine is taken by mouth . swallow the tablet whole . if necessary , your doctor may tell you to take it with or without food . do not chew or crush the tablet . you can take eleade with or just before food , or with other medicines . how long to take take ERleaaa for as short as your health is improving . continue taking erleda for however long as you need to . it is important that you continue taking it for as many days as your doctors tell you , if possible , to
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and tell your doctor immediately if you experience any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , with central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may also be preceded by fever and flu - similar symptoms ( toxic epidermal necrolysis ). serious side effects may occur if taken with erleda . contact your doctor or seek medical attention immediately . the following side effects can be serious : fit - related seizure ( uncommon ) ( may affect up to 1 in 100 people ) take er leada and may cause a serious allergic reaction
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apalutaMIDe - -the other ingredients are colloidal anhydrous silica , croscarmellose sodium , and hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose and silicified microcrystalline cellulose . the film , which contains iron oxide black ( e172 ), iron oxide yellow ( i ) and macrogol ( 6000 ), polyvinyl alcohol , the talc ,and titanium dioxide ( a171 ). what erin looks like and contents of the pack erleda film  tablet - coating : the tablets are slightly yellowish , film – coated tablets of 8 . 7 mm diameter and are scored .
axumin is a radiopharmaceutical product for diagnostic use only . aexumin contains the active ingredient fluciclovine . it is used to help your doctor to get a picture of the cancer during a pet scan . this is to be used if you have previously had treatment for prostate cancer . other tests have shown that the presence of prostate specific antigen ( psa ) in the blood is too strong to be sensitive to pd . your doctor will take an aXumin pet scan to make sure that the cancer is still there . the scan will be repeated at regular intervals . you will receive a single dose of adxumIN to help you decide if the radiopharmaceutician has agreed to spend some time during the use of this procedure with the radiotechnical staff who are trained in the use and handling of radioactivity
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using aexumin and before using it : - patients with kidney problems - people on a low sodium diet should not take a lot of tablets of aXumin to get the best results from their tests . - you should not be given a day to prepare the axxumin scan . it is recommended that at least 4 hours before the scan is performed . you should take your usual medicines at the same time every day for the last 60 minutes after the xumi injection . do not lie down until after urination . the scan should be taken by adults and adolescents under 18 years old . other medicines and azumin tell your
you will not have to store or give radiopharmaceutical products containing axumin . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceutic products will be in accordance with national regulation on radioactivity . the nuclear medicine doctor supervising the procedure will decide on the quantity of aexumin to be used in your case . it will be the smallest quantity necessary to obtain the desired information ( megabecquerel , the unit in which radioactivity is given ). administration of - a transcript of the procedure auxumin is given by injection into a vein ( intravenously ) followed by a flush of sodium chloride solution . duration of the administration of the product you will normally receive the procedure the nuclear doctor will inform you about the usual duration of this procedure . - the scan should be repeated every 5 days after
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies and post - marketing experience , side effects were uncommon ( may affect up to 1 in 100 people ). the medicine was discontinued without cause . side effects of axumin were uncommon  ( may effect up to1 in 100 users ). pain , rash , altered taste in the mouth , and altered sense of smell . this radiopharmaceutical will deliver low amounts of ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects you can help provide more information on the safety of this medicine .
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : axumin will be stored in the healthcare facility where it is used .
what axumin contains - the active substance is fluciclovine . a xum in 1600 mg tablets each tablet contains 1600 mg of flucclovine ( 1600 mg / 16000 ml ). aixumin 3200 mg tablets every tablet contains 3200 micrograms of froluciclovin ( 3200 / 32000 mbq ). the other ingredients are sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 " aXumin has been prepared for you "). - aexumin 1600 mg tablet ( multidose ) is available in packs of 1 , 10 , 1600 / 160000 iu tablets or in multidose packs of 3200 in multi dose packs of 2 , 5 , 6 , 8 , 12 , and 30 , respectively . not all pack sizes
azopt contains the active substance brinzolamide , which belongs to a group of medicines called carbonic anhydrase inhibitors which reduce pressure within the eye . aziopt eye drops are used to control high pressure in the eye in adults who have an illness called glaucoma . when the pressure in your eye is too high , it can damage your sight .
do not take azopt if you have severe kidney problems . if your doctor thinks you may be allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor or pharmacist before taking azyopt : if - you are allergic to medicines called sulphonamides ( also called " slophonamide " medicines used to treat diabetes , infections , diuretics ( water tablets )) or to any of these . take special care with azeopt , if the same allergy applies to a certain type of medicine , as there may be too much acidity in your blood ( hyperchloraemic acidosis ) after taking , or after taking the tablets . talk to : before taking the
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . azopt should only be used in the eyes . 1 ) a clear glass bottle with a lid on it will not stop you from using azyopt . use in children and adolescents a day at the same time each day . it is best to use the bottle at the time of opening the bottle . do not use it in children . the recommended dose is 1 glass bottle a night . wash your hands . twist off the bottle cap . pull off the cap , and then snap collar , as shown in picture 1 ). hold the bottle and pull down the bottle with your thumb and finger . tilt your head back . gently pull down your eyelid with  a clean finger if it is a little tinnit
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , ear pain , and eye discharge , itchy eye , dry eye - abnormal eye sensation , redness of the eye ( side effects not known ) bad taste uncommon side effects may affectup to 1in 100 people - effect on the eye seeing flashes of light , bad taste . uncommon side effect ( may effect up to1 in 100 people)  effects in your eye  blurred or clouded vision  eye irritation ( eye irritation and eye pain ) reporting of side effects 23 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects NOT
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle label and the carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from moisture . once opened a pack containing a single bottle should be used immediately .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brinzolam . -the other ingredients are benzalkonium chloride , carbomer 974p , edetate disodium , and mannitol . the ingredients are purified water , sodium chloride ( e339 ), tyloxapol , hydrochloric acid and sodium hydroxide to keep acidity levels ( ph levels ) normal . what - azyopt looks like and contents of the pack azamopt is a milky liquid ( a suspension ) supplied in a 5 mml plastic ( droptainer ) bottle with a screw cap . it is available in : a pack of one bottle containing one 10 mlitre plastic ( dropstainer
forxiga contains the active substance dapagliflozin . it belongs to a group of medicines called " oral anti - diabetics ". it is taken by mouth to treat diabetes . the insulin is made by your body . forxxiga is used in adults aged 18 years and older . you have diabetes ( type 1 diabetes ) when your body does not make any insulin . your doctor has prescribed forxega for you because you have type 1 diabetic , overweight or obese . type 2 diabetes when your bodies do not make enough insulin or the insulin that your body makes does not work as well as it should . this leads to lowered levels of sugar in your blood . as a result , your body is unable to use the insulin it produces properly . how forxaga works forxi helps control the level of sugar ( glucose ) in your body and reduces the amount of
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking forxega : - when you start taking forixiga : feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , or a bitter or metallic taste in your mouth , an odour to your urine or sweat , rapid weight loss . if any of these apply to you , talk to a doctor or go to  a hospital straight away . you may experience " diabetic ketoacidosis " a rare but serious , sometimes life - long problem you can get with diabetes because of increased levels of " 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . for type 2 diabetes the usual dose is 10 mg twice a day ( taken once a night ). your doctor may prescribe you a lower dose of 5 mg twice daily if needed . if your liver problem is not controlled well enough , your doctor can start you on a different dose . your doctor will prescribe the right dose for you , depending on your condition . the recommended dose is 5 mg once - daily . how much to take adults with type 1 diabetes the recommended starting dose is five tablets once  a morning . taking this medicine swallow the tablets whole with water . you can take forxiga with or without food . it is important that you continue to take forixiga until your doctor tells you otherwise . this will help your blood to work
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are angioedema ( very rare : may affect up to 1 in 10 , 000 people ). signs of angioedia include swelling of the face , tongue or throat , difficulties swallowing , hives and breathing problems . diabetic ketoacidosis ( very common : in type 1 diabetes , may affect more than 1 in every 10 people ) and type 2 diabetes ( rare ): may effect up to1 in every 1 ,000 people . these are the signs of diabetic kidneyoacodiasis ( rare in cases of increased levels of " ketone bodies " in your urine ). these may be symptoms of a lowering of the levels of phosphate in your blood . your doctor will test for these changes . if you have any
what forxiga contains - the active substance is dapagliflozin . each forxega 5 mg film - coated tablet ( tablet ) contains dapaglliflonzin propanediol monohydrate equivalent to 5 mg dapaglovozin ( e339 ). - other ingredients are : tablet core : microcrystalline cellulose ( a complication of cellulose , lactose ( see section 2 under ' forxigan contains lactoses '), crospovidone ( type a tablet ), silicon dioxide ( ph - 803 ), magnesium stearate ( rdna ). film : polyvinyl alcohol ( 0 . 25 %), titanium dioxide ( 3 %)), macrogol 3350 ( talc ( t - 40c ), yellow iron oxide ( nvr
mepact contains the active substance mifamurtide which blocks the growth of certain bacteria which are part of the immune system . mepacting is used to treat osteosarcoma ( bone cancer ) in adults between 2 and 30 years after surgery to remove the tumour . it is used in combination with chemotherapy to kill cancer cells and prevent cancer from coming back .
do not use mepact - if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). - when you are taking medicines containing ciclosporin and other calcineurin inhibitors ( non - semen - related nsaids ). this may increase the risk of your heart or blood vessels forming blood clots ( thrombosis ) and bleeding ( haemorrhage ). warnings and precautions talk to your doctor before using mepacting : - in some cases you may experience inflammation of the veins ( vasculitis ). mepacted treatment may cause long - lasting or worsening symptoms . your doctor will monitor you closely during mepactation . - during asthma or other breathing disorders if your asthma is not well controlled by mepactic treatment 
treatment mepact will be given to you by a doctor or nurse who is experienced in the use of this medicine . they will check with you and will give you more information about the doses you will receive . the recommended dose of mepacting is 2 mg mifamurtide once a day for up to 12 weeks . you will then be given up to 24 weeks without mepactation treatments . your chemotherapy schedule will be carefully followed by your chemotherapy . duration of treatment 36 treatment with mepacted mepacat may be delayed if an interruption occurs in the freeze - dried powder is changed into a liquid suspension before it is given to your doctor . if the filter is broken , mepace is injected into , and the solution is clear , colourless and clear . it will be infused into  a vein over a period of approximately 1 hour . mepacter may
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue may occur when taking mepacat ( especially when transient ). you should be given paracetamol to reduce fever during treatment with mepacting . you may experience stomach problems such as nausea , vomiting or loss of appetite during chemotherapy . tell your doctor immediately if you experience continuing fever or chills during or after 8 hours whilst taking me Pact . this is because you may develop an infection . rash , if any problems breathing or wheezing occur , stop taking mepakt and tell your physician immediately . these effects are usually mild to moderate and go away within a few days of starting treatment with mypact , but can be serious . other possible side effects may include : very common ( may affect more than 1 in 10 people ): di
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in outer carton in order to protect from light . reconstituted suspension : sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection may be stored for up to 6 hours at room temperature ( 20 ). this medicine must not be used if it shows signs of deterioration . any unused product must be thrown away in accordance with local requirements .
what mepact contains - the active substance is mifamurtide . each vial contains 4 mg of mfamurdide - each ml of concentrate for solution for infusion contains 0 . 08 mg of the active ingredient mIFamurmurte - - this medicine is a concentrate for solutions for ingestion . -- the other ingredients are 1 - palmitoyl - 2 - leoyd - sh - grazo - 3 - polycholine ( ph - 1 ) and 2 , dioleoyn - sin , glycero - 3- phospho- l , serum monosodium salt ( ppm ) ( see section 2 ). what me Pact looks like and contents of the pack mepace is essentially a
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it is used to treat redness in the face caused by rosacea , which is also caused by redness of the face . rosa is a condition where patients have high levels of blood flow in the facial skin and enlargement ( dilation ) of the small blood vessels of the skin . mirvase acts by reducing the size of the blood vessels and thus reduces the excess blood flow which causes redness .
do not take mirvaso - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor or pharmacist before taking mirvass . - children and adolescents do not give this medicine to children under 2 years because it can cause side effects . the medicine is injected under the skin . it must not be used in children or adolescents . this is because mirvasa is used in combination with certain medicines for depression and parkinson ' s disease . these include monoamine oxidase ( mao ) inhibitors ( such as selegiline and moclobemide ), tricyclic antidepressants ( imipramine ), tetracyclic antagonistidepressants such as maprotiline , mianserin and mirtazapin . you must not take these
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to use mirvaso is for use on the skin and on the face . your doctor will tell you how much mirvasa you should use . this medicine is for oral use , but your doctor may tell you to use it for any other use if it is not absorbed by your body or into other body surfaces , such as your eyes , mouth , nose or vagina . if your doctor thinks that you should apply mirvass to you , tell your doctor . you should only apply mirvao on your face if the treatment is working . it may be used for up to one month . the treatment will be started by a small amount of gel ( a pea - sized amount ) per day . depending on your symptoms , your
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects are severe skin irritation or inflammation , skin rash , rash with skin pain or discomfort , dry skin , warm skin sensation , and tingling , sensation of pins and needles or swelling . common side effects include worsening of rosacea and may require treatment . symptoms may occur for up to 2 months after you have stopped taking mirvaso . contact allergy ( allergic reaction ) and rash ( rare angioedema , which is a serious allergic reaction to mirvasO ). if you experience a combination of rash and / or rash all over your body , contact your doctor immediately . if this happens , you should contact your physician immediately , as you may need medical attention . allergic reaction with rash is very common in patients
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the tube and pump after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted solution : chemical and physical in - use stability has been demonstrated for 30 days at room temperature .
what mirvaso contains - the active substance is brimonidine . each ml of gel contains 3 . 3 mg of brimoniidine , followed by 5 mg of the active ingredient , brionidine tartrate . - each carbomer contains methylparahydroxybenzoate , and phenoxyethanol , in the solvent . the other ingredients are glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 " mirvass contains methanol and propylahydroxide "). what mirvao looks like and contents of the pack mirvasa is a clear , colourless gel . it is supplied in 2 mL , 10 m3 or 30 m2 of gel in airless pump system . not all pack sizes may be
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that is normally made by the immune system to help defend the body from infection and cancer ). bevacimizumabe binds selectively to a protein called human vascular endothelial growth factor ( vegf ), which is found on the lining of blood and lymph vessels in the body . the veggf protein causes blood vessels to grow within tumours , providing them with nutrients and oxygen . bevacuzumaber causes tumour growth , and the blood vessels provide the nutrients and nutrients needed for growth . mvai is marketed as a medicine for the treatment of adult patients with advanced cancer in the large bowel . it is usually found in the colon or intestine .
do not use this medicine - if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ) - are allergic( hypersensitive) to chinese hamster ovary ( cho ) cell products - or if pregnant . warnings and precautions talk to your doctor or pharmacist before using mvasi . mvai may increase the risk of developing holes in the gut wall . this may increase your risk of inflammation inside the abdomen ( e .g . diverticulitis , stomach ulcers , colitis ) or chemotherapy . talk to you doctor or nurse before using the medicine if any of these apply to you . you may be at increased risk of having an abnormal connection or passageway between two organs or vessels . the risk for developing connections between the vagina and
dose and frequency of administration the dose of mvasi you receive is based on your body weight and the kind of cancer to be treated . the recommended dose is 5 mg , 7 . 5 mg, 10 mg or 15 mg per kilogram of your bodyweight . your doctor will calculate your dose for you . if you are given more mvai than you should if more nma is administered , you may be given mwasi over 2 or 3 weeks . infusions may be delayed or stopped if treatment is interrupted . you should continue to receive this medicine until mvici stops your tumour growing . frequency of infusion mvisi will be given to you by a healthcare professional . it is important that you keep using mbusi every day until your tumour is growing , and for how long you need to keep using it . route of administration m Vasi
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects listed below have been reported . some of the side effect effects were seen when mvasi was given in combination with chemotherapy . these side effects were mostly seen while patients were being given mvai . allergic reactions if you have an allergic reaction , tell your doctor or nurse straight away . this may include difficulty in breathing , chest pain , redness or flushing of the skin or a rash . chills or shivering , feeling sick ( nausea ) or being sick ( vomiting ). if any of these occur , stop taking m Vasi and tell your physician straight away as soon as possible . severe side effects may include : very common : may affect more than 1 in 10 people : diarrhoea , being sick , stomach pain
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the viall in the outer carton in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 8 and / or a sterile environment . when dilsution has taken place in  a stable environment , mvasi may be stored for up to 35 hours at room temperature ( 2 - 8 ) for upto 48 hours below 30 . inspect the vially and the via
what mvasi contains - the active substance is bevacizumab . each ml of concentrate contains 25 mg of bevacibizumabe , corresponding to 1 . 4 to 16 . 5 mg / mL when diluted as recommended . - each 4 mlitre vial contains 100 mg of Bevacizub , equivalent to 1: 4 mg . this means that each 16 mliter vial provides 400 mg of BEvacibub corresponding  to 16. 5 mmol / min . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what vvasi looks like and contents of the pack mvai is a concentrate for solution for infusion . it is essentially a clear to slightly opalescent , colourless to
tecartus is a type of medicine called a gene therapy medicine . it is used to treat mantle cell lymphoma that has not responded to other medicines . refractory mantled cell lymphhoma is essentially a condition where your own white blood cells ( called autologous anti - cd19 - transduced ccd3 + cells ) do not grow or divide . mantles cell lymphma is also a cancer that affects the immune system called b - lymphocytes . in mantlet cell lymphome , b- lymph cells start growing out of control and become active again , making an uncontrolled way to grow , including into the lymph tissue and bone marrow , where they accumulate . this leads to blood from the white blood cell in your blood . the cancer cells then enter your body and collect in
do not use tecartus if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ) if : you are not allergic to any of these ingredients or any other ingredients in the medicine ( see section " tecARTus contains white blood cells " in your blood ( lymphodepleting chemotherapy ). warnings and precautions talk to your doctor or nurse before using tecArtus ( see also section 3 , " Tecartus contains a small number of white blood cell ( autologous use ") tests and checks your doctor will do before and during treatment if these are performed . your doctor may perform tests and check your lungs , heart , kidney and blood pressure . if this happens , your doctor might monitor you more closely . you may experience signs of infection or inflammation associated with your cancer ( graft - versus - host
tecartus will be given to you by a doctor or nurse who is experienced in the use of this type of medicine . tecarus is made from your own white blood cells . your cells will be collected by recombinant dna technology using a catheter placed in your vein ( a procedure call leukapheresis ). tecARTus is given to your doctor or a nurse to collect your white blood cell from your blood . this will take about 3 to 6 hours . you will be monitored while your whiteblood cells are being collected . the first dose of tecArtus is usually given every 2 to 3 weeks . medicines given before tecarcus treatment , your doctor will give you lymphodepleting chemotherapy to make the modified white blood , which will be removed from your body . it will take between 30 to 60 minutes . other medicines given to reduce
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to your doctor or nurse straight away if your side effects get worse . tell your doctor straight away or go to the casualty department at your nearest hospital if you notice any of the following side effects you may need urgent medical attention . side effects of the tecartus infusion very common ( may affect more than 1 in 10 people ): fever or chills reduced blood pressure with symptoms such as dizziness or lightheadedness and fluid in the lungs . all symptoms may be due to a condition called cytokine release syndrome . loss of consciousness , decreased level of consciousness and confusion , memory loss , and difficulty in thinking , understanding , or understanding . if any of these side effects causes you problems , you should contact your doctor immediately . very common : may affect up to 1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and the carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted and infusion bag : chemical and physical in - use stability of liquid nitrogen has been demonstrated at a concentration of 150 micrograms / ml before use . all of this medicine contains genetically modified human blood cells and human - derived material . these measures will help protect the environment 36 .
what tecartus contains - the active substance is autologous anti - cd19 - transduced cc3 + cells . each patient - specific single infusion bag contains a dispersion of anti  c - 19 - stimulated t cells in a volume of 68 ml , corresponding to 2 x 106 anti . - other ingredients are sodium chloride , human albumin , and water for injections ( see section 2 " tecArtus contains sodium "). what Tecartus looks like and contents of the pack tecARTus is a clear , colourless to pale yellow liquid . it is supplied in an infusion bags packed in  a metal cassette . the contents of a single inffusion bag contain approximately 68 mg of cell dispertion .
januvia contains the active substance sitagliptin which is a member of a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4- inhibitors ) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2 diabetic condition . you should continue to take this medicine as long as it is prescribed for you , and continue to follow the advice on diet and exercise given to you by your doctor . it is used in combination with certain other medicines ( insulin , metformin , sulphonylureas , or glitazones ), which also
do not take januvia - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). - in case of inflammation of the pancreas ( pancreatics ). warnings and precautions talk to your doctor or pharmacist before taking janusuvia ( see section 4 ). you may experience blistering of the skin that looks like " bullous pemphigoid ". januervia is not a cure for a disease of the Pancrea , also known as pancreattitis . you may also have gallstones , alcohol dependence or very high levels of triglycerides ( a form of fat ) in your blood . these medical conditions can increase your chance of getting pancreacis ( see also section 4 for more information ). have type 1 diabetes or diabetic ketoac
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is : one 100 mg film - coated tablet 63 once daily by mouth if your doctor thinks you may have kidney problems , your doctor may prescribe lower doses ( such as 25 mg or 50 mg ). you can take this tablet with or without food and drink . your doctor will tell you how many tablets to take . you can also take certain other medicines that lower blood sugar . diet and exercise can help your body use its blood sugar better . if it takes longer than it should if taken with januvia , or if someone else takes your medicine , talk to a doctor immediately . take the tablet if a child swallows the tablet whole . do not chew or crush the tablet before swallowing . it is important that you continue taking
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact your doctor immediately if you notice any of the following serious side effects you may need medical attention : severe and persistent pain in the abdomen ( stomach area ) which might reach through to your back with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatictitis ). a serious allergic reaction ( frequency not known ) may be followed by rash , hives , blisters on the skin / peeling skin , swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing . if any of these side effects causes you problems , or if they get worse , stop taking this medicine and contact a doctor or the nearest hospital straight away . the doctor
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglitin phosphate monohydrate equivalent to 25 mg sitaglin - -the other ingredients are microcrystalline cellulose ( e460 ), calcium hydrogen phosphat e551 , croscarmellose sodium , magnesium stearate and sodium stearyl fumarate . the tablet film – coating contains poly ( vinyl alcohol ), macrogol 3350 , and talc ( containing titanium dioxide ), red iron oxide ( i ) and yellow iron oxide . what a janusuvia looks like and contents of the pack janugavia is a pale yellow to pink film . it is available in opaque blisters ( pvc / pctfe / al - foil ).
what xultophy is xULtophy lowers blood glucose ( glucose ) in adults with type 2 diabetes mellitus . this is a type of diabetes that occurs when your body does not make enough insulin to control the level of blood sugar . insulin degludec is  a long - acting basal insulin . it helps your body to increase your blood sugar levels . xulation is based on two different hormones called liraglutide and glp - 1 , which are used to help you to stay on the diet and exercise plan . you should continue to follow the diet recommended by your doctor while taking xcultophy . oral medicines for diabetes xuriletophy can be used either alone or in combination with oral medicines to treat diabetes ( such as metformin , i . excipients or insulin ) or with certain other
do not take xultophy - if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). - 39 - you are taking a sulfonylurea such as glimepiride or glibenclamide . your doctor may need to adjust your sulphfonilurean dose , depending on your blood sugar levels . warnings and precautions talk to your doctor before taking xULtophy and if any of these apply to you : - have type 1 diabetes mellitus or ' ketoacidosis ' ( a condition that occurs when the medicine is taken together with food ). this is because xulation may cause inflammatory bowel disease , which can lead to delayed gastric emptying ( diabetic gastropar
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . if a person is blind or has poor eyesight and cannot read the dose counter on the pen , you should check your blood sugar level . the recommended dose of xultophy is 41 g / ml before you use xULTOphy . you should take xlophy at least 8 hours before or after you use it . your doctor will tell you how many tablets of XultoPhy to use . how to use the pen read the user ' s manual for instructions on how to do this . read the " instructions for use " provided in the pen before you first use a pen . do not use the dose indicator provided in a pre - filled dial - a - dose pen containing 1 
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are low blood sugar ( very common : may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out ( become unconscious ). serious hypoglycaemia may cause brain damage and may be life - threatening . if you have low blood glucose , take action to increase your blood glucose level . low blood sucre is a very common side effect of hypogliese , see section " warnings and precautions " below . in some cases , it may be serious and may lead to brain damage . for more information , please see " warning and precautionary measures " in this section . serious allergic reaction ( anaphylactic reaction ) has been reported ( frequency not known ) in patients who have had a serious allergic response . it is
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . you may remove xultophy from the refrigerator and store it at room temperature ( not above 30 ) for up to 8 weeks before storing it at 2 - 8 and for 21 days after removing from the fridge . this 21 - day period must be noted on the label .
what xultophy contains - the active substances are insulin degludec and liraglutide . each ml contains 100 units insulin deGludec , equivalent to 3 . 6 mg lilraglutid . one vial of 3 mL contains 300 units insulin desgludeck , corresponding to 10 . 8 mg / mmol l l. -the other ingredients are glycerol , pregelatinised ( maize ), phenol , zinc acetate , hydrochloric acid and sodium hydroxide ( for ph adjustment ) and water for injections ( see section 2 " xULTOphy contains sodium "). pack sizes of 1 , 3 and 5 vials , or a multipack containing 10 ( 3x10 ) vial ( s ) pre -
giotrif is a medicine containing the active substance afatinib , which blocks the activity of egfr [ epidermal growth factor receptor 2 [ erbb1 ] and her2 [ ERbb2 ]). these proteins help to control cell growth and division . by blocking their action , giotrics can kill cancer cells . this medicine can kill some types of cancer cells and kill them . gio trif is used to treat cancer of the lung ( non - small cell lung cancer ). gioTRIf is intended as your first treatment for patients who have received prior chemotherapy treatment for a certain type of squamous type if you have received previous chemotherapy treatment .
do not take giotrif - if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) - for low body weight less than 50 kg - have kidney problems - talk to your doctor if any of these side effects get serious . - lung inflammation ( interstitial lung disease ) warnings and precautions talk to you doctor or pharmacist before taking gioTRIf if : - you have liver problems . your doctor may need to do some liver tests before and during treatment with this medicine , if your doctor determines that you have a severe liver disease . eye problems : severe dry eyes , inflammation of the transparent layer at the back of the eye ( cornea ) or ulcers in the front of the front part of the lens ( ocular tear ). gio trif may cause allergic reactions ( see section
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 40 mg twice a day . you should take this medication at least one hour before or two hours after the last meal . if necessary , your doctor may reduce your dose to one tablet twice . this medicine can be taken with or without food . swallow the tablet whole . do not chew or crush the tablet . your doctor will tell you how many tablets to take . how long to take this medicinal product take this tablet at least 1 hour before a meal , and for 3 hours after a main meal ; this will help you remember to take the tablet as soon as you remember . always take the tablets with food , preferably at the same time each day , so there is always enough medicine in your body . try to take it at
like all medicines , giotrif can cause side effects , although not everybody gets them . side effects related to treatment include diarrhoea ( very common : may affect more than 1 in 10 people ): diarhooeea may occur in up to 2 out of 10 people ( severe diarrehoaea with fluid loss ) ( common - may affect up to 1 in10 people ). low blood potassium , worsening kidney function ( common in patients with diarshoemia ). if you get diararrhea , contact your doctor immediately . your doctor may decide to start appropriate antidiarrhofeal treatment and to start antidiarrhaeal medicine prior to starting giotricf . if any of these side effects occur , they should be treated promptly . very common ( may affect
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of a fatinir . - other ingredients are lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate , all in the tablet core ; hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 ( a ) what giu looks like and contents of the pack giotricf 20 mg film  coated tablets are packed in blisters and in plastic bottles . they are available in packs containing 1 , 2 or 4 film – coated tablets in blister sachets and each blister contains 7 x 1 film ­ coated tablet in an aluminium pouch . not all
orkambi contains two active substances called lumacaftor and ivacafting . it is a medicine used for long - term treatment of cystic fibrosis ( cf ) in adults and children from the age of 6 years with a f508del mutation in the cystic fibrine conductance regulator ( kftr ), which is responsible for the transmission of fluid from the lungs to the cistern . the mutation in ccf is thought to be related to an abnormal c Ftr protein . lumcafor and the ivaftorul work together by blocking the abnormal fftre protein , lum acaffetor , and iii . by blocking this change , ork Ambi causes the abnormal cr protein to work more normally , your breathing and your lung function will
do not take orkambi if you are allergic to lumacaftor , ivacaftar or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ork Ambi . orkami must not be used if the f508del mutation in the gene is present in the ecg gene . if this is the case , orkam may not be suitable for you . talk to a doctor or nurse before taking the medicine if : you have liver or kidney disease . your doctor may need to adjust the dose of orkacco if necessary . you have abnormal blood tests of the liver . tell your doctor before taking any of these symptoms . signs of liver problems such as pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin and the whites
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . adults and children 6 to 12 years of age the recommended dose of orkambi tablet is one tablet once a day in the morning and one tablet in the evening . use in children and adolescents the recommended dosage is one ork Ambi tablet 6 to 11 years of aged or older . orkami 100 mg tablets : take the tablet at least 2 hours before or 2 hours after your meal . children and teenagers 12 years and older the recommended starting dose of the orkacco is one 200 mg tablet in each morning and 2 tablets in the afternoon . your doctor may decide to increase your dose to 200 mg in each day . take the tablets at least 1 hour before or at least 12 hours after the meal , preferably in the early morning and evening , at about the same time each day
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects seen with orkambi in combination with ivacaftor are similar to those seen with other medicines . however , some patients may experience more serious side effects when taking ork Ambi . you should see your doctor immediately if you experience any of the following symptoms : - raised levels of liver enzymes in the blood , which may increase the risk of liver injury - pre - existing severe liver disease - the worsening of liver function uncommon side effects ( may affect up to 1 in 100 people ): if any of these effects occur , tell your doctor as soon as possible : pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the whites of your eyes loss of appetite - feeling sick ( nausea ) or vomiting - if your stomach is
what orkambi contains the active substances are lumacaftor and ivacaftar . ork Ambi 100 mg / 125 mg : each tablet contains 100 mg of lumcaftors and 125 micrograms of iva caftr . - orkam 200 mg - each tablet delivers 125 milligrams ( 200 millilitres ) of lombacaffetor / 25 microgram ivakaftoral . the other ingredients are : orkamba 100 mg or 125 multipacks : - the other ingredient is : tablet core : peach , cellulose , microcrystalline , and croscarmellose sodium , as well as hypromellose acetate suspension . tablet coating : bevelled edge tablet : carnauba wax . what orkaftar
what lynparza is lyinparza contains the active substance olaparib . olarib is a type of cancer medicine called a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ]). it works by stopping mutations ( changes ) in the gene that produce parp ( brca ) ( breast cancer gene ). if you have cancer that is not being treated with parp inhibitions , the death of cancer cells may occur . it works in a similar way to the normal function of an enzyme that helps to repair dna . what LYnparaza is used for lylparza can be used to treat : ovarian cancer ( brc ) that is caused by a mutation ( changes or mutations ) of a protein called ' o
do not take lynparza - if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ) or to any of those other ingredients ( listed under section 2 ). - take special care with lyinparza see your doctor . warnings and precautions talk to your doctor or pharmacist before taking lyngparza and during treatment with LYnparaza . low blood cell counts may be seen in testing . these are low counts of red or white blood cells , and low platelet counts . see section 4 , possible side effects . if these side effects become severe , contact your doctor immediately . do not use 75 if the signs and symptoms include fever , infection , bruising or bleeding . more serious problems with the bone marrow called ' myelodysplastic syndrome ' can occur in
always take lynparza capsules exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of lylnparaza is 100 mg once a day . your doctor may increase your dose to 150 mg once daily . the doses of LYnparzan capsules should be divided into equal doses . do not divide , crush or chew the capsules , as these may affect the way the medicine works . if your doctor prescribes a capsule , it is important that you take it at least one hour before or two hours after a meal . swallow the capsule whole with water . it is best to take a dose of one tablet each day , preferably at the same time each day and not at the exact time of day ; this will help you to remember to take it . for
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ): feeling short of breath , feeling very tired , having pale skin , fast heart beat ( symptoms of a decrease in the number of red blood cells ( anaemia )). uncommon ( may effect up to1 in 100 people ), allergic reactions ( hives , difficulty breathing or swallowing , dizziness ) ( signs and symptoms of hypersensitivity reactions ). other side effects include : common ( might affect upto 1 in 100 users ) : allergic reactions including hive , difficult breathing or taking lynparza , and dizzily . these may be signs andsymptômes of hypersensitive reactions . other side effect include - headache , - ringing in the ears , ears yipping , wh
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . any lynparza capsules that are damaged or show signs of tampering are to be discarded . lyinparza can be stored at room temperature ( up to 30 ) for up to 3 months . throw away any capsules which are damaged . discard the capsules as instructed by your pharmacist .
what lynparza contains - the active substance is olaparib . each capsule contains 50 mg of olarib - each capsule also contains lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( oblong ). what LYnparaza looks like and contents of the pack each hard capsule is a white , opaque , hard capsule imprinted with " opadarib 50 mg " and the astrazeneca logo imprinted on one side . lypaza is available in packs containing 112 or 448 hard capsules and in multipacks comprising 112 hard capsule ( 3 packs of 448 ). not all pack sizes may be marketed .
this medicine contains the active substance naloxone . nnalotone is used to treat opioids such as heroin , methadone , fentanyl , alfuzosin , and oxycodone , buprenorphine / morphine in adults . all three active substances in nyxoid work together in a similar way to opioids . they work together by preventing the absorption of opioids into the body . this medicine is used for a nasal spray for the emergency treatment of opioid overdose . opioid overdosing in patients with opioid over dose is uncommon ( it may take up to 14 days for you to breathe again ). if you have an opioid over dosing , you may experience breathing problems and severe sleepiness . you should also inform your doctor as soon as possible if this happens 
do not use nyxoid - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using nnyxxoide . you may need emergency medical care or emergency services if an opioid overdose occurs . the signs and symptoms of an opioid overload may be similar to those of others who have used this nasal spray for 2 to 3 years . if this happens you must use a new nasal spray at the same time each day . do not take this medicine if any of these apply to you . your doctor may want to monitor you more closely if possible . physical dependence may occur with opioids . opioids include heroin , methadone , fentanyl , or oxycodone , buprenor
nyxoid nasal spray should only be used on the skin and not on the eyes . it should be used in adults only . the recommended dose is 1 spray ( 0 . 5 ml ) at the top of the shoulders and below the ears . this will help to protect the breastbone and sternum . if the spray gets into your ear , use a fingernail to help clear the mouth and nose of any blocksages . keep the mouth , nose and nose clean . 1 . when breathing is the chest moving , move your chest and hear breathing sounds , or breath on the cheek . overdose may cause a decrease in your response to touch or sounds . slow uneven breathing may be a sign of overdose . tell your doctor if you have any questions .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : stop taking nyxoid and seek medical help immediately if you experience any of the following acute withdrawal symptoms . these are usually due to the addictive nature of opioid drugs . symptoms include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps shivering or trembling changes in behaviour , violent behaviour . nervousness , anxiety , depression , agitation , mood swings . tell your doctor straight away if any of these affect you . your doctor may want to monitor you more closely , or to stop your treatment . if possible , your doctor will check you for any
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray delivers 1 . 8 micrograms of nnalovone ( as hydrochloride dihydrate ). - - other ingredients are trisodium citrate dihydrate ( e331 ), sodium chloride , hydroch chloric acid ( s ), and sodium hydroxide ( i . e . purified water ). what yxxoide looks like and contents of the pack nanyxoisd is a clear , colourless to yellow solution for injection in a pre - filled nasal spray , in sprinkling action . it is supplied in : a single dose container . the safety and efficacy of syxid are the responsibility of the user and would normally not be longer than
this medicine contains the active substance follitropin alfa which is a gonadotropin ( a type of hormone that plays an important role in human fertility ). fsh is essentially a hormone produced by the body that stimulates the growth and development of the sacs ( focytes ) in the ovaries that play an important part in the production of sperm . it is used to help develop a mature egg cell which can be grown and sex after treatment with a medicine called " clomifene citrate ". it can be used in women undergoing assisted reproductive technology procedures ( procedures that can help you get pregnant ). this medicine is accompanied by a medication called " lautropin alla ". this is usually given in combination with another gonadotropic " ( " luteinising hormone " or " hcg "). it can also be
do not use ovaleap - if you are allergic to follitropin alfa ( fsh ) or flsh inhibitor , or any of the other ingredients of this medicine ( listed in section 6 ) - have a tumour in your hypothalamus or pituitary gland ( both are parts of the brain ). - are a woman : - with large ovaries or sacs of fluids that line both of your oaries ( ovarian cysts ) of unknown origin - without unexplained vaginal bleeding - or have cancer in your ops , womb or breasts - you have any condition that makes normal pregnancy impossible , such as ovary failure or early menopause - and fibroid tumours of the w - but with malformed reproductive organs ,
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . this medicine is given as an injection into the tissue just under the skin ( subcutaneous injection ). women who have irregular periods should use this product for the first 7 days of their menstrual cycle . the medicine should be given every day . your doctor will tell you how much this medicine to give you , and how often . you will be given the medicine in two doses . if your doctor determines that you should inject this medicine , you will receive either a 75 mg or 150 mg injections of this medicine every day for 7 days or for 14 days . women who weigh 37 . 5 kg or more can weigh 75 kg or less . use this medicinal product to treat a total of 225 mg / m2 of hcg ( h
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects in women allergic reactions may include skin rash or raised itchy areas of skin . severe allergic reactions might include weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 these may affect up to 1 in 10 , 000 people . if you have this type of reaction , your ovaleap injection must be stopped immediately . serious side impacts in women lower stomach ache , nausea and vomiting may be the symptoms of ovarian hyper - stimulation . these may be signs of a lower risk . tell your doctor immediately if they occur . you may experience more severe side effects than in men . other side effects include : very common ( may affect more than 1 in 12 people ): - lower levels of potassium in the blood - increased levels of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . you may use this medicinal product for up to 3 months after the first injection , if not used after this period . if you store it at room temperature ( not above 25 ) you must use this product within 3 months of first use . once the cartridge has been opened , the pen can be stored for upto 28 days below 25 and protected from light ( not below 25 ). keep the pen cap on in order for the pen to protect it from light and moisture . always use the ovaleap pen exactly as described on the carton .
what ovaleap contains - the active substance is follitropin alfa . ovaleep 300 iu in 0 . 5 ml solution for injection : each cartridge contains 300 mbq at reference time ( reference time ). each cartridge provides 300 ufa at reference date ( reference date ) and 22 micrograms ( corresponding to 0. 5 microgram ) at reference times . - ovalep 450 ius in 0-. 75 mL solution for infusion : one cartridge contains 450 microgram ( 333 microgram of f .) fl . alf - alf ( reference day ) in a 0 to 05 mil solution ( reference point ). - one cartridge of ovale ap 900 i u / m2 solution for injecting 
voriconazole accord contains the active substance vorikonazole . voricanazole is an antifungal medicine . it works by killing or stopping the growth of the fungi that cause infections . its main effect is in adults and children ( age 2 years and older ) to treat : invasive aspergillosis ( a type of fungal infection due to aspergosporus sp ), candidaemia ( another type of FUNgal infection caused by candida spp ) in non - neutropenic patients ( patients without abnormally low white blood cells count ), serious invasive candida species ss . infections when the florus is resistant to fluconazoles ( another antifungals medicine ), seriously fungal infections caused by scedosporium st . ( fungus ). how vorizonazole works
do not take voriconazole accord - if you are allergic to vorikonazole or any of the other ingredients of this medicine ( listed in section 6 ). - do not use any other medicines , especially herbal medicines . ask your doctor or pharmacist if your doctor has told you that you are taking any of these medicines during voricanazole agreement treatment . warnings and precautions 46 terfenadine ( used for allergy ) astemizole ( used to treat allergy ). do not give cisapride ( used in patients with stomach problems ) pimozide ( for mental illness ) quinidine ( used as for irregular heart beat ) rifampicin ( used on certain types of tuberculosis ) and efavirenz ( used with strong pain relievers ). talk to your doctor before taking vorizon
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will calculate your dose based on your weight and the type of infection you have . the usual dose is 40 mg per kg body weight , for example if your weight is 40 kg per kg of body weight ( for example in children , adolescents and adults ), and for the first 24 hours 400 mg per kilogram of body fat ( for children and adolescents ) for the second 24 hours 200 mg perkg body weight every 12 hours for the third 24 hours or 200 mg every 12 weeks . if this is not possible , your doctor may decide to increase your dose to 300 mg per day depending on your response to mild to moderate cirrhosis . use in children and infants 2 to less than 12 years of age and adolescents and adolescents from the age of 12 to 14 years
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , most are likely to be minor and temporary . however , some may be serious and need medical attention . serious side effects stop taking voriconazole accord and see a doctor immediately rash , jaundice , changes in blood tests of liver function and pancreatitis . other side effects very common ( may affect more than 1 in 10 people ) visual impairment ( change in vision including blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision / night blindness and swinging vision ). common ( might affect up to 1 in 100 people ). visual impairment , including blurring vision . visual color changes , such as abnormal intolerrance to vision of light and
what voriconazole accord contains - the active substance is vorikonazole . each tablet contains 50 mg voricanazole ( as 50 mg film - coated tablets ). each tablet also contains 200 mg vorisconazoles . - vorizonazoleaccord 200 mg film the tablet contains lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate , and hypromellose ( e464 ), titanium dioxide (  e171 ), lactoses monohydrate and triacetin . what voriscanazoles accord looks like and contents of the pack the tablet is white , round , convex , bevelled , biconvex tablets , with a score on one side and a break in the middle . the film
mvabea is a vaccine to protect you against ebola virus disease in the future . it is given to individuals aged 1 year and older who will be vaccinated against : eba virus . mvasbea should be given as a 2 - dose course of vaccinations to protect your child from getting ebara virus diseases caused by the zaire eebolovirus , a type of filovirus that can infect other people . this vaccine will not protect you from getting filo virus , but will not give you ebala virus Disease . your doctor will tell you when to have your next vaccinations . you should not have zabdeno vaccine until at least 8 weeks later . the recommended dose of mvbea vaccine is zabedeno and mavabea vaccination will not prevent you from being in
you should not receive mvabea if any of the points below apply to you or your child . if you have had a severe allergic reaction to any of these substances ( see section 6 . you have ever had : - a serious allergic reaction after receiving an antibiotic called ' gentamicin '. the vaccine may not be suitable for you or you should be vaccinated with mVAbea in case you or any of your child has had , or is suspected to have , a history of a violent allergic reaction , after any other vaccine injection . tell your doctor or nurse if : you have fainted after an injection you have bleeding or bruise easily you currently have a fever or an infection you are taking medicines that affect the immune system such as high - dose corticosteroids ( such as prednisone ) or chemotherapy ( cancer medicines
mvabea is given to you by a doctor or nurse as an injection into a muscle ( intramuscular injection ) in the upper arm or thigh or a blood vessel . your doctor or health care professional will decide on the date of vaccination . if you are given zabdeno vaccine , the second vaccine will be given 8 weeks later . you will receive mvasbea vaccine as the second vaccination , which will be administered at the same vaccination visit . primary vaccination first vaccination with zabbingo red cap vial ( 0 . 5 ml ) second vaccination with the same dose of mVAbea yellow cap viall ( 00 . 25 mmol ) injected 8 weeks after the first vaccination  with zabadeno . booster vaccination with either zabino or zabea may be given at an interval of up to
like all medicines , this vaccine can cause side effects , although not everybody gets them . the most common side effects are usually seen within 7 days of the injection . tell your doctor or nurse straight away if you notice any of the following side effects you may need to have the injection changed : very common ( may affect more than 1 in 10 people ) pain , warmth , or swelling where the injection is given feeling very tired muscle ache joint pain common ( might affect up to 1 in every 10 people people ), feeling sick ( vomiting ) itching where the inject is given uncommon ( may effect up to1 in every 100 people ). redness and skin hardness where the infusion is given generalised itching reporting of side effects by the national reporting system listed in appendix v . by reporting side effects it is very important that you can help provide more information on the safety of this medicine .
what mvabea contains - the active substance is zaire ebolavirus ( inactivated ) 29 - tai forest ebavirus nucleoprotein marburg , containing 0 . 7 ml of solution ( corresponding to 108 ng / mL ). - each vial contains chicken embryo fibroblast cells . - this vaccine contains trace residues from the manufacturing process . these include gentamicin , sodium chloride , trometamol , water for injections , and hydrochloric acid ( for ph adjustment ). what vvabean looks like and contents of the pack mVAbea is a suspension for injection in a single - dose glass vial with a rubber stopper and yellow cap . pack size of 20 vials .
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . bondronate is used to treat adults with breast cancer that has spread to your bones ( called ' bone ' metastases '). it helps to prevent your bones from breaking ( fractures ). it also helps to reduce other bone problems that may need surgery or radiotherapy bondronates can also help to reduce a raised calcium level in your blood due to : a tumour from what is left from your bones . as a result of this , your bones become weaker .
do not take bondronat - if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) - when you have low levels of calcium in your blood . warnings and precautions this medicine can cause a side effect called osteonecrosis of the jaw ( onj ), which is usually caused by bone damage in the jaw . bondronate can cause cancer - related conditions , including onj occurring after stopping treatment . onj can be a painful condition that can be difficult to treat . in order to reduce the risk of developing osteonocross of the mouth , there are some precautions you should take . before starting treatment , tell your doctor if : - you have problems with your mouth or teeth such as poor dental health , gum disease or a planned tooth extraction - or you are not
this medicine is normally given to you by a doctor or nurse with experience in treating cancer . it is given as an infusion into your vein your doctor will do regular blood tests while you are receiving bondronat . this is to check that you are being given the right amount of this medicine . how much you will be given your doctor may decide how much bondronate you will receive depending on your illness . if you have breast cancer that has spread to your bones , the recommended dose is 3 mg per kg of body weight , given every 3 - 4 weeks . you will usually receive an infected in your vein over at least 15 minutes . your doctor might decide to raise calcium level in your blood over at most 1 to 2 hours . however , you may be given a dose of 2 mg per kilogram body weight depending on the severity of your illness and the medicine will be diluted and given to your body by in
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a nurse or a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain and inflammation new pain , weakness or discomfort in your thigh , hip or groin . you may have early signs of a possible unusual fracture of the thong bone . very rare ( might affect up 1 in 10 ,000 people ). you may experience pain or sore in your mouth or jaw . this may be a sign of severe jaw problems ( necrosis ( dead bone tissue ) in the jaw bone ). ear pain . discharge from the ear . these may be signs of an ear infection . bone damage in the  ear has been reported in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . after dilution the infusion solution can be stored for up to 24 hours . store in the original package in order to protect from light .
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial of concentrate is a concentrate for solution for infusion . one vial contains 2 mg i bandronic acids . - other ingredients are sodium monohydrate , sodium chloride , acetic acid , and sodium acetate . water for injections is also available . what bonroraat looks like and contents of the pack bondronate is : a clear , colourless solution for injection or infusion in a glass vial with a bromobutyl rubber stopper .
what zeposia is zeposa belongs to a group of medicines that affect white blood cells ( lymphocytes ). what ezeposia does zeposition is used to treat relapsing remitting multiple sclerosis ( rrms ), a form of active disease that affects the whole body . what stevens - johnson calls multiple - systemic multiple clerosis (mss ) is multiple , a disease that occurs when the body ' s defenses become weak . white blood cell counts can damage the nerves in the brain and spinal cord , and can damage these nerves . this results in symptoms such as numbness and difficulty in walking .
do not take zeposia - if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ) - have a severely weakened immune system - had a heart attack ( angina ), stroke , mini - stroke / transient ischemic attack ( tia ) or severe heart failure within the last 6 months - are a smoker ( i . e . you are elderly ) warnings and precautions talk to your doctor or pharmacist before taking zeposa : - you have irregular or abnormal heartbeats ( arrhythmias ) which has occurred in some patients receiving treatment - or have severe infection ( hepatitis , tuberculosis )- have cancer - suffer from severe liver problems - think you may be pregnant or are breast - feeding
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take your doctor will tell you how many capsules of zeposia to take each day . this will depend on your heart rate . you will be given a ' treatment initiation pack ' with instructions on how to take it . the recommended dose is : for adults , the first capsule is 1 capsule ( 4 g ) of 0 . 23 mg of ozanimod . for children , adolescents and adults : the recommended starting dose is 4 capsules ( 4 weeks ) once a day , starting at the start of treatment , and then gradually increase the dose to 3 capsules , containing 0. 46 mg of the oznimod per day ; this will be increased every 5 weeks
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects very common ( may affect more than 1 in 10 people ) slow heart rate , urinary tract infection ( blood pressure ). uncommon ( may effect up to 1 in 100 people ). allergic reaction . the signs may include a rash . other side effects include : very common : may affect up to1 in 10 , infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ) or voice box ( larynge ) viruses . a type of white blood cell called lymphocytes common - may affects up to one in 10 persons . not known : frequency cannot be estimated from the available data . reporting of side effects by the national reporting system listed in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special temperature storage conditions . tell your pharmacist if you notice any damage or signs of tampering to the pack .
what zeposia contains - the active substance is ozanimod . zeposa 0 . 23 mg capsule contains 0 ( 0. 23 milligrams of ozonimod ( as hydrochloride ). zepositiona 00 . 46 mg capsule includes 0
what temybric ellipta is tem and three other medicines called fluticasone furoate , umeclidinium bromide and vilanterol . fluticasesone furonate belongs to a group of medicines called corticosteroids ( steroids ). umeklidinium brochure and bilanterol belong to  a class of medicines known as bronchodilators . what mybrick ellippa is used for temibric flatta are used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties that slowly get worse . in copd the muscles that help in breathing ease and improve .
do not use temybric ellipta - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using temibric
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . use temybric ellipta regularly it is very important that you use TEMybrin ellippa every day , as instructed by your doctor to do so . this will help to keep you free of symptoms throughout the day and night . tembric is also used to relieve a sudden attack of breathlessness or wheezing . in order to relieve this attack you must use a quick - acting reliever inhaler ( such as salbutamol ). how
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse straight after using this medicine , stop using it and contact your doctor immediately . pneumonia ( infection of the lung ) in copd patients ( common side effect ) tell your doctor straight away if you get symptoms of a lung infection such as fever or chills increased mucus production , change in mucuses colour increased cough , increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) sore throat , cough . common sideeffects ( may effect up to1 in 10 in 100 people ). cough : - rash , itching , hives , redness of the skin , loss of appetite , weight loss , muscle pain , pain in the joints , back pain - muscle pain
what temybric ellipta contains the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 92 micrograms of fluticasesone furonate ; one inhaler provides 65 microgram ( the equivalent of umecidinium brmide ) and 55 microgram( ml ) umeklidinium and 22 microgram of vilantatate . the other ingredients are lactose monohydrate ( see section 2 under ' temies contains lactoses ') and magnesium stearate . what mybrin ellippa looks like and contents of the pack the ellipine inhalers have a light grey plastic body , with a beige
what zinforo is zin foro is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines called ' cephalosporin antibiotics '. what zforo used for zinfo is used to treat adults with infections of the skin or the tissues below the skin . this is an infection of the lungs called : ' pneumonia ', which can be life - threatening . how zinfordo works zinforumo works by killing certain bacteria , preventing them from developing serious infections .
do not take zinforo - if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). - are allergic or to other cephalosporin antibiotics . - have had previous severe allergic reactions to other antibiotics such as penicillin or carbapenem . warnings and precautions talk to your doctor before taking zin foro . do not use zinfordo if any of these apply to you . take special care with zinfo : - you should tell your doctor if : you have kidney problems . you have ever had seizures ( convulsions ). you have any non - severe allergic reaction to other medicines such as Penicillin or carpenem 26 you have severe diarrhoea while taking antibiotics you are taking , or have ever been sick ( vomiting
the recommended dose of zinforo is 600 mg for every 12 hours . your doctor may increase your dose to 600 mg every 8 hours if you have some infections that your doctor thinks are important . it is given to you in a 12 hour period by a drip into a vein ( intravenously ) over 5 minutes . this dose is increased to 60 mg for each 120 hour period . if your doctor determines that you need an increased dose , your doctor will start treatment at a lower dose of 5 mg for the first 14 days . for skin infections , the recommended starting dose is 5 to 7 mg for pneumonia . you must not be given zin foro if a child has kidney problems . patients with kidney problems your doctor can decide if treatment with zinfordo is right for you . the risk of your child ' s kidneys will be checked regularly while you are
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any of these symptoms you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems - these may be signs of a serious allergic reaction ( anaphylaxis ). diarrhoea , stool , blood or mucus may be present at the start of treatment with zinforo . your doctor may prescribe medicines to help slow bowel movement . this is common ( may affect up to 1 in 10 people ). you may also need a blood test called a ' coombs test ' before you start taking a type of antibiotic . the results of this test may be severe and may be life - threatening . tell your doctor straight away if any
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister . the expiration date refers to the last day of that month . store below 30 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is 600 micrograms ceftaroline fosamil and arginine . what zforo looks like and contents of the pack zinfordo is a pale yellowish - light yellow powder for concentrate for solution for infusion in a vial . it is available in packs containing 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central nuropathic pain : pregabaltin ppfizer is used to control long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral numbness , such as diabetes or shingles . pain sensations may be described as hot , burning , or throbbing , shooting , stabbing  , sharp , cramping , and aching , torsion , feeling tingling , sensation nauseous , uncomfortable , hot - headed , disorientated , nervous , dizzy , lack of motivation , depression , difficulty concentrating , restlessness , sleepiness , mood
do not take pregabalin pfizer if you are allergic to pregabalsin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking pregabaltin ppfizer some patients taking pregamalin may have symptoms of an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat , as well as diffuse skin rash . should you experience any of these reactions , you should contact your physician immediately . pregabralin may cause dizziness and somnolence , which could increase the occurrence of accidental injury ( fall ) in elderly patients . therefore , pregabaliin prifizer may cause blurring or loss of vision or other changes in eyesight . tell your doctor immediately if any changes in your vision occur . some patients with diabetes who
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will determine what dose is appropriate for you , and will determine for how long you should take pregabalin pfizer . for peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder : take the number of tablets as instructed by your doctor and will usually be between 150 mg and 600 mg each day . you should swallow your tablet whole with some water . the usual dose is one tablet of pregabralin ppfizer in the morning and one tablet in the evening . alternatively , your doctor may prescribe a lower dose ( 150 mg ) or 600 mg of pre gabalin per day , depending on how you respond to the treatment . in some cases , patients may take pre gabralin pipf
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common - may affect up to 1 in10 people increased appetite . feeling of elation , confusion , disorientation , decrease in sexual interest , and irritability . disturbance in attention , which may involve clumsiness and memory impairment , loss of memory , or tremor , difficulty with speaking , feeling of an tingling feeling . not known : frequency cannot be estimated from the available data dizzion , light - headedness . uncommon - might affect upto 1 in 100 people increased activity . increased appetite and feeling of depression , lack of motivation , dizzitude , slow or irregular heartbeat , increased blood
what pregabalin pfizer contains the active substance is pregabaalin which is supplied in vials containing 25 mg , 50 mg / 75 mg ; 100 mg : 150 mg . 200 mg - each vial contains 225 mg or 300 mg pregabalsin . the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica , black ink , shellac ; black iron oxide ( i 172 ), propylene glycol ( containing potassium hydroxide )). the 75 mg ( 100 mg ( 200 mg and 225 millilitres ) tablets also contain lactoses . not all pack sizes may be marketed .
xadago is a medicine that contains the active substance sofinamide . it increases the amount of dopamine in your brain . this helps to increase the levels of dopinamine in the brain and helps to control movement in adult patients with parkinson ' s disease . x ad ago helps to prevent parkinsons ' disease in adults by preventing them from happening . sudden swings in your movement may result in you not being able to move or you have difficulties moving at all . the medicine can also be used in combination with levodopa and other medicines used to treat parkinSON 's disease in adult subjects .
do not take xadago - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). - do not use the following medicines : - monoamine oxidase ( mao ) inhibitors : selegiline , rasagiline ; moclobemide ; phenelzine , isocarboxazid ; or tranylcypromine ( used for treatment of parkinson ' s disease and depression ); pethidine ( a strong pain killer ). you must stop 7 days before x xdagot treatment and start treatment with mao inhibitors or pethamine ( used to treat depression ). warnings and precautions talk to your doctor or pharmacist before taking xsad if : you have had a
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of xadago is 50 mg twice a day ( one tablet in the morning and one tablet of 100 mg by mouth ). you should take x ad aadhago with food , if necessary . if your doctor has moderately reduced liver function , the recommended starting dose is 50 micrograms twice  a week . your doctor may prescribe xdag for you if : you have been taking xsadabo for several years and you have raised blood pressure , anxiety , confusion , forgetfulness , sleepiness , lightheadedness , feel sick or be sick , or have dilated pupils or have involuntary jerky movements . tell your
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure , collapse ) has been reported in patients with neuroleptic malignant syndrome ( nms ). it may also be associated with confusion , sweating , muscle rigidity ( hyperthermia ), increase level of enzyme creatine kinase in your blood ( serotonin syndrome ). this may also lead to confusion . it may be associatedwith hypertension , which may also cause muscle stiffness , hallucinations ( hypotension ). the most frequently reported side effects in patients who have parkinson ' s disease are safinamide , levodopa , ramipril , and glimepiride . these effects are usually mild and usually disappear over time . if they
what xadago contains - the active substance is safinamide . each tablet contains 50 or 100 mg of ssafatamide - -the other ingredients are : - tablet core : methansulfonate - microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - film - coating : all in the tablet core are hypromellose , macrogol , titanium dioxide ( e171 ), iron oxide red ( encoding ) what Xad adogo looks like and contents of the pack x adego 50 mg tablets are light pink , oval , biconcave film  coated tablets of 7 mm diameter with metallic gloss engraved on one side and the number ' 50 '
zytiga is a medicine called abiraterone acetate . it is used to treat prostate cancer in adult men whose body does not contain enough testosterone . zytigea lowers the levels of testosterone in men with prostate cancer . how zytaga works zymiga is used in adult women whose disease is not well controlled by hormone therapy ( a treatment that lowers testosterone ( androgen deprivation therapy ) or in combination with another medicine , prednisone or predNisolone . this is used because of high blood pressure in the body due to fluid retention in your blood .
do not take zytiga - if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). - when you are pregnant warnings and precautions talk to your doctor or pharmacist before taking zytigea . - you have severe liver damage . you have prostate cancer . your doctor may need to adjust your dose of this medication . talk to zyta if any of these apply to you . this medicine should not be used in children and adolescents under 18 years of age . warningsand precautions tell your doctor before taking this medicine : - in case you have liver problems such as high blood pressure , heart failure , low blood potassium . low blood sodium can cause heart rhythm problems , or other heart or blood vessel problems . tell your physician if your doctor notices an irregular or rapid heart rate 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 1 , 000 mg once daily . you should take this medication twice a day , once in the morning and once in evening , at about the same time each day . take the tablet with food . do not chew , crush or split the tablet . this medicine is for oral use . swallow the tablet whole with water . zytiga can be taken with or without food , and it is recommended that you take zytigea at least 2 hours before or after food ; if your doctor has told that you need to take a medicine called prednisone or predniesone , your doctor may advise you to take preddnisolone together with the preddinisone . your doctor will tell
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact a doctor immediately if you experience muscle weakness , muscle twitches , a pounding heart beat ( palpitations ), or if your level of potassium in your blood is low . this is called potassium - related side effects ( may affect up to 1 in 10 people ). you may experience a build up of fluid in your legs or feet . these may be due to low blood potassium ( seen in liver function test ), high blood pressure , urinary tract infection , diarrhoea .
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg aberraterone acid . - other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate ( see section 2 " zytigea contains lactoses "). what zetiga looks like and contents of the pack - zytiva tablets are white to off - white , oval tablets of 9 . 5 mm diameter , with " nvr " on one side and " gs " on the other side . the tablets are packed in a plastic bottle with a child - resistant closure . one bottle contains 120 tablets
hefiya contains the active substance adalimumab , a medicine used for the treatment of the following inflammatory diseases : polyarticular juvenile idiopathic arthritis , and enthesitis - related arthritis paediatric plaque psoriasis , paediatic crohn ' s disease , or paediatrin non - infectious uveitis in adults . aad alimUMab is a monoclonal antibody . monoclonacal antibodies are proteins that attach to a specific target in the body . the target of adelimumb is tumour necrosis factor ( tnf ), which is involved in the development of the inflammatory disorders and reduces the inflammation in these diseases . polyarticulary juvenile  ibidiopathic disorders and / or
do not use hefiya - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ) - have a severe infection , including tuberculosis , sepsis ( blood poisoning ) or other opportunistic infections ( unusual infections associated with a weakened immune system ). it is important that you tell your doctor if any of these apply to you . symptoms of infections may include fever , wounds , feeling tired , dental problems - are moderate or severe heart failure . it is also important to tell your dentist if this applies to you at all times . warnings and precautions talk to your doctor or pharmacist before using heifiy if : you have had or have had a serious heart condition . allergic reaction if allergic reactions have been
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the usual dose is 40 mg once a day for patients who weigh at least 20 kg , or 40 mg twice a week for patients weighing at least 30 kg . your doctor may decide to increase the dose to 20 mg once daily if your child weighs at least 40 kg if their doctor determines that the 40 mg dose is too high or too low . polyarticular juvenile idiopathic arthritis age or body weight how much and how often to take ? notes children and adolescents from 2 years of age weighing 30 kg or more 40 mg every other day not applicable children and teenagers from 2 to 10 kg 10 mg every week not applicable 30 mg every month not applicable 20 mg every year not applicable enthesitis - related arthritis age and body weight why should
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . side effects may occur at least up to 4 months after the last hefiya injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash , or hives ; swollen face , hands , feet ; trouble breathing or swallowing ; shortness of breath with exertion or upon lying down or swelling of the feet . tell your doctor as soon as possible if any of these occur . signs and symptoms of infection may include fever , feeling sick , wounds , dental problems , cough , flu - like symptoms , diarrhoea , vomiting , nausea ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . alternative storage : when needed ( for example when travelling ), hefiya may be stored at room temperature ( up to 25 ) for a maximum period of 14 days be sure to protect it from light and to protect the product from light ( for instance when travelling over long distances ). once removed from refrigeration , your pre – filled  ssyre must be used within 14 days or discarded , even if it is later returned to the refrigerator . you should record the date when
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of aad limumumabe in 0 . 4 ml of solution . - - other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid ( e507 ), sodium hydroxide and water for injections . what HEfia looks like and contents of the pack heifia 20 mg solution for injection ( injection ) in pre  12 mL clear , colourless to slightly yellowish solution is provided in a single - use clear type i glass sYringe with a stainless steel needle with  a needle guard
what ritemvia is ritemevia contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritsimabe sticks to this cell , the cell dies . what ritamvia can do for your child ? your child may be given riteemvia for the treatment of their child ' s condition . your child will be given one of the following conditions while you are receiving rite : a ) non - hodgkin '
do not take ritemvia if you are allergic to rituximab , other proteins which are like ritzimabe , or any of the other ingredients of this medicine ( listed in section 6 ) if your child has a severe active infection if the child has been born with a weak immune system if he has severe heart failure or severe uncontrolled heart disease if there is a history of granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris if any of these apply to your child , do not use ritemevia . if anyone else has hepatitis infection . warnings and precautions talk to your doctor before you start using rite m . you may be at increased risk of getting hepatis b . this is because in people who
you will always be given ritemvia exactly as your doctor has told you . you should check with your doctor or nurse if you are not sure . this treatment is administered by a doctor or other healthcare professional . your doctor will watch you closely while you are being given this medicine . in case you get any side effects , your doctor may lower your dose . ritemevia will be given to you as a drip ( intravenous infusion ). medicines given before each ritetvia administration before you are given a dose of riteemvia , you will be told by your doctor , nurse or pharmacist . when riteritemvic is given to your child , other medicines ( pre - medication ) may be given in case of side effects and reduce your dose or stop your treatment . for non - hodgkin ' s lymphoma patients who receive 
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . you may also experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat irritation , cough , indigestion , sore throat , burning sensation when passing urine . these reactions usually disappear in the hours or months after the induction . if they persist , contact your doctor immediately . common : may affect up to 1 in 10 people a feeling of being unwell . uncommon 
what ritemvia contains - the active substance is called rituximab . each ml of concentrate contains 100 mg of ritsimabe . one vial of 10 mL of concentrate includes 10 mg of Rituximib - this mmol concentrate contains sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritamvia looks like and contents of the pack ritemevia is a clear , colourless solution , supplied as a concentrate for solution for infusion in a glass vial . pack of 2 vials 
capecitabine teva belongs to the group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitebine - tva contains cape citrine , which itself is not a cytostat medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine ( more in tumour tissue than in normal tissue ). capecitationbine  t Eva is used in the treatment of colon , rectal , gastric , or breast cancers . furthermore , capecitedbine a can be used to prevent new occurrence of colon cancer after complete removal of the tumour by surgery . it is recommended that capeccitabine
do not take capecitabine teva if you are allergic to capecitebine or any of the other ingredients of this medicine ( listed in section 6 ). you must inform your doctor if any of these apply to you . you must tell your doctor immediately if your child develops an allergy or over - reaction to this medicine , if he or she develops severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ), if the child is pregnant , or if they are breast - feeding , and if there are low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ), or - if children have severe liver or kidney problems , because their body does not produce enough of the enzyme dihydropyrime dehydrogena
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you , so you should take the tablet at the same time each day . the dose of capecitebine teva is based on your body surface area . this is calculated from your height and weight . average adult patients ( 18 years of age and above ): adult patients 1250 mg / m2 of body surface surface area taken two times daily ( morning and evening ). two examples are provided here : a person whose body weight is 64 kg and height is 1 . 64 m has a body surfacearea of 1  . 7 m2, and should take 4
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva immediately and contact your doctor if any of these symptoms occur : - diarrhoea : you may have an increase of 4 or more bowel movements compared to your normal bowel movement each day or any diarhooeal at night . - vomiting : when you vomit more than once in a 24 - hour time period . you may lose your appetite , and may have stomatitis . your doctor will tell you what to do if you have pain , redness , swelling or sores in your mouth and / or throat . hand - and - foot syndrome : these can be signs of an acute form of st . martinson ' s disease :
what capecitabine teva contains - the active substance is capecitebine . capecitationbine : each 150 mg film - coated tablet each film  - film ' coated tablet contains 150 mg capeciabine - capevitabine  each 500 mg film film ­ coated tablet every film : - tablet contains 500 mg capabine ­- the other ingredients are : tablet core : lactose , microcrystalline cellulose ( e460 ), hypromellose ( 6000 ), and croscarmellose sodium ( 5000 ), magnesium stearate ( 8000 ), macrogol 400 ( containing hypromllose , titanium dioxide (  e171 ), yellow iron oxide ( elektron ) and red iron oxide [ e172 ] ( tamper evident in red iron dioxide (
what silodosin recordati is siloudodousin recordingi belongs to a group of medicines called alpha1a - adrenoreceptor blockers . silonosine recordatu is selective for the receptors located in the prostate , bladder and urethra . by blocking these receptors , it causes smooth muscle in these tissues to relax . this makes it easier for you to pass water and relieves your symptoms . what siladoosun recordatis is used for silado sin recordsati can be used to treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as : difficulty in starting to passwater , a feeling of not completely emptying the bladder , and a more frequent need to pass urine 
do not take silodosin recordati - if you are allergic to siloudo sin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking silonosine recordatis : - during cataract surgery , some patients experienced cloudiness of the lens ( cataract surgery that included observation of the eye ) and 26 experienced in such cases . sillodonoshin recordatin may cause a loss of muscle tone in the iris ( the coloured part of the opalescent ) in the eye when having a surgery . your doctor will take appropriate precautions to avoid this , especially when changing the type of medicine and surgical techniques . if any of these apply to you , or if they do not respond to sidodasin recording
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one capsule of silodosin recordati 8 mg taken orally once a day . take the capsule about 8 hours before your next meal . swallow the capsule whole with water . if necessary your doctor may adjust your dose , especially if your doctor thinks you have kidney problems . patients with moderate kidney problems your doctor will prescribe the best dose for you , depending on your condition . for this purpose silofosine recordatis 4 mg is for oral use . you should swallow the whole capsule with a glass of water , about 4 hours after your last meal , and at about the same time each day , preferably at the same times each day ( see section " how to take sillodon
like all medicines , this medicine can cause side effects , although not everybody gets them . some of these effects may be serious and may require medical attention . possible allergic reactions : swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin and hives are a very common side effect of silodosin recordati . dizziness : this is a common symptom of dizzikeit and occasionally fainting . in some cases people may feel weak or dizzy . the symptoms of dizzyness and fainting can be serious . if you fainting occur , stop using siloudoosine recordatis and contact your doctor immediately . complications from a cataract surgery ( eye surgery ) may occur . you should tell your doctor if your eye doctor thinks you may have a problem . this is particularly common in
what silodosin recordati contains - the active substance is siloudoosine . each silódodousin album contains 8 mg of silonodsin . - each sillodolin contains 8 million international units ( sildosin *). -the other ingredients are mannitol ( e421 ), magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( i ) ( if you have any questions about silolinodasin recordingi ), 4 mg of the active ingredient is siladosesin , 4 mg , silofosink . the other ingredients in the capsule are : mannittol , magnesium sterarate and sodium laureilsulfatate . ge
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angioTENsin is a substance produced in your body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzimono blocks the effect of angio Tensin Ii so that the blood vessels relax , and your blood temperature is lowered . this is called essential hypertension ( high blood pressure). ' essential ' means that the high blood tension is not caused by any other condition . high blood - related hypertension , if not treated , can damage blood vessels in several organs , which could lead sometimes to heart attack , heart or kidney failure , stroke , or blindness .
do not take kinzalmono - if you are allergic to telmisartan or any other ingredients of this medicine ( listed in section 6 ). - in early pregnancy see pregnancy section . - when you have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ) or anyother severe liver disease . warnings and precautions talk to your doctor or pharmacist before taking kinzimono and if any of the following apply to you : - you have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren . your doctor may need to adjust your dose of kinzonzono . talk to you doctor or nurse before taking the medicine if : you are taking a tablet of aliskaren ( see pregnancy and breast
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of kinzalmono is one tablet a day . try to take the tablet at the same time each day , preferably at the start of the day - preferably in the morning . you can take kinzymono with or without food . it is important that you take kinszalmonio every day until your doctor tells you otherwise . - the tablets should be swallowed whole with some water . patients with experience in the treatment of high blood pressure , the usual dose of the usual recommended dose for kinzimono for most patients is 40 mg once a morning to control blood pressure over the 24 - hour period . your doctor may prescribe a lower dose of one 20 mg tablet daily . when you
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious and need immediate medical attention : you should see your doctor immediately if you experience any of the following symptoms : sepsis * ( often called " blood poisoning ", is a severe infection with whole - body inflammatory response ), rapid swelling of the skin and mucosa ( angioedema ); these side effects are rare ( may affect up to 1 in 1 , 000 people ) but are extremely serious and patients should stop taking the medicine and see their doctor immediately ( see section 2 ). possible side effects of kinzalmono common side effects ( may effect up to1 in 10 people ). low blood pressure ( hypotension ) in patients at risk of cardiovascular events . uncommon side effects may affect more than 1 in 100 people urinary tract infections , upper respiratory tract
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . you should store your medicine in the original package in order to protect the tablets from moisture . remove your kinzalmono tablet from the blister only directly prior to intake . store in the refrigerator ( 2 8 ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmesartan ( as meglumine ). - other ingredients are povidone , meglumin , sodium hydroxide , sorbitol ( e420 ) and magnesium stearate . what kinszalmonio looks like and contents of the pack kinzialmona 20 mg tablets are white to off - white , round tablets , with " gsi " debossed on one side and " nvr " on the other side . kinzonzalmino is available in blister packs of 14 , 28 , 56 and 98 tablets . not all pack sizes may be marketed .
what afstyla is a , human clotting ( coagulation ) factor viii product , containing the active substance lonoctocog alfa . what fsstlyla is used for a treatment of bleeding episodes in patients with haemophilia a ( inborn factor  vii deficiency ). factor ix is , in some cases , not working . in some patients , factor ii is not necessary for blood clot . this leads to an increased tendency to bleed . how aficstying works in patients of all ages with haémophila b to clone their blood to make it easier for blood to coagulate . a factor v1 is necessary for haematophilian a to re - closing 
you must not be given afstyla - if you have ever had an allergic reaction to a factor 4 or any of the other ingredients of a fsst . - you are allergic to hamster proteins . 46 if any of these apply to you , do not use a Fst.yla without your doctor ' s advice . the patch number is not known and you must keep your treatment diary ( a diary ) with a copy of the code containing the product . warnings and precautions talk to your doctor or pharmacist before using a for a long time . allergic ( hypersensitivity ) reactions to ffshyla may occur during treatment with ftyl . you should seek immediate medical attention if symptoms of allergic reactions occur . these include hives , generalised skin rash , tight
your treatment should be initiated under supervision of a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . the recommended dose of  afstyla is one tablet a day . your doctor will decide the dose of one tablet of ' a fsst yla . treatment should start at the beginning of treatment , depending on your disease the site and the bleeding your clinical condition .  reconstitution and administration general instructions the powder must be mixed with the solvent ( liquid ) provided in the vial and mixed with water for injections . for aseptic conditions , a dose of 1 ml of ffsyla must not be mixed in the same vial with other medicines or solvents , except for solvents listed in section 6 .
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms of allergic reactions allergic reactions may include the following symptoms : hives , generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness and anaphylaxis ( bleeding ). in patients who have received factor viii medicines : inhibitor antibodies ( see section 2 ): common ( may affect up to 1 in 10 people ) if they develop in previous treatment with factor ix ( more than 150 days of treatment ) the risk is increased if you do not respond well to treatment . your doctor will check you for these reactions . if any of these effects occur , your doctor may stop treatment with a factor ii and start a new one immediately
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the afstyla powder in the viall in the outer carton in order to protect from light . use the reconstituted product within one hour . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 25 days at 2 8 8 . record the date on the carton and the new storage in the space provided on the outer container on the product carton . you must use the product immediately after reconstitution .
what afstyla contains the active substance is lonoctocog alfa . each ml of solution contains 250 micrograms in 2 . 5 mL of solution . after reconstitution with 2  . 4 mmol of solution for injections the solution contains 100 microgram ( 100 mg ) lonoctcog all . from a microbiological point of view , reconstitution without 2 , 5 - injectionsthe solution contains 200 microgram( mbq ) of lonoccog altfa per 1000 m2 of solution after reconfiguration with 2 2 : 5 mm of solution to be used . for injection ( injections ) the solution is 400 microgram of lonostocogg alf and 1500 microgram per vial after reconstituted by 5 % water for injection and dilution . the
the active substance of praxbind is idarucizumab . iderucizum ab is a reverse agent . dabigatran ( pradaxa ) is  a blood thinner medicine that helps to prevent blood clot formation . by doing so , praxxbind can rapidly trap dabig atran . you must not be given prasbind if you are not able to take it as soon as possible . your doctor will tell you how long you should be treated with prauchbind . it is important that you keep having pradoxa until emergency surgery is needed or urgent procedures are necessary to prevent uncontrolled bleeding .
do not use praxbind - if you are allergic to idarucizumab or any of the other ingredients of this medicine listed in section 6 . - have a genetic disease called hereditary fructose intolerance ( hereditarian fructosum ) or to the substance sorbitol ( e420 ) as this medicine may cause serious adverse reactions . warnings and precautions talk to your doctor before using praxxbind . this medicine contains dabigatran and other medicines that help to prevent blood clots . dabig atran is a substance present in the body which can cause blood clumps , and this can lead to blood coagulation . you may be given medicines to prevent or treat blood  clottings if your medical condition is not well controlled . talk to you doctor before you are given prasbind
praxbind will be given to you by a healthcare professional . the recommended dose is 5 mg , given as 2 . 5 mg dabigatran . you will receive this medicine for 5 days . this medicine will be injected into a vein . your doctor will decide how much prasbind you will be receiving . if you are given more praxxbind than you should this medicine is not given to your child . during your treatment , your doctor may reduce the risk of blood clot formation . dabig atran will be administered to you within 24 hours . it is very important that you receive this medication every day . make sure that you are taking the correct dose . do not give more than one dose to your baby . contact your doctor if a dose is missed . tell your doctor or nurse immediately if any dose is missing .
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects you can help provide more information on the safety of this medicine . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects, you can provide more details on the reporting of possible side effects by reporting any side effects via the yellow card system listed on the appendices .
what praxbind contains - the active substance is idarucizumab . - each vial contains sodium acetate trihydrate , acetic acid , and sorbitol ( e420 ), polysorbate 20 and water for injections . what px pvp looks like and contents of the pack praxxbind is a clear to slightly opalescent , colourless to slightly yellow solution for injection in a glass vial with a butyl rubber stopper and sealed with an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temmedaca is used for the treatment of specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . you will be given tememedad together with radiotherapy ( concomitant phase of treatment ) and after that alone ( monotherapy phase of treating ) children and adolescents 3 years and older and adult patients with malignant gliomema , such as glionoblasta multiformate or anaplastic astrocytoma in these tumours the doctor will prescribe temtemmed ac in addition to standard treatment .
do not take temomedac - if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ) - have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction include feeling itchy , breathlessness or wheezing , swelling of the face , lips , tongue or throat . - some types of blood cells are severely reduced ( myelosuppression ), such as your white blood cell count and platelet count . these blood cells help to fight infection and for proper blood clotting . your doctor will check your blood to make sure that these cells are adequately protected from treatment . warnings and precautions talk to your doctor or pharmacist before taking temmedacal : - in case you have a history of bleeding or infection .
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will tell you how much temomedac you should take . treatment with temac will vary depending on your size ( height and weight ) and if there is a recurrent tumour and you have had chemotherapy treatment in the past . you may be given other medicines ( anti - emetics ) to take before and / or after taking temmedaca to prevent or control nausea and vomiting . patients with newly - diagnosed glioblastoma multiforme if your doctor determines that you are at risk of developing an illness , treatment will occur in two phases : treatment together with radiotherapy ( concomitant phase ) followed by treatment with only temimedab ( monotherapy phase 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you have any of the following : - a severe allergic ( hypersensitive ) reaction ( hives , wheezing or other breathing difficulty ), - uncontrolled bleeding , - seizures ( convulsions ), or - fever , chills , or severe headache that does not go away . temomedac treatment can cause a reduction in certain kinds of blood cells . this may cause you to have increased bruising or bleeding ; anaemia ( a shortage of red blood cells that may cause fever ) and reduced resistance to infections . the reduction in blood cell counts may lead to anaeemia ( anaplastic analytic ) which may be severe . patients should be monitored closely for signs of their condition . these include
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 30 in the original package in order to protect from moisture . tell your pharmacist if you notice any change in the appearance of the capsules .
what temomedac contains - the active substance is temozolomide . temac 5 mg tablets : one tablet contains 5 mg temazolomide ( as mesilate ). temmedaac 20 mg tablets: one tablets contains 20 mg TEMozolomid ( as temizac ). the temokac 100 mg tablets contain 100 mg  temozalomide [ as memesilate in tablet form ]. tememedad 140 mg tablets are available in packs containing 140 mg / ml of temizolomide and temowac 180 mg tablets ( as well as 180 mg ) of - temomelomide in one tablet . the ml temtemomediac 250 mg tablets contains 250 mg ­ temezlomide as an analogue tablet , 
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , e rect penis suitable for sexual activity . ciali is used to help you get a solid , hard ed penis suitable for sexual performance . you should not be given cialised to help your child get ea . how cialist works cialising contains the active substance tadalafil which belongs to a group of medicines called phosphodiesterase type 5 inhibitors . when cialiser is given , it will stop the blood vessels in your penis from tightening . the result of this is improved el - idolescent , which in turn improves your etile function . your doctor has prescribed cialisse for you because you have
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ). - do not use organic nitrate or nitric oxide donors such as amyl nitărite . - this is a group of medicines (" nits ") used to treat angina pectoris (" chest pain "). cialist does not give this medicine to you unless you have been properly trained by your doctor . you should not take these medicines if any of these apply to you because natrate may be harmful to you and may increase your risk . talk to your doctor before taking ciali if : you have serious heart disease you have recently had a heart attack within the last 90 days you have had , or have recently suffered , a stroke within the past 6 months you have liver
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . cialis tablets are for oral use . swallow the tablets with a glass of water . the tablets can be taken with or without food . you can take the tablets at any time of the day , with or just after food , and at about the same time each day . it is important that you take ciali at the same times each day to achieve the best results and reduce the risk of side effects described in section 4 . tell your doctor about how long you should continue to take ciais . do not stop taking cialiser without talking to your doctor first . men who take a tablet of cialisé will need to take the tablet at the right time every day ; this will help you to get an erection . male patients who have
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects may occur at the start of the medicine or shortly after ( see section 2 ). if you experience allergic reactions such as rashes ( frequency not known ), such as chest pain , seek medical attention immediately . if this happens , do not use nitrates again ( frequency cannot be estimated from the available data ). frequency cannot been estimated from available data or taken priapsim . you may experience a prolonged and possibly painful erection while taking cialis ( frequency unknown ). you may get an er errand more than 4 hours after taking a dose . tell your doctor immediately if a man gets an erinrand , usually at an early age ( frequency is not known or cannot be determined from the unavailable data ) or sudden loss of vision ( frequency
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of ttaalaf . -- the other ingredients are : tablet core : lactose monohydrate ( see end of section 2 ), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose ; sodium laurilsulfate ; magnesium stearate . film - coating : - lactoses monohydrate , indigo carmine ( e132 ), and hypromellose ( 6000 ), triacetin ( 8000 ), titanium dioxide ( E171 ), iron oxide yellow ( ileum ), red ( tan ) and talc ( cb ). what ciais looks like and contents of the pack ciali
enyglid is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your panceras does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . enzyglid helps control type 2 diabetics as they get older . treatment is usually started if diet , exercise and weight reduction alone have not been able to control ( or lower ) your blood glucose . the efficacy of eninessglid in combination with metformin , another medicine for diabetes , is not known .
do not take enyglid : - if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). - in case you have type 1 diabetes . if the acid level in your blood is raised ( diabetic ketoacidosis ). warnings and precautions talk to your doctor or pharmacist before taking enzyglid ( see section " diabetic " below ). you have a severe liver disease . you take gemfibrozil ( a medicine used to lower increased fat levels in the blood ). this may increase the risk of liver problems . in moderate liver 28 disease see " other medicines and eninessglid " below in section 2 . talk to you doctor or a pharmacist before you take  Enyglider : you have had a severely liver disease or kidney problems , as it may be a better idea
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 0 . 5 mg twice a day . swallow the tablets with a glass of water immediately before or up to 30 minutes before each main meal . do not take more than 4 tablets per day , if necessary . if your doctor has prescribed a higher dose , your doctor may increase your dose to 30 mg twice daily . your doctor will tell you how much enyglid you should take each day based on your blood sugar . this may lead to a hypo . you should not take enzyglid more often if he / she tells you to . tell your doctor straight away if this applies to you , or if someone else takes your medicine . it is important that you carry out
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect is hypogliescaemia ( may affect up to 1 in 10 people ). hypoglytic reactions are generally mild / moderate but may occasionally develop into hypoglcaemic unconsciousness or coma . allergy allergy is very rare ( may effect up to1 in 10 , 000 people ) symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . this is called anaphylactic reaction . other side effects are common ( may impact up to one in 10 users ): stomach pain . uncommon ( may occur with up to a third in 100 people ), stomach pain is usually mild . it may also cause indigestion or loss of appetite . if this happens , it may not go away and may be life
what enyglid contains - the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg of replinide ( as mesilate ). - other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , anhydrous , croscarmellose sodium , povidone k25 , and glycerol , magnesium stearate , meglumine , pentamate , yellow iron oxide ( e172 ) only in the 1 mg tablets and red iron oxide e171 . 2 mg tablets : 0. 5 ml , white , round and biconvex with bevelled edges . 1 mg tablet : pale brown , pink , opaque and bikonvex .
what azacitidine mylan is azacitatidine myLAN is an anti - cancer agent . aza citidine myla contains the active substance ' azacite '. what zcitine mylan used for azacatidine mylang is used in adults who are not able to have a stem cell transplantation to treat : higher - risk myelodysplastic syndromes ( mds ) chronic myeloidomonocytic leukaemia ( cmml ) acute myelow leukocytoclastic leucemia ( aml ). these are diseases which affect the bone marrow and can interfere with normal blood cell production . how azacionidine myl works azacriidine mylange works by preventing cancer cells from growing . it also blocks the action of azavitidine , which is incorporated
do not take azacitidine mylan - if you are allergic to azacitabine or any of the other ingredients of this medicine ( listed in section 6 ). - in patients with advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking aza citidine myLAN : - you have decreased counts of platelets , red or white blood cells . - your doctor will check this for you . talk to you doctor if any of these apply to you : you have kidney disease you have liver disease you currently have a heart condition or heart attack you have lung disease you are due to have blood test you will have blood tests before you start treatment with azacionidine my Lan and during treatment you will go through a ' cycle '. this is to check that you have enough blood cells and that your liver and kidneys are working properly before you begin treatment with this medicine
before giving you azacitidine mylan , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor may change your dose of this medicine based on your age , height and weight . you will be given azacitamylan once a day for one week , followed by a rest period of 3 weeks . this " treatment cycle " will be repeated every 4 weeks , up to 6 weeks ). this medicine will be administered under the skin ( subcutaneously ) by spit ( s ) of your child ( thigh , tummy or upper arm ). if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , and reduced appetite . confusion , restlessness , fatigue . symptoms of kidney failure include : - increased blood pressure , - decreased appetite , weight loss , headache , sleepiness - dizzie , weakness , chills , dry mouth , pain in the muscles , muscle pain . - rash , joint pain - muscle pain ( arthralgia ), - reduced kidney function , common
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the vial label and the carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . use in children and adolescents this medicine should not be used after the expired expiry dates which are stated on labels and cartons . for single use only , the suspension must be stored in a refrigerator ( 2 8 ) for up to four weeks . if the azacicitidine melan suspension is prepared using water for injections that has not been refrigerated , it must be used within 8 hours . once the zacitine mylan suspension has been prepared using liquid for injection ( 2 ml ), it must not be refrigerate or be stored for upto eight
what azacitidine mylan contains - the active substance is azaсitidine . one vial of powder contains 100 mg of azacitabine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / mL azacipitidine ( as mesilate ). - other ingredients are mannitol ( e421 ). what zacitine mylan looks like and contents of the pack aza citidine myLAN is a white powder for suspension for injection and is supplied in a glass vial containing 100 mg azaccitidine , supplied in packs of 1 vial or 7 vials . not all pack sizes may be marketed .
duotrav eye drop solution contains two active substances , called travoprost and timolol . travapross is a prostaglandin analogue that is made specifically for the eye . while tramololl is  a beta blocker , it reduces fluid within the eye and reduces pressure within the area of the eye that is not being absorbed . duototrav eyes drop solution is used to reduce high pressure in the eye which can be a sign of an illness called glaucoma .
do not use duotrav - if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). - when you have respiratory problems such as asthma or severe chronic obstructive bronchitis . - in severe lung disease that causes wheeziness or difficulty in breathing . talk to your doctor if your long - standing cough is not a problem . warnings and precautions talk to you doctor before using duotarrav : - during treatment with duototrav you may develop breathing problems such , such as severe hay fever . you may experience a slow heartbeat , heart failure or a disorder of heart rhythm ( irregular heartbeat). the colour of the liquid in the eye may change ( cloudy
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in the eye or eyes , once a day in the evening . duotrav should only be used in your eyes . use duo trav at the same time each day . you can use it at any time of the day , with or without food . if necessary , your doctor may tell you to use eye drops at the following times : 1 , 2 , 3 and 4 after using a bottle , wait at least 1 hour before using duototrav . wash your hands . twist off the bottle cap , and squeeze it , until it is fully opened . hold the bottle . press down with your thumb and fingers , gently squeeze the bottle to release a little while before using
like all medicines , this medicine can cause side effects , although not everybody gets them . you should stop using the drops and start using duotrav at the same time each day . very common side effects ( may affect more than 1 in 10 people ) effects in the eye eye redness . common side effect ( may effect up to 1 in10 people ), in the eyes , eye eye surface inflammation or surface damage . signs and symptoms include eye pain , blurred vision , abnormal vision . dry eye , itchy eye . eye discomfort . not known ( frequency cannot be estimated from the available data ) signs and conditions that may cause eye irritation ( such as burning and stinging ). uncommon side effects are : eye irritation , such as stingling , hives , swelling , redness of the eye ; hiveness , or itching . reporting of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . store below 30 . throw away the container 4 weeks after first opening , to prevent infections . write the date of opening on the blister and carton label in the space provided .
what duotrav contains - the active substances are travoprost and timolol . each tablet contains 40 mg travaprosst . - each tablet also contains 5 mg titmololl ( as tti molol maleate ). - other ingredients are polyquaternium - 1 , mannitol , propylene glycol ; polyoxyethylene hydrogenated castor oil 40 ; boric acid , sodium chloride , water , hydrochloric acid ; purified water ; sodium hydroxide and hydroch chloric acid to keep acidity levels ( ph levels ) normal .
nplate ' s active ingredient is romiplostim , a protein that is used to reduce low platelet counts in adults with immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease that affects your body 's immune system that produces too many platelets . platelets are important as they help your blood to form blood clots . very low platelets counts can lead to bruising and serious bleeding . n plate is used in adults and children ( aged 1 year and above ) who have had their spleen removed or who have chronic itp or who had previously taken corticosteroids or immunoglobulins , but who have not been able to take nplace .
do not use nplate - if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). - you are also allergic to other medicines that are produced by recombinant dna technology ( escherichia coli (  e . coli ). warnings and precautions before you are given n plate , tell your doctor if : you have a low blood platelet count ( thrombocytopenia ). you should not be given a dose of nplace if your platelet counts is too low . you have an increased risk of blood clots . blood coagulants can increase the risk of getting blood clumps , which increases the risk for blood clitting . your doctor may want to monitor you closely . talk to your doctor about any signs of
always use nplate exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents ( aged 1 to 17 years ) your doctor will tell you how many n platelets you need and how often you should use . npla is given by injection under the skin ( subcutaneous ). it is usually given as an injection underthe skin ( under the dermatology ). the recommended dose is 1 ml of nplatte . your doctor may decide to give you neplate if your platelet counts are too high or too low . you will need regular blood samples to check your platelets and to check how well your platelette count is working . the number of clotting in your blood will be checked at regular intervals . use in children and adolescents n plates are usually taken from the age of 1 to 16 years . platelet count in children
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : itp common ( may affect up to 1 in 10 people ): headache - allergic reaction upper respiratory tract infection common ( might affect upto 1 in10 people ), bone marrow disorder ( increased bone mmarrow fibres ) trouble sleeping ( insomnia ) dizziness - tingling or numbness of the hands or feet ( paraesthesia , migraine ) redness ofthe skin and flushing ( oedema ) uncommon ( may effect up to1 in 100 people ). not known ( frequency cannot be estimated from the available data ) - increased blood sugar ( hypoglycaemia ) reporting of side effects 23 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaf
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . nplate may be stored at room temperature ( below 30 ) for up to six months before use . store in the original package in order to protect from light and moisture .
what nplate contains - the active substance is romiplostim . n plate 125 mg solution for injection contains 230 mg of romisplost . each vial contains 125 micrograms of romeplosstim in a deliverable amount of 0 . 25 ml solution ( equivalent to 125 milligrams / mL ). - each vially contains a total of 500 microgram of ROMiplottim - one vial of n Plate , containing 250 microgram ( corresponding to a combined total of 375 microgram / milliliter ). each viall contains 250 microliters of the active ingredient romaploslim . one vially of a delivered amount of 5 . 5 mml solutions ( equivalent of 250 millilitres ) of riploplo
what tovanor breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what tovonor  Breezhalers is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : - a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . that makes breathing difficult . by tightening these muscles in the lungs , this helps to open the airway and so improve the flow of air in the air . you should use this medicine every day and always with food . it does not cure copd until you have established your own response to the medicine .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using tovanator breezehaler and during treatment if any of these apply to you : - you have kidney problems - your doctor may need to adjust your dose - have an eye problem called narrow - angle glaucoma - difficulty passing urine during treatment with tovanlor breezihaler ( see section 4 ). if this applies to you then , do not take this medicine and tell your doctor immediately - get tightness of the chest , coughing , wheezing or breathlessness immediately after using to vanor  Breezhalers . this may be a sign of bronchospasm ( difficulties in breathing or
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much tovanor breezhaler to use the usual dose is to inhale the content of one capsule each day . you only need to inhake once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . use in children and adolescents do not give this medicine to children under 75 years of age because there is no experience with the use of this product in children under 18 years of health . this medicine is inhaled through the use as an inhaler and capsules ( in blisters ) provided in the pack . the medicine is a concentrate for inhalation powder . only use the capsules with the inhalers provided in this pack ( tovano breeze
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycopyronicum broMIDe equivalent to 50 microgram of glycopyrnoium . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram ( mg ) of glycopronium - this is equivalent if you use more glycopyrurium than you should if your inhalation powder is dissolved in water for inhalations . - - other ingredients in the capsules are lactose monohydrate and magnesium stearate . what to vanor brewing - tovanour breezehaler 44 microlitres inhalers are hard capsules containing a white powder and a device called an inhalator . capsules should be inhaled into blisters
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it affects the brain ' s natural chemical ( dopamine - 6 ) and serotonin . these substances have calming effects and relieving aggressive behaviour . adesuve is used to treat acute symptoms of mild - to - moderate agitation in adults with schizophrenia or bipolar disorder , diseases characterised by symptoms such as schizophrenia ( hearing , seeing or sensing things which are not there ), mistaken beliefs , incoherent speech and behaviour and emotional flatness . people with bipolar disorders may also feel depressed , guilty , anxious or tense . this can help to keep you mentally alert and help to remember things that are important to you and help others to remember what you have been given .
do not take adasuve if you are allergic to loxapine or amoxapin . symptoms include wheezing and shortness of breath . these may be signs of lung problems like asthma or chronic obstructive pulmonary disease ( copd ). this can cause narrowing of the airways ( bronchospasm ). if this happens you should tell your doctor . if wheeze , cough , chest tightness and shorten of breath 25 if any of these apply to you . warnings and precautions talk to your doctor before taking aadosuve and if : you have neuroleptic malignant syndrome ( nms ). you have symptoms associated with nims . you have been told by your doctor that you have these symptoms for a long time . high fever and rigid muscles may occur during treatment with 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 9 . 1 mg / kg body weight taken twice daily , in the morning and evening . your doctor may prescribe a lower dose ( 2 . 5 mg ) or higher if necessary , depending on your condition . wash your hands thoroughly before you use the device . if your doctor has told adasuve , he or she may give you the medicine as soon as possible . do not shake the tablet , as it may cause the following symptoms : extreme tiredness , sleepiness , trouble breathing , low blood pressure , throat irritation , or a bad taste in the mouth , muscle or eye movements that do not go away . contact your doctor immediately if these effects occur . you should not
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any breathing symptoms ( e . g . wheezing , cough , shortness of breath , chest tightness or irritating ) while you are taking adasuve . these may be signs of a problem with your airways , such as asthma or copd . light - headedness or fainting . this may be a sign of lowering of your blood pressure . worsening agitation , confusion , fever , muscle stiffness . all of these may indicate a severe condition called " neuroleptic malignant syndrome ". other side effects include : very common ( may affect more than 1 in 10 people ): - numbness , tingling or burning sensation of the skin , or 
keep out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep an open or torn pouch in order to protect from light . adave does not require any special temperature storage conditions . physical damage may occur if adesuve is accidentally frozen .
what adasuve contains - the active substance is loxapine . each single - dose inhaler delivers 5 micrograms of lox apina . - delivers 4 . 5 microgramms of the active ingredient , delivering 4 , 5 microliters of solution for inhalation of a dose of 0 . 4 mg of lucapin . what - aadosuve looks like and contents of the pack adesuve 4  . five microgram inhalers are available in a pack containing : - disposable white plastic inhalER with label and loxane - each inhalator is sealed foil pouch . one pack of : one pack contains one inhalor of - one inhaled dose of 4 : 5 inhalations .
what azacitidine betapharm is azacitatidine betabharm is an anti - cancer agent which belongs to a group of medicines called ' anti  cisacites '. aza citidine be tapharm contains the active substance ' azacatidine ' ( a substance that is similar to the active ingredient in a medicine ). what zacicitine betaphar is used for azaciditidine is used in adults who are not able to have a stem cell transplantation . it is used to treat : - higher - risk myelodysplastic syndromes ( mds ). - chronic myeloidomonocytic leukaemia ( cmml ). acute myeloweloid leukemia ( aml ) these are diseases which affect the bone marrow but which can affect
do not take azacitidine betapharm - if you are allergic to azaсitidine or any of the other ingredients of this medicine ( listed in section 6 ). - in patients with advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacitabine betaphar : - had decreased counts of platelets , red or white blood cells . - have kidney disease . liver disease : have had a heart condition or heart attack . lung disease ; blood test : you will have blood tests before you start treatment with azacionidine betabharm and during treatment , you will go through a ' cycle '. this is to check that you have enough blood cells and that your liver and kidneys are working properly . you will be monitored carefully for signs that you are receiving aza citidine be tapharm . talk to a
before giving you azacitidine betapharm , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor may change your dose of this medicine based on your age , height and weight . you will be given azacitabetapharm once a day for 3 days , followed by a " treatment cycle " of 4 weeks and 6 weeks . this medicine will be injected under the skin ( subcutaneously ) by sprinkling water under the surface of your thigh , tummy or upper arm . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common side effects are drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , and reduced appetite . confusion , restlessness , fatigue and symptoms can occur during treatment with azacitidine betapharm . if you experience any of these , seek medical advice immediately . very common : may affect more than 1 in 10 people drooling , hives , swelling of hands , ankles or feet . common - may affect up to 1 in 100 people a feeling of heaviness 
keep this medicine out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . after preparation of the suspension , use within 45 minutes . if the azacicitidine betatapharm suspension is prepared using water for injections , the suspension must be used within 8 hours . once the zacitine betaphar suspension has been prepared using liquid for injection , it must be stored in the refrigerator ( 2 8 ). the suspension should be used immediately after it has been stored in a refrigerator ( 25 ) for up to 22 hours , but the suspension can be stored at room temperature ( below 25 ). you must use it within 30 minutes if large particles are present in
what azacitidine betapharm contains - the active substance is azaсitidine . each vial contains 100 mg of aza citidine - after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / mL azacitabine . - your doctor or pharmacist will determine the amount of mannitol ( e421 ). what zacitine betaphar looks like and contents of the pack azacriidine betabharm is a white to off - white powder for suspension for injection and is supplied in a glass vial containing 100 mg aza citiidine , which is essentially ' sodium free '.
cerdelga contains the active substance eliglustat and is used for the long term treatment of gaucher disease type 1 in adults . gaucher diseases type 1 is a rare , inherited condition in which your body does not produce enough glucosylceramide to support its growth . it happens naturally in the spleen , liver and bones . eleglustat works by blocking the activity of glucoscosylzeramide in these affected organs . this medicine can be used in adults and children . you should continue to take this medicine for as long as your doctor has told you . the effects of cerdeslgа may be slow speed and poor metabolisms may be reduced . your doctor will prescribe cer delg based on a simple laboratory test . patients with gaucher disorder can be treated with cerdemlgage if they have 
do not take cerdelga - if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). - when you are taking medicines known as moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine ) 31 - during treatment with moderate cycl3a inhibitors , such as erythromycin or itraconazole , these medicines reduce your body ' s ability to break down and digest food . do not increase the amount of cerdeslg , or stop cerdlgif you take medicines that have a poor metaboliser ( for example , medicines with strong cc2d4 inhibitors such as itracone ). medicines that reduce your level of your body' 's ability , you must also tell
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . - the recommended dose is one tablet a day . do not change the dose unless your doctor tells you to . you should take metaboliser at least one hour before or two hours after taking cerdelga . the recommended daily dose is 84 mg ( two tablets a morning ). swallow the tablets with a glass of water . it is best to take cerdeslg if the tablet is broken or broken . how to take take cdelgga with or without food . before you take a tablet , take the blister / wallet or the sleeve out of the refrigerator . press down your thumb or finger to release the pen to release it . when you are ready to take the tablet :
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ) headache , dizziness , change in taste ( dysgeusia ), palpitations , throat irritation , heartburn ( dyspepsias ), feeling sick ( nausea ), diarrhoea constipation , abdominal pain , stomach ache ( upper abdominal pain not caused by acid reflux disease , gastrooesophageal reflux disease) bloating ( abdominal distension ), inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( diarseminated uric acid ) indigestion ( urination ) diarrelga may cause indisposition ( constipated ) or vomiting ( indiindigestion ) low blood sugar ( hypog
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and sleeve after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . sleseve should be used only once a month , unless sachet has been opened . keep the blister in the outer carton in order to protect from moisture .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg of eleglustat in 1ml solution . - other ingredients are microcrystalline cellulose , lactose monohydrate ( see section 2 ' cerdesga contain lactoses '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate ( e551 ), titanium dioxide (  e171 ). - printing ink containing yellow iron oxide ( i ) and indigotine ( a light yellow ink consisting of shellac , black iron oxide , propylene glycol and ammonia solution ). what cdelgara looks like and contents of the pack cerdlg capsules are light orange to yellow
the active substance in zoledronic acid hospira is zolédronic acids , which belongs to a group of substances called bisphosphonates . zoleric acid works by attaching itself to the bone and slowing down the rate of bone change . it is used : to prevent bone complications , e .g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the bones ). to reduce the amount of calcium in the blood in adult males where it is too high due to the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of calcium from bone is increased . this condition is known as tumour - induced hypercalcaemia ( tih ).
follow carefully all instructions given to you by your doctor . your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment at regular intervals . you should not be given zolzolic acid
- zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously , i . e . through a vein , (' iv ' administration ). - your doctor will recommend that you drink enough water before each treatment to help prevent dehydration . how much zolédronic acids hospria is given the usual single dose given is 4 mg . you should not be given if you have a kidney problem . your doctor may decide to give you a lower dose depending on the severity of your kidney problem as zoleric acid is given to reduce the risk of bone complications due to bone metastases . infusion : zolledronic adsorba may reduce the amount of calcium in your blood . this will be monitored by your doctor before each infusion of zolez
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common ones are usually mild and will probably disappear after a short time . tell your doctor about any of the following serious side effects straight away : common ( may affect up to 1 in 10 people ): - severe kidney impairment ( will normally be determined by your doctor with certain specific blood tests ). - low level of calcium in the blood . uncommon ( may effect up to1 in 100 people ). not known ( frequency cannot be estimated from the available data ) - pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth or jaw discharge , feeling of numbness or a feeling of warmth in the jaw / loosening of a tooth . these could be signs of bone damage in the ja
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly . - your doctor or nurse will check whether the medicine is working properly and will tell you if it is suitable for you .
what zoledronic acid hospira contains - the active substance is zoleric acid ( s ). one ml of concentrate contains 4 mg zolédronic acids ( as monohydrate ). - other ingredients are : mannitol , sodium citrate and water for injections . what z zolledronic acne hospria looks like and contents of the pack zol dronic alfa - hospra is supplied as a liquid concentrate for solution for infusion ' ( also known as ' sterile concentrate '). it is available in packs containing 4 mbq of zolezdronic alcohol . each pack contains one vial of concentrated .
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) when having cancer treatment chemotherapy . chemotherapy destroys nerve cells that communicate with the brain . this makes people feel sick , and makes them feel sick ( sick ) later on . rolapatant works by blocking the activity of these nerve cells , which in turn reduce nausea and vomiting .
do not take varuby : - if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). - when you are taking an herbal medicine containing st john ' s wort ( hypericum performatum ) ( used to treat depression and difficulty sleeping ). ( see section 2 " what varubY contains "). warnings and precautions 27 talk to your doctor or pharmacist before taking varubies : 27 - in case you have severe liver or kidney problems - take certain medicines containing the following active substance : the active substance is rifampicin ( used for the treatment of tuberculosis and other infections ) - the active ingredient is carbamazepine ( used in the treatment and prevention of epilepsy and to prevent nerve pain ) or phenobarbital ( used
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 180 mg taken once daily . you can take varuby with or without food . swallow the tablets with a glass of water . do not crush or chew the tablets . how much to take the recommended starting dose is one tablet of varubY 90 mg twice daily , taken at the same time each day . take the tablet at least 2 hours before or 2 hours after your chemotherapy cycle . chemotherapy is a time of sickness . it is important that you continue to take va ruby until you are ready to go to bed . if sickness occurs , do not take this medicinal product . tell your doctor straight away . when you are having chemotherapy , you may need another chemotherapy cycle or you are feeling sick or being sick after chemotherapy . your
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : rare side effects ( may affect up to 1 in 1 , 000 people ): symptoms of an allergic reaction may include sudden shortness of breath , swelling of the lips or tongue , change in taste , scaling of skin or tissue , sudden rash , fever and faster heartbeats . tell your doctor immediately and start appropriate treatment . other side effects include : common ( may effect up to1 in 10 people ). headache , constipation , feeling tired . common ( might affect upto 1 in 10 users ) headache . constipations , being tired , dizziness , tingling or numbness . uncommon ( may impact up to 2 in 100 people ), diarrhoea , stomach pain 
what varuby contains - the active substance is rolapitant . each tablet contains 90 mg of rolapatant - -the other ingredients are : tablet core : lactose monohydrate ( see section 2 under ' varubies contains lactoses '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . what va ruby looks like and contents of the pack varubY is a clear , colourless to light blue , capsule - like shape with a " r " on one side and " 90 " on the other side . varubry is
what enerzair breezhaler is enerszair contains three active substances : - indacaterol - glycopyrronium - mometasone furoate indabacaterol and glycopyrurium belong to a group of medicines called bronchodilators . they relax the muscles of the small airways in the lungs , helping to open the airways . this helps to open more airways and makes it easier for air to get in and out of the pulmonary airways to get into and out the intestine . momeason furoates belongs to  a class of medicines known as corticosteroids ( also known as steroids ). corticostroidoids reduce the swelling and irritation ( inflammation ) in the small  airways into the arteries and so gradually ease breathing problems . corticotrosteroids also
do not use enerzair breezhaler - if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor and do not take enzerzair brezhale . if any of these apply to you ( or you are not sure ), talk to your doctor or pharmacist before taking enersair . warnings and precautions talk to you doctor or pharmacy before taking this medicine if : you have heart problems , including an irregular or fast heartbeat . you have thyroid gland problems . your doctor may want to monitor you more closely . You have diabetes or high blood sugar . it is possible that you have seizures ( fits ) or you have severe kidney problems ; you have severely liver
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one capsule twice a day . you only need to inhale once a morning and once if the medicine is not working properly . enerzair breezhaler is for inhalation use . it is for use in adults . this helps to control your asthma and reduce your symptoms . when to use enzerzair brezhalers inhaler inhalers are provided in a pack containing an inhalator and capsules . each pack contains the medicine in an inhaled capsule . only use the inhalr when you have the medicine out of the bottle . do not use the capsules after the instructions on how to use the cartridge . how to store the capsule in the blister : when you
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious stop using enerzair breezhaler and get medical help immediately if you have any of the following : common ( may affect up to 1 in 10 people ) difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). other side effects other side effect types include : very common ( might affect more than 1 in every 10 people people ). common ( will affect upto 1 in each 10 people not known ) sore throat or runny nose , sudden difficulty breathing and feeling of tightness in the air . uncommon ( may effect up to1 in every 100 people ), hiccups . reporting of side effects 25 if your child gets any side effects talk to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from light and moisture .
what enerzair breezhaler contains - the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ) and mometasone furoate . each delivered dose ( the dose leaving the mouthpiece of the inhaler ) contains 150 micrograms of inddacatrol ( AS aate ), 63 microgram ( mg ) glycopyrrronium bromid , and 50 microgram( ml ) of glycopyrpyrroniUM ( as brmide and 160 microgram ) momeason furoates . the delivered dose is equivalent to 134 microgram of inacaterolul ( as as ace ), and 58 microgram glycopyronum bromides ( as pentazone ) per inhalation . one inhales a single
clopidogrel acino pharma gmbh contains the active ingredient clopizide which belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called trophosis ). clodogrell acan pharma grbh is taken to prevent blood cluts ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosis which can lead to atherathrombotic events ( such as stroke , heart attack , or death ). you have been prescribed cloclopid
do not take clopidogrel acino pharma gmbh if you are allergic ( hypersensitive ) to clopogrell or any of the other ingredients of clodogrela pharma or any other ingredients in clodegrel ascino pharm gme if your doctor has told you that you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain if the doctor has severe liver disease . if any of these apply to you , or if anyone else is taking cloclopid ogreil acan pharma go : if there is a risk of bleeding sucha as - a hospital condition that puts you at risk of internal bleeding ( such as an stomach ulcer ) - or a blood disorder that makes you prone to internal bleeding or bleeding inside any area of your
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopdogrell acan pharma mgbh per day to be taken orally with or without food , and at the same time each day . take a total of three 75 mg tablets of coagulation atopyric acid , with or immediately after food and drink . if clodogresl - acini pharma goggh is for oral use . swallow the tablets whole with water . do not chew or break the tablets before swallowing . contact your doctor , pharmacist , or your nearest hospital emergency department because of the increased risk of bleeding . keep the tablet bottle with you so that you can easily describe what
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon (affecting less than 1 to 1 user per 10 , 000 ) rare ( affecting 1 to10 users in 10 000 ), very rare (affecting more than1 user in10 ,000 ) very rare side effects ( affect less than1 patient in 10 10 . 000 ). contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or eyes ( jaundice ). -
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special storage conditions . clodogrell acan pharma may pose a risk of damage of blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains the active substance is clopizid . each tablet contains 75 mg of clodogrell ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : microgol 7000 ethylcellulose ( f462 ) titanium dioxide (  e 171 ) what clincher looks like and contents of the pack cloclopidagrel ambh 75 mg film – coated tablets are white to off - white , marbled , round and biconvex . they are supplied in cardboard cartons containing 14 , 28 , 30 , 50 , 84 , 90 and
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults . it belongs to a group of medicines called ' antiretroviral medicines '. it contains two active substances : doravirine , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine , also known as a nucleonide analogue reverse transcript
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine listed in section 6 . if your doctor or pharmacist prescribes you any of these medicines , please ask your doctor for advice . do not give delStrigo to children and adolescents . warnings and precautions talk to your doctor , pharmacist or nurse before taking del strigot if : you are taking any of following medicines : carbamazepine / oxcarbazepine ( e . dexbarbital ) or phenytoin ( medicines to prevent seizure ) rifampicin / or rfapentine ( medicines for tuberculosis ) deltstri
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one tablet a day . do not take more than the recommended daily dose . your doctor will tell you how many tablets of delstrigo to take . the dose is based on how well delson is working for you , and will usually be calculated by your doctor . you will need to take delstrugo for at least 12 weeks before starting your treatment with delspigo . if deltrigo is not suitable for you to take it with food . delrgo can be taken with or without food , but your doctor may advise you to change the dose , or may ask you to stop taking it . when to take take dellstrig take de lsrgo at least one hour before or two
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and tell your doctor straight away if you notice any of the following : common ( may affect up to 1 in 10 people ) abnormal dreams , difficulty in sleeping ( insomnia ) headache , dizziness , sleepiness , cough , nasal symptoms feeling sick ( nausea ) diarrhoea , stomach pain , vomiting , wind ( flatulence ) hair loss rash muscle symptoms ( pain or stiffness ) feeling tired ( nausea and vomiting ) rash joint pain ( arthralgia ) uncommon ( may effect up to1 in 100 people ). you may experience muscle pain ( weakness ) or muscle pain when getting up from a lying or sitting position , headache . you may also experience muscle spasms or cramps , pain in the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . keep the bottle tightly closed in order to protect from moisture . delstrigo is for single use only . once the bottle has been opened , the contents should be used immediately .
what delstrigo contains - the active substance is doravirine . each tablet contains 300 mg lamivudine , 245 mg tenofovir disoproxil ( as fumarate ). - other ingredients are : tablet core : croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate ( e470b ), microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fumarat . - coating material : carnauba wax e903 , film - coat : iron oxide yellow ( i ) lactose monohydrate , titanium dioxide e171 , triacetin . what dellstrig looks like and contents of the pack del
spravato contains the active substance esketamine . it belongs to a group of medicines called anti - depressants . this medicine is used to treat your depression . s Pravato helps to control the symptoms of depression : - feeling sad , anxious or worthless , - sleeping difficulties , change in appetite , loss of interest in favourite activities , feeling of being slowed down . you can also take another antidepressant at the same time , for 2 weeks after you start taking it . talk to your doctor about antidepressive medicines .
do not use spravato - if you are allergic to esketamine ( the active substance in ketamine ) or any of the other ingredients of this medicine ( listed in section 6 ). - when you have an aneurysm ( a weak spot on a blood vessel wall that bulges out ). this may increase the risk of bleeding in the brain . - in case you have recently had a heart attack within 6 weeks . this may cause a temporary increase in blood pressure . it is important that you carefully read all the information about serious complications in these conditions before using s Pravato and during treatment with this medicine . warnings and precautions talk to your doctor or pharmacist before using this medicine and if : you have a cardiac problem or if there is poor blood flow to the blood vessels . your doctor will check this regularly . you have problems
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the spravato nasal spray is for single use only . the nasal spray device is a single use device that can be used for 1 , 2 or 3 nasal spray devices . you can use one nasal spray applicator for 4 sprays at a time . your doctor may change your dose , or stop treatment , if necessary . if your doctor thinks you may have used more s Pravato than you should if he or she thinks that you may be having too much of this medicine , talk to your doctor immediately . nausea and vomiting can occur after 2 weeks of treatment . it is recommended that you wait at least 30 minutes before using this medicine and during the first few sprays , you do not need
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : common ( may affect up to 1 in 10 people ) feeling disconnected from feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity in your mouth area spinning sensation vertigo vomiting nausea common ( might affect upto 1 in 100 people  ) being extremely anxious feeling extremely happy ( euphoria ) not feeling agitated , irritable , lack of energy , difficulty sleeping , dizziness , headache , change in sensation of taste , feeling sleepier or less able to sleepy increased feeling or tolerance in your jaw area spinning sense of vertigor vomiting nausea uncommon ( may effect up to1 in 100 persons ) very rare ( may impact up to 2 in 10 , 000 people ). not known
what spravato contains - the active substance is esketamine . each nasal spray device contains esesketamine hydrochloride equivalent to 28 mg eketamine ( as mesilate ). - other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what rpravat looks like and contents of the pack spruvato is supplied as a nasal spray solution for injection . this medicine is a clear , colourless solution in a single - use nasal spray unit . sprivato comes in packs of 1 , 2 , 3 or 6 nasal spray devices . not all pack sizes may be marketed . the product is available in packs containing one or more nasal spray units . every nasal spray appliance is individually sealed in sprayed vial 
zelboraf is an anticancer medicine containing the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body or cannot be removed by surgery . if you have cancer that has a change ( mutation ) in a gene called melama , your doctor may prescribe zelbaf that targets proteins that are involved in the growth and spread of your cancer .
do not take zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash and fainting sensation when taking zeloraf ( see " warnings and precautions "). allergic reactions can be life -threatening . allergic reactions to zelburaf can be very serious . tell your doctor straight away if any of these apply to you . if your doctor thinks any symptoms of an allergic reaction are severe , including swelling ofthe face . lips or mouth , having difficulty breathing or rash , fainting sense , severe skin reactions , or severe skin reaction . do not swallow the capsules whole . warnings to take zboraffe if : you experience
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 4 capsules taken twice daily ( each capsule contains 8 capsules ) taken once daily ( one capsule contains 4 capsule contains 2 capsules of 4 capsule ) once daily . your doctor may reduce your dose if side effects occur . during your treatment with zelboraf , you may experience vomiting when taking zeloraf ( see section 2 ). take zelbaf on an empty stomach . swallow the capsule whole with water . do not chew , crush or split the capsules as they may affect the way the medicine works . if possible , take a tablet of zelbaraf and this leaflet with you , if necessary , with food . you can take zeboraffe with food or
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions may occur , including swelling of the face , lips or tongue , difficulty breathing rash fainting sensation when you are given zeloraf , or radiation treatment . tell your doctor immediately if you notice any of the following side effects as they may be due to radiation . during zelbaraf treatment , radiation may be absorbed by the skin , episophagus , bladder , liver , rectal , and lungs . you should contact your doctor if they cause any of these . contact your physician immediately : skin rash with blistering , peeling / discoloration of the skin shortness of breath a cancer of the lining of the mouth , throat or genitals ( adenocarcinoma 
keep out of the reach and sight of children . do not use zelboraf after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special storage conditions . if you have any unwanted tablets , do not throw them away . ask your pharmacist how to throw away tablets you no longer use . these measures will help to protect the environment .
what zelboraf contains - the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemoraf , as a co - precipitate of VEmura Fenibe . - other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , and hydroxypropyl cellulose . film coating : iron oxide red ( e172 ), macrogol 3350 , polyvinyl alcohol , the combination of talc and titanium dioxide ( irradiated ). what zeboraffe looks like and contents of the pack zeloraf 24 mg film  5 mg tablets are pinkish white to orange white , round , biconvex ,
duoplavin contains two active substances : clopidogrel and acetylsalicylic acid ( asa ) and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , it prevents blood vessels from forming . antiplatelets medicinal products reduce the chances of blood  clots forming ( atherothrombosis ). duopolivin is used to prevent blood cluts from clunked or hardened arteries , a process known as atheroidal thrombotic events ( such as stroke , heart attack , or death ). you should keep using duoplanvin exactly as your doctor has told you .
do not take duoplavin if you are allergic to clopidogrel , acetylsalicylic acid ( asa ) or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor thinks you may be allergic to other products , including non - steroidal anti - inflammation products if the treatment of painful and / or inflammatory conditions of muscles or joints has been associated with a medical condition such as asthma or nasal discharge if there has runny nose , polyps ( type of growth outside the nose ) have a medicinal condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain or severe severe allergic reaction if any of these apply to you , tell your doctor before taking duolavin . warnings and precautions talk to your doctor or pharmacist before taking this medicine if :
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take the recommended dose of duoplavin is one tablet a day . try to take it at the same time each day , taking it at about the same times each day to help you remember . swallow the tablet whole . you may take duolavin with or without food . if possible take your medicine with you , just in case you have a heart attack . take duotroplavin until your next scheduled dose of one tablet of duotropine , or at the next scheduled time . contact your doctor and the nearest hospital emergency department because of the increased risk of bleeding . keep your tablet bottle with you so that you can easily describe what you have taken . to help protect your medicine , take your tablet at the right time every day
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in some cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . the most common side effects reported with duoplavin are : very common side effect ( affects more than 1 user in 10 ): a decrease in the number of red blood cells ( an
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special storage conditions . tell your pharmacist if you notice any visible sign of deterioration . these measures will help to protect the environment .
what duoplavin contains duolavin 75 mg / 75 mg film - coated tablets 46 the active substances are clopidogrel and acetylsalicylic acid ( asa ): each 75 mg tablet contains clopogrell ( as hydrogen sulphate ) and each 75 - mg tablet also contains acetolsaltylic acid . the other ingredients are mannitol , macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose . maize starch , hydrogenated castor oil ( see section 2 ' duo plavin contains hydrogenated castingor oil '). what duplavin looks like and contents of the pack duopolivin is a white , round , flat , biconvex , film  shaped tablet , debossed with
simbrinza contains two active substances , brinzolamide and brimonidine tartrate . brinzola belongs to a group of medicines called carbonic anhydrase inhibitors . brimoniidine tartrat belongs to another group of medications called alpha - 2 adrenergic receptor agonists which reduce pressure within the eye . simbr inza is used to reduce pressure in the eyes in adults aged 18 years and older to treat eye conditions known as glaucoma or ocular hypertension ( high pressure in both eyes ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor thinks you may be allergic to sulphonamides , medicines used to treat diabetes or infections if they are taken with diuretics ( water tablets ) or with a monoamine oxidase ( mao ) inhibitors ( medicines used for depression or parkinson ' s disease ) and certain antidepressants if any antidepressive medicines you take with or without a prescription if : you have severe kidney problems you have too much acidity in your blood ( hyperchloraemic acidosis ) you have less than 2 years of age or older if this applies to you . you are taking simbrine for longer than 2 months without undergoing medical
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in the eyes ( s ) once a day in the morning . do not use simbrinza in both eyes . wash your hands thoroughly . 1 2 ) close the bottle tightly after each use . remove the cap and snap collar . if the medicine is not working properly , it should be used immediately . use the dropper with your fingers . hold the bottle , pointing down , between your thumb and fingers , until the drop is completely empty . tilt your head back . pull down your lower eyelid with a clean finger until there is a ' pocket ' between the eyelid and your eye . when you have used the drop , put the bottle back on . it should not
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : if you have a reaction to the medicine ( frequency not known , cannot be estimated from the available data ), you may have an allergic reaction . if severe skin reactions ( rash , redness and itching all over your body or eyes trouble breathing , chest pain or irregular heart beat tell your doctor immediately extreme tiredness and dizziness . side effects of simbrinza may occur with other medicines . this medicine may increase the risk of brinkling . tell your doctors if any of the following occur . these side effects are very common and may occur very commonly in combination with other medicine containing st john ' s wort or stomatitis . you may experience a combination of fever and diarrhoe
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after opening the bottle , use simbrinza within 4 weeks to prevent infections and use a new bottle . keep the bottle tightly closed in order to protect from light . this medicinal product does not require any special temperature storage conditions . throw away simbrINza via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . each ml of suspension contains 10 mg of brinzolate and 2 mg of brimoniidine tartrat equivalent to 1 . 3 mg brimondidine . - this is the other ingredient in simbrine . the other ingredients are benzalkonium chloride ( see section 2 " simbr inza contains sodium "). - simbrinka contains benzalskonium chlorine in the solvent . other ingredients : propylene glycol , carbomer 974p , boric acid , mannitol . sodium chloride , the active substance is tyloxapol . hydrochloric acid and sodium hydroxide are contained in purified ethanol . what simmbrinz looks like and contents of the pack simbriza
what filgrastim ratiopharm is filgrasestim ratioppharm contains the active substance filgraskastim . filgrastastim is a protein produced by biotechnology in bacteria called escherichia coli . it belongs to a group of proteins called cytokines and is similar to , a natural protein , found in the blood called granulocytes . when filgrasent is made , it stimulates the bone marrow to produce new blood cells . this means that more blood cells are made - white cells are important as white cells help your body fight infection . what filgranstim relationopharm is used for filgrattim ratioopharm can be used in adults who are receiving chemotherapy and who are undergoing bone - mutton transplantation and who suffer from severe chronic neutropenia ( dcn ).
do not use filgrastim ratiopharm - if you are allergic ( hypersensitive ) to filgraştim or any of the other ingredients of filgrasestim ratioppharm . if this applies to you , tell your doctor and do not take filgrastorstimratipharm until you have checked with your doctor . warnings and precautions talk to your doctor or pharmacist before taking filgrastastim relationpharm: - contact your doctor immediately if : you experience a cough , fever and difficulty breathing . this may be a pulmonary disorder . your doctor may want to monitor you more closely . you may experience side effects similar to those described below . sickle cell disease 57 if any of these apply to you left upper abdominal pain or pain at the tip of your shoulder . it may be due to a systemic , a possible spleen
always use filgrastim ratiopharm exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . your doctor will tell you how many tablets of filgratim ratioppharm to use . do not take more than the recommended dose . take filgrasestim ratioopharm every day until your doctor tells you otherwise . it is very important that you do not stop filgrastastim relationopharm without your doctor ' s advice . how much filgram ratiophrefarm you will receive your first dose of filgranstim proportionopharm during chemotherapy . the usual dose is 0 . 5 million international units ( miu ) per kilogram of body weight . this will be given to you in the form of 60 kg or 30 kg . depending on your treatment , your doctor may change the dose , or stop your treatment 14 days
do not use filgrastim ratiopharm if you have sickle cell disease 57 if your child gets left upper abdominal pain or pain at the tip of your shoulder . this may be a sign of a spleen disorder . see section 4 . possible side effects your doctor will do regular blood tests while you are taking filgrasestim ratioppharm . your doctor may check the number of neutrophils or other types of white blood cells in your blood . these numbers will be checked regularly during treatment . other medicines and filgrastistim relationopharm tell your doctor or pharmacist if they are taking , have recently taken or might take any other medicines , including medicines obtained without a prescription . pregnancy and breast - feeding ask your doctor for advice before taking any medicine . you must tell your healthcare provider if any medicine you are using , or think you may be pregnant , think
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . filgratim ratioppharm must not be used if the solution is cloudy or if it contains visible particles . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgrasestim . one ml of concentrate for solution for infusion contains 60 million international units [ miu ] ( 600 microgram ) of filgraskastim - each vial of filgranstim relationpharm 30 miu in 0 . 5 mL solution for injection contains 30 million international unit [ mius ] [ mime ] or 30 million [ mi miu
what riluzole zentiva is rilsuzola zentivea contains the active substance rizole which is a messenger in the nervous system . what reiluze zetiva can be used for rilluzolen zenta is used in patients with amyotrophic lateral sclerosis ( motor neurone disease ). in motor neurones , the nerve cells responsible for sending messages between the muscles become damaged and they become weak , muscle waste and paralysis . the destruction of nerve cells in motor nerve disease may be caused by too much glutamate ( a chemical messenger ) in the brain and spinal cord . rILuzolе zentapa blocks the effect of glutamates and so reduces the number of the nerve cell .
do not take riluzole zentiva - if you are allergic to rilsuzola or any of the other ingredients of this medicine ( listed in section 6 ). - have any liver disease . - are at risk of increased blood levels of some enzymes of the liver ( transaminases ). warnings and precautions talk to your doctor before taking rilluzolе zentivea : - you are pregnant or breast - feeding . you must not take this medicine if any of these apply to you . take special care with riuzoler zenta if : you have any heart problems , yellowing of your skin or the whites of your eyes ( jaundice ), itching all over , feeling sick , being sick - your kidneys may not work very well - fever . this may be
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet a day . try to take the tablet at the same time each day , preferably in the morning . you can take the tablets with or without food . swallow the tablets whole , with some water or other non - alcoholic drink . if necessary , the tablets can be taken with or just after food , and at the time of the day ; however , it is recommended that the tablets be taken by mouth . do not take more tablets than your doctor tells you to . contact your doctor, pharmacist , or your nearest hospital emergency department for advice . keep the tablet bottle with you so that you can easily describe what you have taken . it is important that you take the pack with you and provide this leaflet with
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever ( increase in temperature ). riluzole zentiva may cause a decrease in the number of white blood cells . your doctor will take a blood sample to check the number and type of white cells , which are important in fighting off infections . - you may experience the following symptoms : yellowing of your skin or the white of your eyes ( jaundice ), itching , feeling sick or being sick , because you may have liver disease ( hepatitis ). you will have to take regular blood tests while you are taking rilsuzola zentivea . you may cough , have difficulties in breathing , or have other lung problems . this is linked to the way your medicine works . for these reasons
what riluzole zentiva contains the active substance is rilsuzola . the other ingredients are : - tablet core : anhydrous dibasic calcium phosphate - micro crystalline cellulose , anhydrOUS colloidal silica , magnesium stearate - film - coating : crohn ' s wort ( e468 ), croscarmellose sodium - printing ink : shellac , hypromellose , macrogol 6000 , titanium dioxide ( en passant passant passant wind ). what silate zentivea looks like and contents of the pack the tablets are white to off - white , biconvex , oval tablets , debossed with " rl 50 " on one side and plain on other side . rilluzol
emgality contains the active substance galcanezumab , a medicine that blocks the activity of the calcitonin gene associated with migraine ( cgrp ). it is used in adults who have increased levels of cggrp in their blood and who are also taking eemggality for migraine ( in children and adolescents aged 4 years and older ) and who have migraines . egality has been shown to reduce the frequency of migraine headache in adults . it also helps to improve your quality of life .
do not use emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may have a serious cardiovascular disease . if the medicine has been prescribed for you , you must not use it . warnings and precautions serious cardiovascular diseases and allergic reactions emigality can cause serious allergic reactions and some of these reactions may be serious . you must stop using emegality 40 immediately and contact your doctor if a severe allergic reaction occurs . such signs and side effects can be seen in section 4 . children and adolescents egality is not recommended for children and teenagers under the age of 18 years . other medicines and emmgality tell your doctor or pharmacist if any of these apply to you . pregnancy and breast - feeding if this applies to you or your child
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of emgality is 240 mg once a week . you should inject egality under your skin ( subcutaneous injection ) at about the same time each day . your doctor will tell you how many injections of mgal to give . after proper training your doctor may decide to give you 240 doses . if a dose is missed , inject the missed dose as soon as you can . inject the next dose at the usual time . do not inject a double dose to make up for a forgotten dose . take your next dose as scheduled . it is important that you continue to inject mmgally for as long as your physician prescribes it for you , as long you continue as your treatment continues
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may occur , with rash and itching . these are rare but serious allergic reactions ( may affect up to 1 in 1 , 000 people ). difficulty breathing or swallowing , low blood pressure ( dizziness or light - headedness ), swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , a red rash or raised bumps . other side effects include : very common side effects ( may effect more than 1 in 10 people ) injection site reactions ( e . g . pain , swelling , redness or raised lumps ) reporting of side effects 23 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after preparing the solution you should use it immediately . however , if you cannot use it within 7 days , it may be stored at room temperature ( up to 30 ) for up to one month , even if it is still in its liquid form . discard this medicine if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 8 hours at room temp . once reconstituted emgality is stable for upto 7 days at room temperatures . this medicine is for single use only . any used product should
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcanézumabe in 1 ml solution . - other ingredients are l - histidine , l- histhidine hydrochloride monohydrate , polysorbate 80 , sodium chloride and water for injections . what hemgalism looks like and contents of the pack emmgality is a solution for injection in a clear glass syringe . the solution is colourless to slightly yellow . it is supplied in : - single - dose pen containing 1 , 2 or 3 pre  dose pens . not all pack sizes may be marketed .
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hvvd ) in adults . this condition occurs when the blood vessels in the liver become damaged and blood clots form . hCVd is used in combination with medicines prior to a stem cell transplantation in adults to remove defibrotoide from the blood and lead to the blood arteries . by blocking the hvie - 2b cell from these cells , it helps to prevent the blood to clottings from forming . you will be given this medicine by your doctor or nurse .
do not use defitelio - if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) - when taking other medicines to prevent blood clots ( such as tissue plasminogen activator warnings and precautions ), or if this is the case . - in combination with medicine to prevent bleeding , if there is a possibility of heavy bleeding and you need a blood transfusion after surgery . warnings : - be sure your doctor knows if your condition is not well controlled . you may be at increased risk of problems with blood circulation . your doctor will monitor you at a constant blood pressure ( see section 1 ) and may ask you to take other medicines . this includes medicines to reduce blood coagulation such as acetylsalicylic acid , and heparins
your doctor will decide on the correct dose and duration of the treatment . defitelio will be given to you by a doctor or nurse . it is given after stem cells transplantation ( into one of your veins ) as an ' intravenous infusion ' ( drip ). this treatment will be administered over 21 days . if your symptoms do not improve after 18 hours , defitlia should be stopped and the treatment stopped immediately . your doctor or a nurse will check that you have received enough defit liu . tell your nurse if you have missed a dose . do not take a double dose to make up for a forgotten dose , if a missed dose is due . contact your doctor if any of the above applies to you .
like all medicines , defitelio can cause side effects , although not everybody gets them . when you take defiterio you may experience side effects related to the way your medicine works . if you experience any of these side effects you should contact your doctor immediately . very common ( may affect more than 1 in 10 people ): low blood pressure common ( might affect up to 1 in10 people ). bleeding in general bleeding ( including the nose bleeding , the brain bleeding ), the gut vomiting , blood bleeding in the lungs bleeding . blood in the urine , in the mouth bleeding ; and in the skin coagulopathy ( disturbance in blood clotting ). reporting of side effects 25 if your child gets any side effects talk to your child ' s doctor . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting
keep out of the reach and sight of children . do not use defitelio after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . defitlia may be stored for up to 24 hours at 2  c to 8 oc . keep the vial in the outer carton in order to protect from light . before use , defitelfio must not be used if it is cloudy or if there are particles in it . any unused product must be thrown away correctly . discard any discarded via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what defitelio contains - the active substance is defibrotide . each 2 . 5 ml vial contains 200 mg defibrototide and each mml solution contains 80 mg debiotide ( 23 mg / mL ). - other ingredients are sodium citrate dihydrate , hydrochloric acid ( for ph - adjustment ) and sodium hydroxide ( for solution for injection / infusion ). see section 2 " defit eliso contains sodium ". what deFITelo looks like and contents of the pack defit
daklinza contains the active ingredient daclatasvir . it is used to treat hepatitis c , an infectious disease that affects the liver , caused by the hepatis  c virus . this medicine stops the hpatiti cvirus from multiplying and infecting other cells of the body . the virus is found in large amounts in your blood . daklinezza is used in combination with other medicines to treat your hepitis b infection . please refer to the package leaflets for the other medicines that you will be taking with dakliinza . if you have any questions about your medicines , please ask your doctor or pharmacist .
do not take daklinza - if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) or to any of those taken by mouth . - take the following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital for epileptic seizures . do not use rifampicin / rfabutin - do not give riffapentine - antibiotics for tuberculosis . dexamethasone , which is a steroid used for allergic and inflammatory diseases . medicines that contain st . jenna ' s wort ( sjs ) and sloetin ( a medicine used to treat s
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of daklinza is 60 mg once a day . this has been associated with an unpleasant taste . you should take daklinezza at least one hour before or two hours after some other medicines that you may take at the same time . your doctor will tell you how many tablets of daknza to take . if this applies to you , do not take dakza more than once . take these medicines as directed by your doctor at the right time for you ; however , you should contact your doctor for advice . how long to take daclinza your doctor may tell you to take one or more of these medicines . do not change your daily dose of diklinze without talking to your doctor first . duration of the treatment your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is given in combination with sofosbuvir and ribavirin , the following side effects may occur : very common ( may affect more than 1 in 10 people ) headache fatigue common ( might affect up to 1 in every 10 people) difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching and tender muscles when daknza ( taken in combination treatment with sofranbuvir / rib avirine ) may be given in combinations with a combination of sofasbuvar and / or ribsbuvin , but can be very serious . if you experience any of these , contact your doctor immediately . side effects reported very commonly ( may effect more than one in 10 users ) are 
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 or 60 mg of daclaatasvirus ( as dihydrochloride ). - -the other ingredients are microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate , all in the tablet core ; hypromellose , titanium dioxide ( e171 ), macrogol 400 , indigo carmine aluminium lake ( 6000 ), yellow iron oxide ( oblong ) ( pfizer ) 51 what daknza looks like and contents of the pack 51 daklianza 30 mg film  coated tablets are light blue , oval , with " bms " debossed on one side and " dcb " on the other side .
proquad is a vaccine to prevent measles , mumps , rubella and chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will make antibodies against the meases , mucus , or rubella - related varicelli viruses that cause the antibodies to diseases caused by these viruses , making them resistant to proquade . proquadas is used to prevent the two most commonly occurring diseases in adults , including measley , moles / rubella or chickenpow ( varicela ). the vaccine works by causing the body to produce its own protection ( antibodies ) against the diseases caused or prevented by these virus . the vaccine is usually given within 12 months after the first dose . however , proquaa may be given to up
do not receive proquad - if you are allergic to any varicella vaccine , measles , mumps or rubella vaccine or any of the other ingredients of this vaccine ( listed in section 6 ) or to neomycin - this is a blood disorder or type of cancer that affects the immune system . warnings and precautions talk to your doctor , pharmacist or nurse before receiving proquade : - patients who have a weakened immune system due to treatment with medications that weaken the immune response ( such as low - dose corticosteroid therapy , asthma ) who need replacement therapy - those with a weak immune system because of a disease ( including aids ), congenital or hereditary immunodeficiency ( deficiencies in the absence of immune competence ) - active untreated tuberculosis (
proquad is given by injection into the muscle of the upper thigh or upper arm . it is given as injections into the same muscle as in the tissue area or upper arms area . the recommended injection site is : - a blood clotting disorder resulting from low levels of platelets . when the vaccine is given into the skin , it may reduce the risk of bleeding . - proquade must not be given into a muscle . only a qualified healthcare professional can administer proquader into  a large blood vessel . your doctor will decide if and when you should receive proquaD as an injection .
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions such as hives may occur . these reactions may cause difficulty in breathing or swallowing , which may be signs of an allergic reaction . other side effects of proquad may occur with up to 1 in 100 doses given . seizures if you get a fever uncommon ( may affect up to1 in 1 , 000 doses ) bronchiolitis - difficulty breathing , cough and unsteadiness with walking . side effects reported with proquade may occur in up to 10 in 100 patients . injection site complaints if any of these occur , please tell your doctor or nurse . very rare ( may effect up to one in 10 ,000 doses of proqud ): - injection site reactions ( including difficulty breathing and cough ) and unwellness with walking side
what proquad contains the active substances are : measles virus1 ( edmonston strain ) 3 . 00 mumps virus1 , jeryl lynnTM ( level b ) strain 4 . 30 m rubella virus2 , varicella virus3 , merck strain 3 , 99 ml mrc - 1 strain : cellulose , plaque - forming units 1 , 2 - chick embryo cells , and fibroblasts ( mc ). msc . powder sucrose , hydrolysed gelatin , sodium chloride , ( 0 . 5 %), sorbitol ( е420 ), monosodium glutamate , potassium phosphate , water , bicarbonate . what proqud looks like and
jylamvo is an anticancer medicine that works by blocking certain receptors in the body , which are involved in the unwanted reactions . jyeramvo has been shown to be an immunosuppressive agent with an anti - inflammatory effect jYlamva is used to treat rheumatic and skin diseases in adults with active rhusatoid arthritis or polyarthritic forms in the joints . severe juvenile idiopathic arthritis in adults jia is used in adults and adolescents aged 3 years and older who have not used non - stemoidal anti  - ininflammatory drugs ( nsaids ) or who are inadequate o severe or disabling psoriasis when treatment with phototherapy or pspooralen is not appropriate or has not worked well enough to stop ultraviolet a radiation ( puva ) therapy .
do not take jylamvo - if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) - have a severe kidney impairment - suffer from a liver impairment . - are suffering from blood disorders ( such as bone marrow hypoplasia , leukopenia or thrombocytopenia ) or significant anaemia 34 - know that you have weakened immune system - had a serious infection such as tuberculosis , hiv - like ulcers in the stomach or intestines , or an inflammation of the mucous membrane of the mouth , including mouth ulcers . this may occur when taken with non - oncologic indications - such as a complication of a condition called a " cyp3a4 "
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . jylamvo can cause severe side effects or even death . your doctor will decide if the treatment should be stopped . this includes rheumatoid arthritis , severe juvenile idiopathic arthritis . severe psoriasis . you should not be given severe soriatic arthritis if your doctor determines that you should be treated with jYlamvre as a long - term treatment . the use of jlamva is not recommended for the treatment of rhumatic and skin diseases ( jia ), but it should be done under close supervision of a physician experienced in the treatment , especially for patients with p . and psesoriasesis if
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching ( especially affecting your whole body ). other side effects may include : breathing problems , feeling of illness , dry , irritating cough , shortness of breath , or difficulty in breath . chest pain ( fever ) spitting or coughing blood , serious peeling or blistering of the skin , redness of the eyes , coughing , itching , pain in your stomach , stomach ache , vomiting , nausea , constipation , loss of appetite , diarrhoea , abdominal pain , discomfort in stomach . uncommon side effects ( may affect up to 1 in
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store below 25 . keep the medicine tightly closed in order to prevent accidental spillage . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user . for the unopened vial , see section 3 for more information . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotredxate ( as methotrxate in one mL ). - - other ingredients are macrogol 400 , glycerol , orange flavour , sucralose , epidermal parahydroxybenzoate ( e218 ), sodium methyl parahydroxybenzoate ( ( c218
what enurev breezhaler is this medicine contains the active substance glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what Enurev braezhalers is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : - a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . that makes breathing difficult . by tightening these muscles in the lungs , this helps to open the airway and so improve the way the air sacs in the air . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using enuresv brewing . talk to a doctor if any of these apply to you . - patients with kidney problems . you have an eye problem called narrow - angle glaucoma . your doctor may need to adjust your dose . patients with difficulty passing urine should stop treatment with enurév  Breezhalers and start using this medicine immediately after using it . contact your doctor : - when you experience tightness of the chest , coughing , wheezing or breathlessness immediately after taking enUREv BREezhalER . this can be a sign of bronchospasm 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose is one capsule in the morning and one capsule at the evening . the recommended daily dose is two capsules in the evening and one inhalation in the afternoon . this medicine is for inhalations use only . do not swallow the capsules whole . if necessary , you can use this medicinal product at any time of the day . it does not matter whether you use it for at least 24 hours before or 72 hours after using this medicine . you will find an inhaler and capsules ( in blisters ) that contain the medicine as inhaling powder . only use the capsule ( s ). the inhalers in this pack ( enurev breezhaler inhalator ) after you have used them
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious uncommon ( may affect up to 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia , which is a combination of typical symptoms , excessive thirst , hunger and frequent urination ) rash , itching , hives , difficulty breathing or swallowing , dizziness ( signs of allergic reaction ) swelling mainly of the tongue , lips , face or throat ( signs and symptoms of angioedema ). if you get any of these side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycopyronicum broMIDe equivalent to 50 microgram of glycopyrnoium . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram ( mg ) of glycopronium - this is equivalent - - what - particulate matter is in the inhaled powder . - other ingredients in the powder are lactose monohydrate and magnesium stearate . what  Enurev brezhalers looks like and contents of the pack enuresv brewing 44 microlitres inhalation powder , hard capsules contain a white powder and are marked with the company logo and the company symbol in black on the body . they are equipped with a device called
what riximyo is rximyon contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritsimabe sticks to this cell , the cell dies . what ? when ? your doctor may prescribe rrixmyo for the treatment of several different conditions . your doctor will discuss with you the type of medicine that is most suitable for you . the active ingredient in r ) non - hodgkin ' s lymphoma this is the disease of the lymph tissue ( part of the immune system ) that affects a certain type of whiteblood cell called b- lymphocyocytes , also called lymphocytes
do not take riximyo if you are allergic to rituximab , other proteins which are like ritsimabe , or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if there is a severe active infection at the moment . this may be a sign that you have a weak immune system . for example , if your doctor has severe heart failure or severe uncontrolled heart disease , including granulomatosis , polyangiitis / microscopic polyangitis or pemphigus vulgaris . do not use rximye if any of these apply to you or your child . warnings and precautions talk to your doctor or pharmacist before using rrixyo and during treatment with risim
you will be given riximyo under the supervision of a doctor experienced in the use of this treatment . you will receive this medicine in a hospital or clinic , under the direction of - your doctor , pharmacist or nurse . this is in case you get any side effects . rximyon will be administered to you by your doctor or nurse as a drip ( intra - venous infusion ). medicines given before each ritchimya administration before you are given a dose of r , you will always receive riximo . your doctor may prescribe other medicines ( premedication ) to prevent or reduce possible side effects from your treatment , including those obtained without a prescription . for non - hodgkin ' s lymphoma if you are treated with risimye alone riskimyok
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . you may also experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , diarrhoea , nausea , vomiting , rash , redness of the skin , swelling of the face , difficulty breathing , burning sensation , pain in the chest , chest pain , muscle spasms . uncommon side effects may affect up to 1 in 100 people a
what riximyo contains - the active substance is rituximab . each 10 ml vial contains 100 mg of ritsimabe ( 10 mg / mL ). - each 50 mml ampoule contains 500 mg of of  Rituximib ( 10 % /ml ). the other ingredients are sodium citrate , polysorbate 80 , sodium chloride , water for injections , and sodium hydroxide and hydrochloric acid ( see section 2 " rximya contains sodium "). what if you use rrixmyo for your doctor or nurse will give you a clear or slightly yellowish solution for infusion . pack sizes of 2 or 3 vials of 1 vial or 2 vial . not all pack sizes may be marketed .
topotecan actavis contains the active substance topoten . topotécan activis is used to treat adults with small cell lung cancer that has come back after chemotherapy . advanced cervical cancer if surgery or radiotherapy is not possible . in this case topotercan actanis treatment is combined with medicines containing cisplatin .
do not take topotecan actavis - if you are allergic to topotencan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking topotécan activis . your doctor will check your blood cell counts regularly and may adjust your dose if necessary . if this applies to you , tell your doctor and do not stop taking totopotekan actavi . tell your healthcare professional if any of these apply to you as you may need to be monitored more closely . you may be advised not to take to potecan actingavis in case of severe kidney impairment . talk to you doctor before taking this medicine if : you have liver problems . topotacan actas is not recommended if your doctor determines that you have severe liver impairment , lung inflammation ( signs include cough ,
topotecan actavis will be given to you by a doctor who is experienced in the treatment of the disease . your doctor will carry out blood tests before you start treatment and regularly during treatment . adults small cell lung cancer the usual dose is 1 . 5 mg per square metre of body surface area given once a week for 5 consecutive days . this treatment cycle will normally be repeated every three weeks . cervical cancer the normal dose is 0 . 75 mg per sq . m2 of bodysurface area given twice a day for 3 consecutive days this treatment cycles will normally include two additional doses of cervical cancer and another anticancer medicines called cisplatin . you will be prescribed ciplatin only if you have impaired kidney function . the doctor will monitor your kidney function regularly while you are receiving topotécan activis . it is important to take topotenactavis
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side - effects : infections . common ( may affect up to 1 in 10 people ): fever . this may be a sign of your general condition . local symptoms , such as sore throat or burning sensation , severe stomach pain or fever , diarrhoea or bowel inflammation ( neutropenic colitis ). topotecan actavis may reduce your ability to fight infections ; lung inflammation . rare ( may effect up to1 in 1 , 000 people ). difficulty in breathing . not known ( frequency cannot be estimated from the available data ) - headache . - dizziness . uncommon ( may occur in up to one in 100 people ), - indigestion .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). keep the viall in the outer carton in order to protect from light . after reconstitution and dilution chemical and physical in - use stability has been demonstrated for 24 hours at 25  2 , in hdpe bottles , at 2 8 and in the refrigerator ( 28 ). from a microbiological point of view , the drug product solution should be used immediately after dilsution in solutions for infusion ( nacl 0 . 9 % and glucose 5 %) has been shown to be present at room temperature ( 20 - 25 ) for 4 hours . from , from - 24
what topotecan actavis contains - the active substance is topotencan . 1 ml solution contains 4 mg of topotécan ( as hydrochloride ). after reconstitution 1  mL solution contains 1 mg of tpotekan . - other ingredients ( excipients ) are mannitol ( e421 ), tartaric acid ( a type of hydroch chloric acid ) and sodium hydroxide . what to potecan actsavis looks like and contents of the pack topotercan actavid is supplied in a pack of 1 vial . it is supplied as a clear glass vial with grey bromobutylic stopper and aluminium seals with plastic flip - off caps , which are sealed in sleeve . the pack contains : 1 viall containing
the active substance of rivastigmine hexal is rivascal . rivizastigmin belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson 's disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivagestigine works by blocking the enzymes that break down aceticylcholline : aceylchorlinestee and butyrylcholinesterrase . by blocking these enzymes , the result is improved ability of delivering acetelcholine to the brain and reduce the symptoms .
do not take rivastigmine hexal - if you are allergic to rivassistigmin ( the active substance in rivascastigmit heexal ) or any of the other ingredients of this medicine ( listed in section 6 ). - in case of a previous skin reaction ( allergic contact dermatitis ) to rastigemine . if this applies to you , tell your doctor and do not use rivabstigmine himxal. warnings and precautions talk to your doctor before taking rivstigine heXal : - when taking rascal - have irregular or slow heartbeat - are suffering from an active stomach ulcer - experience difficulties in passing urine - suffer from seizures - asthma or severe respiratory disease - had impaired kidney function - or have impaired liver function . talk to you doctor if
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . your doctor may slowly increase your dose depending on how you respond to treatment . the highest dose that should be taken is 6 . 0 mg twice a day . you should swallow the tablet whole . it will help to keep you on the right way to take it . do not stop taking rivstigmin heexal without talking to your doctor first . this is because it has not been studied in the clinic , but it is recommended that you take it for no longer than three days . taking this medicine tell your doctor straight away if your doctor thinks it is safe for you to take the
like all medicines , this medicine can cause side effects , although not everybody gets them . you may get side effects more often when you start your medicine or when your dose is increased . usually , the side effects will slowly go away as your body gets used to the medicine . very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ), diarrhoea common ( might affect up to 1 in 100 people ). anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling , feeling confused or confused tremor on standing up , difficulty concentrating , changes in sense of taste , being less hungry , lack of energy , problems with digestion , constipation , dry mouth , indigestion , wind ,
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister . the expiration date refers to the last day of that month . store below 30 .
what rivastigmine hexal contains 64 - the active substance is rivistigmine hydrogen tartrate . - other ingredients are hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ) and titanium dioxide (  e171 ). - printing ink : shellac . each rivage heexal 1 . 5 mg capsule contains 1 , 5 mg of rivattigmine and each rastigemine hxal 3 mg capsule contain 3 mg of the active substances rivustigmine in each capsule . the other ingredients in the capsule are : - core : peach - peach colour , - titanium dioxide , and - shellacao .
what cabometyx is cabrometyn is a cancer medicine that contains the active substance cabozantinib . it is used to treat adults with a type of kidney cancer called renal cell carcinoma , or liver cancer when one of the active substances in the medicine , sorafenib ( s ) is not suitable . what scabomettingyxis is used for cabômetyc blocks the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the growth of new blood vessels that supply them . these proteins can be present in high amounts in cancer cells . cabmetys is indicated for the treatment of these conditions .
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabrometyc : - in case of high blood pressure , or if there is an aneurysm ( enlargement and weakening of a blood vessel wall ) or a tear in a vein wall . - contact your doctor if any of these apply to you . you may experience diarrhoea , have a recent history of significant bleeding . surgery : have had in the last month or have had surgical procedures , including dental surgery . evidence of inflammatory bowel disease ( crohn ' s disease or other conditions that affect the bowel ) including pain , swelling
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will monitor you and decide if your treatment is suitable for you , as you may be more prone to serious side effects . during treatment with cabometyx , the usual dose is 60 mg of cabrometyn taken once a day for 2 hours . you should not take cabombyx more than 1 hour after taking the medicine . swallow the tablets whole with water . do not chew , crush or split the tablets before swallowing . if possible , you can take a tablet at any time during the day , or with food . it is best to take - up to 12 hours between doses . the recommended dose is 12 tablets per day .
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects while you are taking cabometyx , but your doctor may prescribe other medicines to help control your side effects ( see section 2 ). tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : symptoms include pain in the abdomen , nausea ( feeling sick ), vomiting , constipation , fever and a gastrointestinal perforation ( a hole that runs from your stomach to your intestine ). severe or uncontrollable bleeding . symptoms include vomiting blood , black stomachs and / or red blisters ( stools ). these can be symptoms of a stomach ulcer . if they happen , stop taking a tablet and contact your doctor immediately . tell your dentist if any of these side effects occur . other
what cabometyx contains - the active substance is cabozantinib ( s ) malate . cabombyx 20 mg tablet contains cabazantine ( f ) ( as malate 20 mg cab zantib ). cabrometyyx 40 mg tablet includes cabcabozzantininia ( r ) in its entirety ( as male ) as malated 40 mg / 0 . 5 mg , i . besilate ). each tablet contains approximately cabantinab . each tablet also contains a desiccant containing cabsantinimab ( in ss ), as malat 40 mg of cabzant inib in its pure form . the desiccants are a white to off - white tablet 
pemetrexed hospira is a medicine used in the treatment of cancer . pemetreixed hospira will be given to you in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . when pemetreced hompira was given in combination mit cISplatin for the initial treatment of patients with advanced stage of lung cancer : pemetreexed houspiral can be prescribed to you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy ; pemetreexed
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetrexxed or any of the other ingredients of this medicine ( listed in section 6 ). - when breast - feeding is allowed or recommended , your doctor may decide to stop treatment with pemetreexed . - before you receive a vaccine against yellow fever , you must not receive pemetreced hompira until you have established that you have problems with your kidneys . warnings and precautions talk to your doctor or hospital pharmacist before receiving pemetreexed as you will be monitored carefully before each infusion to check that you are getting enough blood cells and that your kidney and liver function are working properly . you should not receive Pemetrex hospria if your blood cell counts are too low . when given in combination with cisplatin , it is important
the dose of pemetrexed hospira is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your area , and your doctor will use this body surface area to workout the right dose for you . this dose may be adjusted , or treatment may be delayed depending on your blood cell counts and on your general condition . a hospital pharmacist , nurse or doctor will have mixed the pemetreced hompira powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution for injection before it is given to you , in a vein . the infusion will last approximately 10 minutes . when using pemetreexed hesperia in combination with cisplatin the doctor or hospital pharmacist will work out your dose based on your height  and
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : fever or infection ( common ): if your doctor gets a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if caught early , you may start feeling chest pain ( common in patients with a fast heart rate ), pain , redness , swelling or sores in your mouth ( very common in people ). allergic reaction : - skin rash ( common with burning or prickling sensation ) or fever ( common among patients with skin reactions ). death has been reported with pemetrexed hospira . most cases of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . when prepared as directed , chemical and physical in - use stability of recombinant dilution of infusion solutions of pemetrexed was demonstrated for 24 hours at refrigerated temperature . use the reconstructed solution immediately after reconstitution . parenteral medicines : do not store this medicine in the original carton in order to protect from light . any unused solution must be discarded after reconversion .
what pemetrexed hospira contains - the active substance is pemetreixed ( as pemetrexxed disodium hemipentahydrate ). pemetreexed hompira 100 mg : each vial contains 100 milligrams of pemetreXed( as pemeterxeded dissodium hydropent hydrate ) while the other ingredient is pemeterixe hospria 500 mg ; each vially contains 500 millilitres of Pemetrex ed [ dimetrexeed disobedihydrate ]) while it is being diluted . pemetreuxed
ganfort contains two active substances called bimatoprost and timolol , which help to control pressure in the eye . bimatophoprostain belongs to a group of medicines called prostamides , and is a prostaglandin analogue to temololl . both belong to  a class of medicines known as beta - blockers . when the eye is first opened , a clear , watery liquid starts to build up inside the eye and the liquid stays in the liquid for a long time . this helps to control the pressure in your eye and reduce the risk of glaucoma . it also helps to reduce the amount of liquid that the eye needs . ganfordt eye drops are used to reduce high pressure inthe eye , also known as glauscoma in adults . the combination of gan
do not use ganfort eye drops - if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of ganforces ( listed in section 6 ) - for respiratory problems such as asthma , severe chronic obstructive bronchitis - this is a serious , long - standing cough that can cause wheeziness or difficulty in breathing , or long  - lasting cough - as this can increase your risk of heart problems such : low heart rate , heart block or heart failure warnings and precautions before using this medicine , tell your doctor if : you have coronary heart disease ( symptoms include chest pain , chest pain or difficulty breathing ) you have severe chronic or chronic bronchospasm ( severe chronic chronic occlusive pulmonary oe
always use ganfort exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to use your doctor will tell you how much ganforcet to use . the recommended dose is one bottle in each eye for three days . treatment should be started by taking the bottle at the neck . step 5 . wash your hands before you use ginfort . do not touch the bottle with your head or face . 2 . pull down your upper eyelid until there is a small pocket . 3 . gently squeeze the bottle to release gan fort into your eye . if the medicine is injected into your eyes , the doctor may decide to stop treatment . 4 . close the lid of your eye 5 - gently squeeze one drop of ganft into the eye by pressing a finger into the corner of your eyes (
like all medicines , ganfort can cause side effects , although not everybody gets them . you should stop using the drops and see your doctor immediately if you notice any of the following side effects after using gan fort ( multi - dose or single - dosing ). very common side effects ( may affect more than 1 in 10 people ) - the eye redness . common side effect ( may effect up to 1 in 9 people ). - a drop in the eye burning , itching , or stinging , irritation of the conjunctiva ( the transparent front part of the eye ), sensitivity to light , eye pain , sticky eyes , dry eyes - feeling of something in the eyes . small break in the vision , small break or tear in the iris ( the coloured part of your eye ). reporting of side effects 23 if your child
keep out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and the bottle label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . solution for eye infections should be used within 4 months after first opening . discard any unused solution via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what ganfort contains - the active substance is bimatoprost , 0 . 3 mg / ml solution for injection contains timolol ( equivalent to 5 mg of titmolollol maleate , equivalent to 6 . 8 mg ). - other ingredients are benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate . - purified water , hydrochloric acid and sodium hydroxide . what g ganforce looks like and contents of the pack ganft is a clear , colourless to slightly yellow eye drop solution in a plastic bottle . each pack contains 1 bottle with 3 bottles with a screw - cap and 3 bottles without a mouth - gap . the
gefitinib mylan contains the active substance gefitib which blocks a protein called ' epidermal growth factor receptor ' ( egfr ). this protein is involved in the growth and spread of cancer cells . gefiteinib melan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan - if you are allergic to gefit inib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking gefitib melan . tell your doctor if any of these apply to you . do not use gefiteinib in your everyday life . some lung problems may get worse during treatment with gefitineib . talk to a doctor , pharmacist or nurse before taking this medicine if : you have any other lung problems . your doctor may want to change the dose of gefitINib your doctor has given you , if these apply for you : - you have problems with your liver . children and adolescents do not give gefitInib to children and teenagers under 18 years . other medicines and gefitnib tell your
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one 250 mg tablet once daily . swallow the tablet whole . do not chew , crush or split the tablet before swallowing . if necessary , you may take an additional 250 mg dose . you may need to take antacids on an empty stomach , 2 hours before or 1 hour after taking gefitinib mylan . take the tablet at the same time each day . it is best to take it at the right time each night . try to take your tablet at about the same times each day to make sure it works for you , preferably at the wrong time each week . this will help you remember to take the medicine . for children , adolescents and adults , children and adolescents , the recommended daily dose is
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives ( nettle rash ) and difficulty breathing . serious breathlessness : sudden worsening breathlessness with a cough or fever . this may be a sign of an inflammation of the lungs called ' interstitial lung disease '. this is uncommon ( may affect up to 1 in 100 people ). stop taking gefitinib and see a nurse straight away and see your doctor straightaway if they happen . severe skin reactions have been reported in some people taking geFITini B . these reactions have spread to other parts of the body 
what gefitinib mylan contains - the active substance is gefiteinib . each film - coated tablet contains 250 mg of gefitib ( as mesilate ). - other ingredients are lactose monohydrate , microcrystalline cellulose ( e460 ), crospovidone ( type a ), povidone( k30 ), sodium laurilsulfate , magnesium stearate ( s ), polyvinyl alcohol , macrogol 4000 , titanium dioxide (  e171 ), red iron oxide ( ileopardosilicate ) and yellow iron oxide , all in the tablet coating . what geFITini B mylan looks like and contents of the pack gefit inib melan tablets are pink , oval , biconvex film , tablet of 11 .
reblozyl contains the active substance luspatercept and is used to treat myelodysplastic syndromes ( mds ). myelaodys plastic syndromes , m , are caused by many different blood and bone marrow disorders that can cause red blood cells become abnormal . these can be signs and symptoms of a low red blood cell count ( anaemia ) and red bloodcell transfusions . reglazyl can be used to reduce the number of anaemic adults with mcs who need red blood plate transfusion ( erythropoietin therapies ). beta - thalassaemia ( a blood problem caused by genetically altered ms ) is a condition where genes are altered and the cells become altered over time . it is caused by the way the blood cells are made . this can occur
do not take reblozyl - if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) - ( if this applies to you )- - are pregnant or planning to become pregnant ( see pregnancy section ). warnings and precautions talk to your doctor or pharmacist before taking this medicine - have had your spleen removed - had a blood clot - need hormone replacement therapy - lost or increased risk of a previous blood clumping of blood . prevention measures recluzyl may not be suitable for you . if a new clotting occurs , you should be carefully monitored by your doctor . your doctor may recommend preventive measures ( such as taking medicines to prevent a bleeding ) or to treat high blood pressure . you should not take the medicine if any of these apply to
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will carry out blood tests before you start using reblozyl . reglazyl is given as an injection under the skin . you or your caregiver must weigh at least one kilogram ( kg ) before each injection . the injections should be given at least 1 . 1 mg per kilogram of body weight . this dose may be adjusted by your doctor based on your blood pressure . when reblazyl should be used in patients with myelodysplastic syndromes the maximum single dose is 1 , 75 mg per kg of body weigh . in patients of beta - thalassaemia the maximum simple dose is 11 . 25 mg perkg of bodyweight . use in children and adolescents your doctor may tell you to use reblizyl at
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you experience any of the following : difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , especially if only on one side of the body , blurred vision and / or symptoms of a stroke blood clots swelling of the area around the eyes , face - lips , mouth , tongue or throat allergic reactions including rashes and rash , which may be severe . they usually occur within a few days to a couple of weeks . these reactions usually go away as treatment continues . if they persist , contact your doctor immediately . your doctor may decide to reduce your dose or stop your treatment . side effects that may occur are
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution , the product may be stored at ambient room temperature ( up to 25 ) for up to 24 hours . from a microbiological point of view , reblozyl should be used immediately . any unused medicinal product or waste material should be disposed of in accordance with local requirements .
what reblozyl contains - the active substance is luspatercept . each vial contains 25 mg or 75 mg of luspatiercept ( as excipients ). after reconstitution , each ml of solution contains 50 mg of the active ingredient luspattercept - this product does not contain excipiants , citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( for the phe adjustment ). what retinol looks like and contents of the pack rebrozyl is a white to off - white powder . reglazyl 25 mg and 75 mg luspaspaterception are available in packs containing one or two vials . not all pack sizes may be marketed .
the active substance in fotivda is tivozanib , a protein kinase inhibitor . tivolinib works by stopping the growth of the cancer and slows down the growth and spread of cancer cells . this helps to build new blood vessels . fotiva is used in adults with advanced kidney cancer when other treatments with alpha or interleukin - 2 have not helped to stop your disease .
do not take fotivda - if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). - when you are taking st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor or pharmacist before taking fotiva . high blood pressure . fotiv da may raise your blood pressure when you start taking foivida and your doctor will check your bloodpressure regularly while you are on a medicine . it is important that you take foividas every day until your blood temperature is controlled . your doctor may also prescribe fotivdas together with a medication for high bloodpressure . you should not take this medicine if it does not work . low blood pressure can occur if treatment with fotivdea
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of fotivda is 1340 mg / 21 mg capsules for adults and children aged 7 years and over . take 1 capsule ( 100 mg ) once a day in the morning . capsules should be taken at least 4 hours after the first dose . do not take fotiva more than once , as this may increase the risk of unacceptable side effects . if severe side effects occur , your doctor may decide to stop fotivdada therapy . your doctor will decide if and when you should stop fotiveda . fotiv da 890 mg capsule for adults , children and adolescents 21 kg and over the age of 7 years : one capsule should be swallowed whole with water , and 1 capsule should not be swallowing
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure : a common side effect that may affect up to 1 in 10 people , see section 2 ' warnings and precautions '. tell your doctor immediately high blood blood pressure has been reported . symptoms may include severe headaches , blurred vision , shortness of breath , changes in your mental state or feeling anxious , confused or disorientated . your doctor may need to adjust your dose of fotivda . if you have high blood tension , you may need a medicine to treat your high bloodpressure . it is important that you take fotiva every day , as long as your doctor prescribes it for you . this is to reduce the risk of side effects and reduce the dose of the medicine you are taking for your high cholesterol . you should not take fo
what fotivda contains - the active substance is tivozanib . each capsule contains tivonib hydrochloride monohydrate equivalent to 890 mg tivolinib ( as tivor ). - other ingredients are mannitol , magnesium stearate , gelatin , titanium dioxide ( e171 ), indigo carmine ( k25 ), yellow iron oxide ( i ) ( pfizer ), propylene glycol ( a type a ), strong ammonia solution , and titanium dioxide , tartrazine aluminium lake ( hdpe glass ). printing ink contains shellac , propyen glycol . - strong ammona solution and indig orange carmine aluminium water for injections . fotiva 1340 mg hard capsules are available in packs 
stribild contains two active substances : elvitegravir , an antiretroviral medicine known as an integrase inhibitor cobicistat , a booster ( pharmacokinetic enhancer ) of the effects of eelvisegravar emtricitabine , which is an antiregular medicine known only as a nucleoside reverse transcriptaser inhibitor ( nrti ) and tenofovir disoproxil , another antirétroviral medication known as  a nuclear nucleic oxide reverse transcriptor ( rtis ). strebild is available as : in a single tablet regimen for the treatment of human immunodeficiency virus ( hiv ) infection . s tribild is used to treat hiv in all age groups .
do not take stribild - if you are allergic to elvitegravir , cobicistat , emtricitabine , or tenofovir or tanofovar disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking treatment with any medicine containing ten ofovir disoproproxil . your doctor will monitor your kidney function and may adjust your dose if necessary . these medicines may be taken together with alfuzosin ( used to treat an enlarged prostate gland ) amiodarone , quinidine ( used for irregular heartbeats ) 47 dabigatran ( used in adult men to prevent blood clots ), carbamazepine , carbazine . if your doctor determines
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . adults ( 12 to less than 18 years of age ) the recommended dose is 35 mg taken by mouth twice daily . your doctor may adjust the dose or stop your medicine depending on how you respond to the treatment . you may take medicines such as oral supplements , antacids and laxatives containing minerals ( such as magnesium , aluminium , calcium , iron , zinc ) taken for at least 4 hours before or after taking stribild . if your doctor thinks that the effect of sTRIbild is too strong or too weak , talk to your doctor immediately . take the tablet at the same time each day . it does not matter whether you take it with or without food . swallow the tablet whole with water . do not
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood cholesterol sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether some of the unwanted effects are caused by stribild or by the hivi disease itself . serious side effects tell your doctor immediately if you get lactic acidosis ( excess lactic acids in the blood ) which may be a common side effect of some hiv medications . lactic Acidosès may be more common in people who are overweight or have liver disease . the risk of lacticacidosis is deep , rapid , fast , or
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each sTRIbild film - coated tablet contains 150 mg of eelvisegrav , 150 mg cobicistent , 200 mg emetricit , and 245 mg of the active substance , in each tablet . the other ingredients are : tenovir diseaseproxil 300 mg / tenoffovir diproxil fumarate , or 136 mg of each ten ofovir . - the other ingredient ( excipients ) are croscarmellose sodium , the hydroxypropyl cellulose , lactose monohydrate , magnesium stearate ( e470b ). what steiger
zyprexa contains the active substance olanzapine . zy prexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , which are characterised by symptoms of excitement or euphoria . using zypréxa has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olangzapinе treatment .
do not take zyprexa - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a swelling face , or swollen lips and shortness of breath . if this has happened to you , tell your doctor . you may have eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor or pharmacist before taking zy prexa you should tell your dentist that you are taking zeprexа if : you are being treated for dementia . serious side effects some people taking medicines have been reported in patients who have had movements mainly of the face or tongue . your doctor may want to monitor you more closely while you are on 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of zyprexa tablets is one 5 mg tablet taken once a day . your doctor may increase your dose to 20 mg once  a night . consult your doctor if your symptoms return but do not stop taking zyPrexa without consulting your doctor first . you should take your zypréxa tablet at the same time each day , preferably at the start of the day ; if necessary , your doctor will tell you to take your tablets at the right time every day if needed . zy prexa coated tablets are for oral use . swallow the zypresa tablets whole with water . do not chew , crush or split the tablets as they may break easily . take the zeprexxa table with water and drink it
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( an uncommon side effect which may affect more than 1 in 100 people ). especially in the legs ( symptoms include swelling , pain and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if any of these symptoms occur , contact your doctor or pharmacist immediately . very common side effects ( may affects more than one in 10 users ) effects mainly affects the face and tongue . blood clumps may also occur as a result of taking zyprexa . common sideeffect ( may effect up to one in 100 users
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . zyprexa should be used within six months after first opening . these measures will help to protect the environment .
what zyprexa contains - the active substance is olanzapine . each zyPrexa tablet contains either 2 . 5 mg , 5 mg or 7 . 5, for doses of 10 mg / 15 mg or 20 mg . - your zypresa tablet pack contains lactose monohydrate , hyprolose , crspovidone , microcrystalline cellulose , magnesium stearate , and hypromellose . the tablet coating contains titanium dioxide ( e171 ), and carnauba wax . what zeprexа looks like and contents of the pack the different zypréxa tablets strengths are white to off - white , round tablets with " ol2 " debossed on one side and " nvr " on the other side . one zy prexa 2
what prolia is prolisa contains denosumab , a protein ( monoclonal antibody ) that attaches to another protein that causes bone loss , in patients with osteoporosis . treatment with proloa helps to make bone stronger and strengthen the bone . it also increases the amount of oestrogen that is produced during the menopause . as a result , the amount and strength of bones decreases . this process makes it harder for your bones to become thin and fragile . what is osteoponomics ? osteoporotic women with osteoponis often have high levels of testosterone and / or glucocorticoids , which are used to treat osteopossesis , but these women have no symptoms but are often short lived .
do not use prolia - if you have low calcium levels in the blood ( hypocalcaemia ). - are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using proloia ( see section " prolisa contains lactose "). if any of these apply to you , tell your doctor before using proton - free prolide . if the use of prolinia in children and adolescents is not recommended . talk to the doctor or nurse before using the product if : you have a skin infection with symptoms such as a swollen , red area of skin usually on your leg that feels hot or tender ( cellulitis ). symptoms can include fever . these symptoms may be due to an allergy to latex .
always use prolia exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one pre - filled syringe of 60 mg / ml given once every 6 weeks as a single injection under the skin ( subcutaneous ) in your thighs , abdomen or upper arm . prolisa is available in packs containing stickers , calcium and vitamin d supplements to help you remember to take prola . if your doctor decides that you can use prolaia with or without food , talk to your doctor . it is important that you follow your doctor and nurse ' s instructions exactly as described in this leaflet . do not try to inject proloa yourself . your doctor will tell you how to inject yourself if and when you need to inject it .
like all medicines , this medicine can cause side effects , although not everybody gets them . prolia may cause skin infections ( cellulitis ). tell your doctor immediately if you get any of these symptoms while being treated with prolis : - if your doctor notices that your leg is swollen , red area of skin on one side of your leg and feels hot and tender ( symptoms may be fever ). while being given prolium , you may experience pain in the mouth and / or jaw , swelling or non - healing of sores in the jaw or jaw including discharge , numbness or a feeling of heaviness in the hands or feet or loosening of a tooth . these may be signs of bone damage in the legs . osteopathy in patients treated with anti - osteopathy treatment with prolaminia : common side effects (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . your pre - filled syringe may be stored at room temperature ( up to 25 ) for a single period of up to three months . once the injection has been completed , it must be used within 25 days or disposed of . you must use it within 30 days of the date on the viall and the date after which it should be discarded . use in accordance with local requirements , the product should be used immediately . in accordence with local requirement , these measures will help to protect the environment .
what prolia contains - the active substance is denosumab . 1 ml solution for injection contains 60 mg of denosomab ( 60 mg / mL ). - other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prolaia looks like and contents of the pack proloa is a clear to slightly pearly , colourless to slightly yellow solution for infusion in a pre - filled syringe with or without a needle guard .
ambirix is a vaccine used to protect children and adolescents from 1 year up to and including 15 years against two diseases , called hepatitis a and hepatis b . infection with the hepa a virus can cause the liver to become swollen and inflamed . the virus can be passed from person to person , or it can be spread to other people . if the virus is found in an infected person : the virus may be found in faeces , serum or saliva . symptoms may occur up to 3 to 6 weeks after infection has stopped . you may feel sick with a fever , aches and pains or you may not feel better after a few days . it may take longer than one month for the virus to come back . tell your doctor if you have any of these signs or symptoms , for example
do not receive ambirix if you are allergic to ambirx or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . these may be signs of a possible allergic reaction . as with any vaccine against hepatitis a or hep b diseases , you may have a severe infection with a high temperature ( over 38 ). if this applies to you , the vaccine may not be suitable for you . a minor infection such as a cold should not be a problem , but talk to your doctor first . warnings and precautions talk to you doctor or pharmacist before you are given ambirice if : you have been given ambriix to prevent hepatis  a and b infection within the last four weeks or
your doctor or nurse will give you ambirix as an injection into a muscle , usually in the upper arm . ambirx will be given into , or into - a vein . the injection will be injected into the thigh muscle . you will receive a total of two injections . if you have not previously received the injections within 12 months of the first injection , the second injection should be given between 6 and 12 months after the first one . your doctor will decide when you should receive extra doses and future booster dosing . two injection s may be given at the same time . it is important that you follow this advice carefully so that it is clear what your doctor has told you to . tell your doctor if your child is receiving more ambiriix than he / she should . patients who have received more amburix than they should if they think
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : allergic and anaphylactic reactions the signs may include a rash , itchy , blistering and swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . side effects reported in clinical trials for ambirix were : common ( may affect up to 1 in 10 people ) headache loss of appetite feeling tired or irritable pain in arms or legs , loss of strength , weight gain , increased weight , confusion , dizziness . reporting of side effects 25 if your child gets any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can
what ambirix contains 26 the active substances are : hepatitis a virus ( inactivated ) 1 , 2 - 720 elisa units / dl , hepatis b surface antigen 20 - human diploid ( mrc - 1 ) cells - aluminium hydroxide , water for injections - the other ingredients are , in the powder : saccharomyces cerevisiae ( csc ) and aluminium phosphate 0 . 4 ml - sodium chloride - water for injects what ambilix looks like and contents of the pack suspension for injection in a pre - filled syringe . ambirx is a white , slightly milky liquid . it is available in packs of 1 vial and in packs containing 1
what bexsero is and what it is used for bexxserso is a meningococcal group b vaccine . bexsono is given to protect against the bacteria neisseria meningeritidis group a . how bexzero works bexsiero is used to treat children and adolescents ( from 2 years of age ) with a type of disease called the naeisseris meningitidic group c bacteria . these bacteria cause infections called meningitsis ( inflammation of the brain and spinal cord ) and sepsis ( blood poisoning ). when bexsentido is administered the body ' s natural defence system ( immune system ) produces its own protection ( antibodies ) against the disease .
do not receive bexsero if you are allergic to any of the ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before vaccination with bexSero and during treatment if : you have a severe infection with a high temperature ( over 38 ). in this case your doctor may recommend vaccination with h1n1 . a minor infection such as a cold should not be a problem . your doctor should discuss this with you before vaccination . you have haemophilia or any other problem that may prevent your blood from clotting properly , such as the use of blood thinners ( anticoagulants ) during treatment which stops your immune system from working properly ( eculizumab ). you have been vaccinated with bexxsere against disease caused by the neisseria meningit
bexsero is given to you by your doctor or nurse . the recommended dose is 5 micrograms given as an injection into a muscle , usually in the thigh or upper arm . your doctor will decide how many injections you need . this is a total of 2 to 5 microlitres given three times a week . you will receive an additional injection ( booster ) after the first injection . if you miss an injection , you may not be able to go back to your regular schedule . however , if it is less than 2 months since your first injection your doctor may decide to give the injection - you will be given the second injection at least 2 months apart . depending on the dose you receive , the interval between injections may be longer than 1 month . in most cases , your doctor can give the interval from 2 months . when a booster is given 
like all vaccines , this vaccine can cause side effects , although not everybody gets them . bexsero may cause the following side effects which may occur during treatment with bexmero : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the inject site ; swelling of the flesh at the vaccine injection site and hardness on the skin around the injection area . common ( might affect up to 1 in 100 people ). fever . loss of appetite . skin at injection site side effects of this vaccine are listed below . very common : may affect upto 1 in10 people : fever , loss of muscle , muscle and joint pain . uncommon ( may effect up to1 in 100 persons ) : tremor , numbness , pain , tenderness . not known 
what bexsero contains the active substance is recombinant neisseria meningitidis group b nhba fusion protein . 1 , 2 or 3 vials contain 50 micrograms of rerecombinate nezeisseriia maningititididis group group a nada protein , 1 x 2 or 2 x 3 viales contain 50 milligrams recominant noreseria meringitidas group c nadaprotein , 3 x 50 microgramms of the rekominant nuisseridia nneisses group fhbp fusion proteins , in 1  , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 25 microgram ( 0 . 5 milli
nitisinone mdk contains the active substance nilinione . this medicine is used to treat a rare disease called hereditary tyrosinemia type 1 in adults , adolescents and children of all ages . in this disease your body is unable to break down the amino acid tanyrosine ( amino acids are building blocks of our proteins ) and are unable t to break them down properly . nitsinone helps to prevent tyingrosine from building blocks and the harmful substances it produces . your doctor has prescribed this medicine to help lower the amount of tychrosine that your body produces , and to reduce the levels of low tirosine and phenylalanine ( another amino acid) in your body .
do not take nitisinone mdk if you are allergic to niitisine or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . pregnancy and breast - feeding do not breast – feed while taking nitsinone madk and do not wash your eyes . during natisinine mndk treatment you may develop red eyes that look like water . tell your doctor immediately for an eye examination . eye problems may be a sign of inadequate dietary control ( see section 4 , possible side effects ). before you start the treatment , your doctor will take blood samples to monitor you during the treatment to check for side effects and blood disorders . liver and other parts of the disease affect how your liver works . the disease effects on the liver and kidneys
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take treatment with this medicine depends on the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 mg per kg of body weight , taken once daily . the recommended daily dose is 20 mg per kilogram of bodyweight , given once daily by your doctor in accordance with official recommendations . in this patient population , the usual dose is one capsule . after swallowing the capsules , you may take a small amount of water or formula diet to help you remember to take nitisinone mdk . if this happens , do not take more capsules than your doctor tells you to . contact your doctor as soon as possible if any of the above applies to you , or if your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . nitisinone mdk can be stored for up to 2 weeks at a temperature not above 25 . keep the container tightly closed in order to protect from light .
what nitisinone mdk contains - the active substance is niitisine . nitsinone one mk 2 mg capsules contains 2 mg natisinine - nităisinon - each ntk 5 mg capsule contains 5 mg / ml of nITisino - one nitchenone - two nites per capsule - another nistisininone two mndk 10 mg capsule containing 10 mg , nlitisine - other ingredients : gelatin , titanium dioxide ( e171 ), black iron oxide ( ilealand ) and shellac glaze what st . august , 2012 - 2013 - 2014 - 2015 - 2016 - 2017 - 2018 - 2019 - 2020 - 20 mg
the active substance in docetaxel accord is docetaxil . docetaxiall is a substance derived from the needles of yew trees . becquerel belongs to the group of anti - cancer medicines called taxoids .. dozeaxel acord has been prescribed by your doctor for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer . gastric cancer and head and neck cancer : - for the diagnosis of advanced breast cancer the combination of docetal accord may be administered in combination with doxorubicin , trastuzumab , and capecitabine . - pentru the treatment and prevention of early breast cancer and lymphoma , the combination may be prescribed for the prevention of lymphoblast growth .
docetaxel accord should not be used : - if you are allergic ( hypersensitive ) to docetaxil or any of the other ingredients of docetacel accord ( listed in section 6 ) - because the number of white blood cells is too low you have a severe liver disease warnings and precautions before each treatment with docetal accord , you will have blood tests to check that you have enough blood cells and sufficient liver function to receive docetachl accord. in case of white and blue blood cells disturbances , your doctor may experience associated fever or infections , and you should contact your doctor immediately if your doctor experiences abdominal pain or tenderness , diarrhoea , rectal haemorrhage , blood in stool , fever and / or fever . if any of these apply to you , tell your doctor . warnings :
docetaxel accord will be administered to you by a healthcare professional . usual dose the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m2 ) and will determine the dose you should receive . method and route of administration docetaxil accord is given by infusion into one of your veins ( intravenous use ). the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . the dose may vary depending on your blood tests , your general conditions and your response to docetal accord . in particular , please inform your doctor in case of diarrhoea , sores in the mouth , feeling of numbness or pins and needles , fever and give her / him results of your blood
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord alone are : decrease in the number of red blood cells or white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea , tiredness . in most cases , the severity of adverse events of doceaxel may be increased . docetaxil accord may be given in combination with other chemotherapeutic agents . during the infusion at the hospital the following allergic reactions may occur . very common ( may affect more than 1 in 10 people ): flushing , redness , itching , burning sensation , pain in the joints , muscle spasms
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the vially in order to protect from light . after dilution , the medicine should be used immediately . if not used immediately the infusion bag may be stored at room temperature ( not above 25 ) for up to 6 hours below 25 . when refrigerated , allow the inffusion solution to come to room temperature prior to use . non - pvc bags may be kept at room temperatures ( not below 25 or below 25 for a single period of up to four hours ). the infuzation solution should be clear and colourless . once removed from
what docetaxel accord contains - the active substance is docetaxil . each ml of concentrate for solution for infusion contains 20 mg of docetaxiall - each 1 mL vial of concentrated concentrate contains 20 milligrams of docotaxel , each 4 mlitre vial containing concentrate contains 80 mg of doncetaxell . one vial in the 8 m mluice glass vial contains 160 mg of didcetaxe - one vially in the solvent . - - other ingredients are polysorbate 80 , ethanol anhydrous ( see section 2 ) and citric acid anhydrously . what dotaxel acord looks like and contents of the pack docettaxel accord concentrate for concentrate for infuse is a clear pale yellow to brownish - yellow to pale yellow solution . it is supplied in glass vially
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . your child must not take this medicine if your child is impulsive ( hyperactive ) and cannot behave normally ( as expected ). this medicine is used to treat ' attention deficit hyperactivity disorder ' ( adhd ) in adults who are already taking current stimulant medication . if current medication does not reduce adhd symptoms , your child will be given the medicine together with a treatment programme that will include psychological therapy , educational therapy and social therapy . intunev is used in adults 38 who are unable to resist the impulse or will not stop taking adhd until they have recovered . adhd is a condition that can be treated in adults .
do not take intuniv - if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine : - take special care with intunev : talk to a doctor or go to st . john ' s wort if any of these apply to you . low or high blood pressure . heart problems . talk to the doctor if your family / carer notices any signs of heart problems such as : you have ever fainted or have recently had thoughts or feelings of suicide . you are or have ever had any other psychiatric conditions . withdrawal symptoms if a person suddenly has increased heart rate or high heart pressure , you should stop taking this medicinal product and see your doctor immediately . these problems
your treatment should be initiated by a doctor experienced in the treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your treatment will start with the dose 1 mg / kg bodyweight . the recommended dose is 1 mg per kg body weight . you will start treatment at a low dose of 0 . 05 mg , followed by 0
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell while you are taking your medicine , stop taking it and talk to a doctor straight away . serious side effects tell your doctor straightaway if any of the following side effects occur : feeling drowsy , feeling dizzy ( hypotension ), slow heart beat ( bradycardia ), feeling faint , loss of conciousness ( syncope ), a serious withdrawal side effect . high blood pressure , with symptoms such as headaches , being confused , nervousness , agitation , and tremors ( hypertensive encephalopathy ). other side effects include : very common ( may affect more than 1 in 10 people ): feeling weak ( hypotonic ) feeling weak or dizzy feeling faint ( hypotensives
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister pack after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from moisture . the tablets should be taken immediately after opening the blister pack .
what intuniv contains - the active substance is guanfacine hydrochloride . - 1 mg of guantacine per 2 ml solution for injection contains guangfacina hydroch chloride , corresponding to 2 mg of the active ingredient . each 2 - mg tablet contains GUanffac . the 3 - dose tablet contains 3 mg of of GUANfaC . every 4 - day tablet contains 4 mg of deltoid guinfacate hydrochchlorides , equivalent to 4 mg guansfacci . what infunivi looks like and contents of the pack intunev is a white , round , flat , bevelled - edge tablet marked with " gs / gl " on one side . intui
ecalta contains the active substance anidulafungin . it is used to treat adults ( aged 1 to 18 years ) with a type of fungal infection that affects the blood or other internal organs ( called invasive candidiasis ). it is when the infection is caused by fungal cells called candida , which are called echinocandins . these medicines help to prevent serious fungal infections caused by the growth of fung cell walls . eCALta is used when fungal cell walls become damaged or do not work properly . the active ingredient in ekalta makes fungal plants have incomplete or defective cell walls that are fragile and unable to grow .
do not use ecalta - if you are allergic to anidulafungin , other echinocandins ( such as caspofungin acid ) or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using ekalta and during treatment : - your doctor will monitor your liver function and will decide if this medicine is suitable for you . - you have liver problems during or after your treatment . your doctor may prescribe you other anaesthetics while you are receiving your treatment with echelta ( see section 4 ). - an allergic reaction which may include itching , wheezing or blotchy skin ( known as an infusionrelated reaction ). you may experience a rash , hives , itching and redness ,
the treatment will be started by a doctor who is experienced in the treatment . the recommended dose is 200 mg ( 100 mg ) given once a week . use in children and adolescents ( aged 1 month to 18 years ) the recommended dosage is 3 . 0 mg ( 200 mg ), given once every week in two equal doses . this dose will be increased by 1 . 5 mg ( 1 , 000 mg ). the dose given will be based on the patient ' s weight . how ecalta is given eCalta will be given to you by  a slow infusion ( a drip into a vein ) over approximately 1 - 5 minutes . your doctor will decide how much you will be treated . it will be necessary to administer the dose over a period of time . depending on the dose prescribed for you , your doctor may slow down the in
like all medicines , this medicine can cause side effects , although not everybody gets them . some of these side effects may be serious and may include life - threatening allergic reactions , difficulty breathing , wheezing or an existing rash . stop using ecalta and tell your doctor straight away if you notice any of the following serious side effects such as convulsion ( seizure ), flushing , rash ( pruritis ), itching , hot flush , or hives , sudden contraction of the muscles , coughing ; difficulty of breathing other side effects include : very common side effects ( may affect more than 1 in 10 people ): dizziness , headache , diarrhoea , nausea , vomiting , stomach pain , constipation , dry mouth , abdominal pain . uncommon side effects are :
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . use the reconstituted solution immediately or within 24 hours after reconstitution . if not used immediately , the infusion solution may be stored at room temperature ( up to 25 ) for up to 48 hours . once re - use the product immediately or in the original package , in order to protect from light .
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 mg of anidulationfungin ( as mesilate ). - other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide and hydrochloric acid . what a ekalta looks like and contents of the pack eCALta is supplied as a powder for solution for infusion . the powder is white . it is supplied in a box containing 1 vial with 100 mg concentrate for solution . eCalta does not contain any other ingredients .
adynovi contains the active substance rurioctocog alfa pegol and pegylated human coagulation factor viii . the human - coagulating factor ixi is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a , it is missing or not working properly . if you have not received factor ii before , you should have been given adenovi for the treatment and prevention of bleeding in adults and adolescents 12 years of age and older and in children with haechophiliiaa b ( an inherited bleeding disorder caused by lack of factor  vii ).
do not use adynovi if you are allergic to rurioctocog alfa pegol , octtocogg alfalfa or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using adenovi and if any of these apply to you as you may be allergic . warnings and precautions talk to your doctor or pharmacist before using the medicine : if : you have ever had an anaphylactic reaction ( a severe , sudden allergic reaction ) to aynovis . allergic reactions such as rash ( common ) 95 - hives , wheals , generalised itching - swelling of lips and tongue - difficulty in breathing - wheezing - tightness in the chest - general feeling of
treatment with adynovi will be started by a doctor who is experienced in the care of patients with haemophilia a . always use adenovi exactly as your doctor has told you . check with your doctor if you are not sure . treatment of bleeding your doctor will decide on the dose of aadinovi you should receive . the replacement therapy with dyni is usually started at a low dose . your doctor may prescribe a different dose to help prevent or treat bleeding . aynovis is used as the replacement treatment . you should continue using aDynovit for a lifetime - long treatment , as this medicine is not intended to stop bleeding ; your doctor should prescribe the right dose for you based on your body weight and the factor viii levels to be achieved . use in children and adolescents the dose in
like all medicines , this medicine can cause side effects , although not everybody gets them . if severe , sudden allergic reactions ( anaphylactic ) occur , the injection must be stopped immediately . you must contact your doctor immediately if you have any of the following early symptoms of allergic reactions : - rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , coughing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . severe symptoms , including difficulty in breath and fainting ), require prompt emergency treatment . patients who have received previous treatment with adynovi may experience similar symptoms . these may include : very common side effects ( may affect more than 1 in 10 people ):  severe allergic reactions including anaaphylaxi
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . before use , the powder vial may be stored at room temperature ( up to 30 ) for a single period of up to 3 months . if you store adynovi at room temp ( upto 30 ), it must be used within 3 months or discarded . you must record the date when the powder has been removed from the refrigerator and the date after which it should be discarded ( no more than 3 months from the freezer ). if the powder is not used immediately , it should not be thrown away .
what adynovi contains - the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains nominally 250 , 500 , 1000 , or 2000 iu rurileoctacog pegol . - each ml of the solvent vial is then diluted in 5 mL sterilised water for injections . the other ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrate and tris ( hydroxymethyl ) aminomethane , polysorbate 80 and water for injecting . what synovis looks like and contents of the pack 
rekovelle contains the active substance follitropin delta , a frogcle stimulating hormone ( fsh ), which is similar to the hormone produced naturally by your body , which stimulates female fertility . gonadotropins play an important role in human fertility and reproduction . in women with assisted reproduction programmes ( in vitro fertilisation ( ivf ) or intracytoplasmic sperm injection ), these hormones play a major role in producing female fertility and resulting in many egg sacs .
do not use this medicine - if your fertility problems are not controlled with follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) - have tumour of the uterus ( the ovaries that contain the breasts , pituitary gland or hypothalamus ) or if you have enlarged oaries or cysts on your odes - suffer from polycystic ovarian disease ( bleeding from the vagina ) after an early menopause - or malformations of the sexual organs . pregnancy and breast - feeding have been reported in women treated with fibroids of the unborn baby . this may lead to pregnancy . ovary hyperstimulation syndrome ( ovar hypersmulation syndrome ) has been reported with other medicines containing fsh . it is important to tell your doctor 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will calculate the rekovelle dose for you and will tell you how often you should use it . the recommended dose is one injection in the morning . you will start your first treatment cycle with anti - millerian hormone ( a hormone that stimulates your ovaries to produce hormones called gonadotropins ). the dose you receive depends on your body weight . a blood sample will be taken in the last 12 months of treatment . this is based on your weight and how you respond to treatment , and on your response to treatment your doctor may decide to increase the - dose you take . it is important that you keep using the r - ovulation of the follicles during the first treatment period . when you are injected with 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects may occur due to the changes in the hormones involved in infertility . this medicine may cause a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms may include pain or discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain , and difficulty breathing . contact your doctor immediately if you experience any of these symptoms . a side effect may occur with up to 1 in 10 women : headache and nausea ( ovulation syndrome is a very common complication of ovary hypersstimulation syndrome ) in women . the frequency of this effect is not known . however , it is possible that rekovelle may cause symptoms such as pain and discomfort ;
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution : store in the original container in order to protect from light . you may take rekovelle out of its refrigerator and keep it at room temperature ( up to 25 ) for no longer than 3 days . if not used within 3 days it must be used within 28 days or disposed of . this medicine must be discarded after the treatment any unused solution must be returned to the refrigerator . medicines should not be disposed in accordance with local requirements . these measures will help protect the environment .
what rekovelle contains - the active substance is follitropin delta . each multidose cartridge contains 12 doses of flotropindelta in 0 . 36 millilitre of solution , corresponding to 33 . 3 mg of  FollitropIN delta in each milliliter of solution ( corresponding  to phenol ). - other ingredients are polysorbate 20 , 3 - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrate and concentrated phosphoric acid , water for injections . what retinol looks like and contents of the pack rekorelle is a clear and colourless solution . it is supplied in a pack containing 1 cartridge and 3 pen injection needles , each adapter adapter .
the active substances of revinty ellipta are fluticasone furoate and vilanterol . each revinting ellipinta tablet contains fluticasesone furóate 92 mg and / or vilantrol 22 mg fluticassenfuroate 184 mg and/ or alfa - vilantirol 22 mpa / mpd 92 / 22 . the mpu / 32 is used to treat chronic obstructive pulmonary disease ( copd ) in adults and adolescents aged 12 years and older . 184 / 25 is used for the treatment of asthma in adults of 12 years or older , who weigh 184 kg or more and who are at high risk of having too much of a burden on their wallet . when used for copd the recommended dose of rev inty
do not use revinty ellipta - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using revinnty
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use asthma the recommended dose to treat asthma is one inhalation ( containing fluticasone furoate and 22 micrograms of vilanterol ) once daily . if severe asthma occurs , your doctor may prescribe the higher strength inhaler ( corresponding to one inhaled dose of fluticasesone furonate and 20 microgram of vlasmol ) as directed by your doctor and will prescribe you the lowest dose . the higher strengths in the inhalers ( delivering fluticanone furaate and 21 microgram vilantrol ), is used to treat copd . in copd the recommended starting dose of one inhing ( referring to one dose of Fluticasine furoated and 22 mega
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you get any of the following symptoms while using ellippa stop using this medicine and tell your doctor immediately : skin rash ( hives ) or redness swelling , usually of the face or mouth ( angioedema ). becoming very wheezy and coughing or having difficulty in breathing , feeling weak or light headed , if this happens to you , or if it happens to your normal routine . tell your physician if any of these occur . other side effects may include : very common ( may effect more than 1 in 10 people ): diarrhoea feeling very common : dizziness feeling very tired feeling very sleepy or having dizzy
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . each 92 mg inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 92 micrograms of fluticasesone furonate and 22 microgram of vilantrol ( as trifenatate ). each 184 mg inhaled dose (the dose leaving your mouthpiece) contains 184 microgram ( the equivalent of fluticsone fuoate ) and 22 trifénatate . the other ingredients are lactose monohydrate ( see section 2 ) or magnesium stearate . what revINty is used for revinny elisa is a light grey inhaler with a yellow mouthpiece cover and a dose counter . it is supplied in a pocket containing a do
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ) and emtricitabine , another nucleolar side reverse transcript
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . take one tablet at the same time each day . swallow the tablet whole . atripla should be taken by mouth . you can take atriplap with or without food . if your stomach is empty , at least 1 hour before or 2 hours after taking atrip la . some side effects ( e .g . dizziness , drowsiness ) may occur when taking atrippingla . your doctor will tell you how many tablets to take . when to take atrapla take at least one tablet in the morning and one tablet twice a day , in combination with efavirenz , or emtricitabine , and tenofovir disoproxil . this is when your doctor tell
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood fats sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . possible serious side effects are lactic acidosis ( excess lactic acids in the blood ) which may affect up to 1 in 1 , 000 people . if you get this type of side effect , tell your doctor immediately . other possible signs of lactic arrest include deep rapid breathing , drowsiness , feeling sick ( nausea ), being sick ( vomiting ), stomach pain . in case of laceatosis you must stop taking atripla and contact a doctor immediately ( see section 2 ). if
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atripLA film - coated tablet contains 600 mg of eef Avirenz . this equals 200 mg of the active substance emmtricit abine , and 245 mg of each tenovir diseaseproxil ( as fumarate ). the other ingredients are croscarmellose sodium , the active ingredients are as follows : hyprolose , magnesium stearate ( e572 ), microcrystalline cellulose ( i . e ., sodium laurilsulfate ( a ) see section 2 " atriplap contains sodium ". the tablet film coating contains iron oxide black ( oblong ), iron oxide red ( 0 . 5 mg )
orgalutran contains the active substance ganirelix . it belongs to a group of medicines called anti - gonadotrophin , which stimulate the natural gonadotropin releasing hormone ( gnrh ). gndrh regulates the release of gonadotropics and follicle stimulating hormone ( foetus ). gonadophagins are necessary for the growth and development of f - fl - cells in the ovaries . ffolliculars are small round sacs that contain the egg cells . they release the mature egg cells into flies that are ready to be produced , and they can be collected and given back to your mother . orgalurtran is used in combination with assisted reproduction techniques ( such as in vitro fertilisation ( ivf ) or other methods .
do not use orgalutran - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). - are hypersensitive to gonadotrophin releasing hormone ( gnrh ) or to a gndrh analogue . - have a moderate or severe kidney or liver disease . ( it is also better to avoid orgalurtran allergic reactions in women with an active allergic condition ). warnings and precautions talk to your doctor or pharmacist before using orgalugatran allergic reaction if any of these apply to you , tell your doctor immediately . your doctor may recommend additional monitoring during treatment . allergic reactions allergic reactions may be generalised , including hives ( urticaria ), swelling of the face , lips tongue and / or throat that may cause difficulty in breathing or swallowing ( angioedem
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will decide on the correct dose of orgalutran based on your response to the treatment . the recommended dose is : the dose is calculated by the doctor and will be calculated by adjusting the dose . you will be assisted by a doctor experienced in the use of assisted reproduction techniques ( in vitro fertilisation ( ivf ), ovarian stimulation , and follicle stimulating hormone ( corifollitropin ) on day 2 or every 3 weeks . orgalugatran is injected under the skin ( subcutaneously ) every week for 5 to 6 weeks , before administering or giving fsh . for the preparations , different injection sites are used . daily treatment with orgalurtran may be started at the same time each day 
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get a side effect , talk to your doctor or pharmacist . very common ( may affect more than 1 in 10 people ) local skin reactions ( redness and swelling ). the local reaction usually disappears after 4 to 4 days . uncommon ( may effect up to 1 in 100 people ), headache , nausea , malaise . rare ( may impact up to1 in 10 , 000 people , ) allergic reactions rash facial swelling and difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat which may cause difficulty in breathing or swallowing ( dyspepsia ). not known ( frequency cannot be estimated from the available data ) seizures ( fits ) tremors ( dysphorias ) difficulty in swallowing
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . syringes should be stored in the original package to ensure that clear , particle - free solutions are available .
what orgalutran contains - the active substance is ganirelix , 0 . 5 ml , of which at least a third is acetic acid . - mannitol and water for injections were used to adjust the ph . the other ingredients are : sodium hydroxide and acettic acid ( see section " orgaluntran contains sodium "). what or galutran looks like and contents of the pack orgalurtran is a clear , colourless aqueous solution . it is supplied in a glass vial . one vial contains the solution for subcutaneous administration . only the needle is inserted into the vial and the other end of the vially contains dry natural rubber / latex . orgalugatran is available in packs containing 1 vial or 5 vials . not all pack sizes may
what blitzima is bblitzma contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a specific type of white blood cell called " b - lymphocyte ". when ritsimaab sticks to this cell , the cell dies . what billitzimа is used for bblastima may be used to treat the following conditions in adults : a ) non - hodgkin ' s lymphoma this is the disease of the lymph tissue ( part of the immune system ) that affects a certain type of type of black blood cell ( called b- lymphocytes ). blizima can be given alone or with other medicines called " chemotherapy ". in some cases , 
do not take blitzima if you are allergic to rituximab , other proteins which are like ritzimabe , or any of the other ingredients of this medicine ( listed in section 6 ) if your child has a severe active infection or a weak immune system if the child has severe heart failure or severe uncontrolled heart disease if he has granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris do not receive bblitzia bif your baby has ever had or might now have a hepatitis infection . blitima could cause hepatis b to become active again , which can be fatal in some cases . patients who have ever had heptagitis this infection will be carefully checked by their doctor for signs of this
you will always be given blitzima exactly as your doctor has told you . you should check with your doctor or nurse if you are not sure . this treatment is administered by a doctor or other healthcare professional . your doctor will watch you closely while you are being given this medicine . it is very important that you are given this product exactly as described in this leaflet . in order for this medicine to work , it is important that your doctor tell you exactly how many treatments you need . blitima is given to you as a drip ( intravenous infusion ). medicines given before each bblitzimia administration are given at the same time with each  Blitzimam administration . when billetima has been given to your child , you will be given other medicines ( pre - medication ) to prevent or reduce possible side effects . how long will your treatment be 
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . you may also experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , diarrhoea , nausea , vomiting , stomach pain , fever . these reactions usually disappear in the hours following infusion . tell your doctor or nurse straight away if you notice any of these signs . other side effects include : very common ( may affect more than 1 in 10 people )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light .
what blitzima contains the active substance is called rituximab . each 10 ml vial contains either 100 mg of ritsimabe ( 10 mg / mL ), 50 mg or 500 mg of ( 0 . 5 mg ) of raituximabob ( 10 % w /w ), sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what brisbane looks like and contents of the pack bblitzma is a clear , colourless solution for infusion , supplied in glass vials containing 2 m , 50 mcg , or 1 vial . not all pack sizes may be marketed .
roactemra contains the active substance tocilizumab , a monoclonal antibody - like antibody to interleukin - 6 that is found on cells in your body . this reduces the inflammation in your organs . rroaktemmrra is used to treat symptoms such as pain and swelling in your joints . using raactememr helps reduce the damage to the cartilage , the material that supports the bone and joints , and slow down the progression of the disease . in adults , it is used in addition to racteemremrre for moderate to severe active rheumatoid arthritis , an autoimmune disease , when previous therapies have not worked well enough or are not suitable for you . you may be given rofem
do not use roactemra - if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). - you have an active , severe infection . warnings and precautions talk to your doctor or nurse before using r oact mrra and during the infusion if any of these apply to you . if the inffusion with rroaktemmrre causes allergic reactions such as chest tightness , wheezing , extreme dizziness or light - headedness . swelling of the lips or skin rash during the administration of the induction , you may experience allergic reactions more easily . infections tell your doctor if : you get infections more easily during the treatment , or you feel unwell . you may receive ractememr , reduce
roactemra will be given to you by a doctor or nurse into a vein . your doctor or a nurse will supervise the intravenous infusion . the treatment with rroaktemmrra is started at a low dose for up to 8 weeks . it is given every 4 weeks , followed by up to 4 weeks off . you will be monitored during treatment with your raacteem adolescent for up - 4 weeks continuously for upto 8 weeks continuously . rreactera may be given every 2 weeks by : - a drip in the vein ( intravesnous infustion ) is given once every 2 months . this dose is given twice a week . adults the recommended dose of ractememrre is 30 mg / kg body weight every 12 weeks
like all medicines , roactemra can cause side effects , although not everybody gets them . the most common side effects are seen in children ( age 3 months and older ) taking rroaktemrapa . serious side effects common ( may affect up to 1 in 10 people ) allergic reactions , including difficulty with breathing , chest tightness , light - headedness ; rash , itching , or hives ; swelling of the lips , tongue or face ; serious infections , such as fever and chills , especially in the mouth and / or the mouth . if you get any of these symptoms , tell your doctor straight away . your doctor may decide to stop your treatment with raacte mrra , stop taking it and talk to your doctor . reporting of side effects 25 if your child gets
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). keep the vially in the outer carton in order to protect from light . this medicine may pose a risk to the environment .
what roactemra contains - the active substance is tocilizumab . each vial contains either 4 mg or 80 mg of tocilizamab in 20 ml , or 10 mg or 200 mg of TOcilizum ab per 20 - mL or 20 mg of 400 mg of Tocilizumаb per 200 m mmol . -the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphata dihydrate and water for injections . what if you use rroaktemmrra for solution for infusion is provided in a pack of r - vial containing 4 mg , 10 mml or 20 g concentrate for solution , for infuse .
onbrez breezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . it relaxes the muscles in the walls of the small air passages in the lungs . onbreezhalers is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . this makes breathing difficult . you have this medicine designed to relax these muscles in your lungs and so improve the flow of air into the pulmonary passages .
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using onbriez breezehaler for asthma . before using the medicine you should tell your doctor about any of your medical conditions , including : heart problems , epilepsy , thyroid gland problems ( thyrotoxicosis ) diabetes . during treatment with onbezhalers , tell your physician immediately if : you experience tightness of the chest , coughing , wheezing or breathlessness immediately after using the product . you develop a condition called bronchospasm . tell your healthcare professional immediately : if your doctor thinks you have a problem with your breathing or swallowing (
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one capsule each day . you only need to inhale once a day because the effect of the 150 microgram capsule lasts for at least one hour . your doctor may decide to increase your dose to 150 microgramms each day ( i . e . two capsules of 300 micrograms ). your doctor will tell you how many capsules to inhaled each day and how often you should inhaling them . this will help you to remember to use your inhaler . use within 24 hours after you have used onbrez breezhaler ( inhalation powder ) and inhalate the medicine as intended ( inhaulated ). the onbriez breezehaler inhalers provide you with the
what onbrez breezhaler contains - each onbezhalers 150 microgram capsule contains 150 microgramms of indacaterol as inddacatrol maleate . - the other ingredients are lactose and the capsule is made of gelatin . each onbeezhalER 300 microgram hard capsule contains 300 microgrammes of dacacaterol and ind acateral maleate as lactoses and the cap is made from gelatin and the rest of the capsule are made of inhalation . what onberez brewing breezehaler looks like and contents of the pack onbreezhale is an inhaler that contains capsules in blisters . the capsules contain a white powder . onbré brezhaler 150 microcapsuls are available in packs containing 150 microlitres , each inhale
clopidogrel hcs contains clopizid and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). clodogrell hhcS is taken by adults to prevent blood ovaries ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosesis , with an increased risk of atherathrombotic events ( such as stroke , heart attack , or death ). you have been prescribed cloclopidegrel
do not take clopidogrel hcs if you are allergic to clopizide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking clonogrell hs . if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . in case you suffer from severe liver disease , your doctor may want to reduce your dose of clodogreil hCS . warnings and precautions cloclopidegrel highcs may cause an increased risk of bleeding sucha - if your doctor determines that you have a medicinal condition that puts you at risk of internal bleeding ( such as an stomach ulcer ). it may also be a blood disorder that makes you prone to internal bleeding , such as bleeding inside any
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if your doctor has prescribed you a higher dose for severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogral hecs ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one 70 - mg tablet , taken or injected at the right time each morning with or immediately after food . you should take clopogrell 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in some cases , red pinpoint diamonds and a feeling of confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the spine . this may be the signs of an allergic reaction . tell your doctor if your skin starts to peel . very common side effects ( may affect more than 1 in 10 people ): diarrho
what clopidogrel hcs contains the active substance is clopizid . each film - coated tablet contains 75 mg of clodogrell ( as hydrochloride ). the other ingredients are ( see section 2 ' clonogreil hhcS contains hydrogenated castor oil '): microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castingor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( 233 ), yellow iron oxide , the tablet coatings by talc and macrogol 3000 . what clumps into the film  coating are engraved with the company symbol ' 75 ' on one side and plain on the other side . 
fetcroja contains the active substance cefiderocol . it is an antibiotic medicine . this group of antibiotics , called cephalosporins : antibiotics help to fight bacteria that cause infections . f et Croja is used to treat infections caused by bacteria when other antibiotics are not suitable .
do not take fetcroja - if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). - are allergic or to other antibiotics ( e . g . cephalosporins ). have had a severe allergic reaction to certain antibiotics , such as penicillins or carbapenems . have severe skin peeling and swelling of the hands , face , feet , lips , tongue or throat which may cause difficulty swallowing or breathing . warnings and precautions talk to your doctor or pharmacist before taking ffeet Croja : - have had any allergic reaction or to any of other antibiotic medicines . you should not take the tablets faetcronja if : you have kidney problems . your doctor may decide to reduce your dose of diarr
this medicine will be given to you by a doctor or nurse as an infusion ( a drip ) into a vein . it will take about 3 hours , but may be longer than 2 hours . your doctor will decide how many days of fetcroja treatment you need . this is to check that you are getting the right amount of medicine . infection tell your doctor if you notice any signs of your infection , or if there is any pain during the ftcrojan infusion . the doctor may decide to give you into fentcroja if it is given into  a different vein , for example if a person with kidney problems is being treated . patients with kidney problem should not be given fencroja when they are given . if they think you may have kidney problems , your doctor may reduce your dose of  Fet Croja .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : severe allergic reaction - you may experience sudden swelling of your lips , face , throat or tongue , with a severe rash or other severe skin reactions , difficulty swallowing and breathing . this reaction may also be preceded by diarrhoea and stools that may contain blood or mucus . your doctor may decide to reduce the dose or stop treatment , or stop medicines that may slow bowel movement . other side effects include : very common side effects ( may affect more than 1 in 10 people ): - common ( may effect up to 1 in10 people ). - uncommon ( may impact up to1 in 100 people ), - very common : 
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg of cefideocol ( as sucrose ). - other ingredients are sodium chloride and sodium hydroxide . what fertcroj looks like and contents of the pack ffeet Croja is a white to off - white powder for solution for infusion supplied in a vial . one pack contains 10 vials .
depocyte is used to treat lymphomatous meningitis . lymphomatolus meningitsitis is a condition in which tumour cells form in the membranes of the brain and spinal cord . depcyto works by blocking the activity of lymphoma tumour cells .
do not take depocyte - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). - you have a meningeal infection . - have severe neurological side effects . warnings and precautions talk to your doctor or pharmacist before taking dep cell . you may experience symptoms that affect the nervous system ( such as convulsions , pain , numbness , or tingling , blindness ), visual disturbances . these symptoms may be caused by the way dep cells work . do not swallow depcell whole . talk to a doctor or nurse before taking any depamethasone tablets . your doctor will check for unwanted effects and monitor you for your side effects and if necessary treat you if they do occur . tell your doctor if any of these occur , as
there are strict laws on the use , handling and disposal of depocyte . it will only be used in special controlled areas , under the supervision of a physician experienced in the treatment of cancer . dep cell will only ever be used and given to you by people who are trained and qualified to use it safely . they should follow the instructions given to them by their doctor , pharmacist or nurse . the following information is intended for the specialist only : - handling of lumber sac - administration of depeccants - disposal of reconstituted depcell - use of water for injections - storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 1 hour at 5 ml of dexamethasone per vial - this will be done by a healthcare professional at 5 hour intervals . - each depice dose should
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most common side effects ( affects more than 1 user in 10 ) are : common ( affect 1 to 10 users in 100 ): uncommon ( affect1 to 10 user in 100 and affects 1 to10 users in 10 not known ) and very rare ( affect less than 1 to 1 user per 10 ). very rare : affects less than1 user in every 10 , 000 adverse events have been reported with depocyte in combination with other chemotherapeutic agents . common ( effect in more than1 patient in 10 people ) were : nausea vomiting weakness , confusion fever headache headaches dizziness , headaches , dizzier , drowsiness , sleepiness . not known (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . depocyte can be stored at room temperature ( up to 25 ) for up to 4 months . keep the container tightly closed in order to protect from light . once dep cell has been dissolved , it should be used immediately . this medicine must not be used if it shows severe discolouration or a changed appearance or if the product is damaged . a defective container should be discarded . use in children depcell should not be given to children under 18 years of age because it has not been studied in this age group . it should not to be used in children whose condition has been resolved after
what depocyte contains - the active substance is cytarabine . one ml of suspension contains 10 mg cychtarabin . each vial of 5 mL contains 50 mg of ccyarabine ( as mesilate ). - other ingredients are cholesterol , trioleoylphosphatidylcholine , dipalmitoyllphosphatideylglycerol , sodium chloride , water for injections . what depeocyte looks like and contents of the pack depcyto is a clear , colourless solution for injection ( 5 g ) solution for infusion in a single injection in  a separate vial .
what bemrist breezhaler is bem breezeezhalers contains two active substances called indacaterol and mometasone furoate . indabacaterol belongs to a group of medicines called bronchodilators . it relaxes the muscles of the small airways in the lungs . this makes it easier for air to get in and out of the . when it is taken regularly , it helps to keep the airways open . mometabe furoates belongs to one of a class of medicines known as corticosteroids ( also known as steroids ). corticostosterides reduce the swelling and irritation ( inflammation ) in the small  airways into the pulmonary airways and so gradually ease breathing problems . corticotrosteroids also help to prevent attacks of asthma . bemmrrist brezhal
do not use bemrist breezhaler - if you are allergic to indacaterol or mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor and do not take the medicine . if any of these apply to you ( or you are not sure ), talk to your doctor before using bem breezehaler and if the medicine is not suitable for you . warnings and precautions talk to you doctor or pharmacist before using this medicine : if : you have heart problems such as an irregular or fast heartbeat . you have thyroid gland problems . your doctor may want to monitor you more closely . tell your caregiver if: you suffer from diabetes or high blood sugar . it may also cause seizures . there may be a low level of potassium in your blood
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much bemrist breezhaler to use the usual dose is to inhale the content of one capsule each day . you only need to use one capsule a day , so you only use the medicine once a morning . this will help control your asthma and reduce your symptoms . when to inhalate bemmrrist brezhale bem breezehaler is for inhalation use . bemreist  Breezhalers is available in different pack sizes . each pack contains an inhaler and capsules that contain the medicine . the inhalers only remove the medicine from the capsules and only remove them from the inhaled capsules . do not swallow the capsule whole . if the capsule is
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious . tell your doctor straight away if you notice any of the following : common ( may affect up to 1 in 10 people ) difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives ( signs of allergic reaction ). uncommon ( may effect up to1 in 100 people ), swelling mainly of the mouth , lip lips . face and throat ( signs indicate angioedema ). other side effects include : very common ( might affect more than 1 in every 10 people people ). difficulty breathing and swallowing ( signs include , but not limited to , difficulty swallowing and swelling ofthe tongue . lips  , face or throat ( possible signs of angio edemum ). reporting of side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from light and moisture .
what bemrist breezhaler contains the active substances are indacaterol ( as acetate ) and mometasone furoate . each delivered dose of bemmrister breezeezhalers 125 micrograms / 62 . 5 microgram ( equivalent to 173 microgram ) of inddacatrol aate and 150 microgram of indecaterol . the recommended dose is one inhalation of 80 microgram( ml ) momeason furoates . what berist brezhale looks like and contents of the pack bemreist briezhaling is a white to off - white powder . it is inserted into the mouthpiece of the inhaler and contains 125micrograms of indracaterol and 62, 5 microlitres of mometab
zyllt contains the active substance clopidogrel which belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). zylt prevents blood cluts ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosesis , with an increased risk of atherathrombotic events ( such as stroke , heart attack , or death ). you have been prescribed zylling to help prevent blood coagulants from forming during these severe events and reduce the risk of these severe thrombocytes .
do not take zyllt - if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). - in case you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - have severe liver disease . do not use zylt if any of these apply to you . warnings and precautions before you take zllt you should tell your doctor if : you have an increased risk of bleeding such if your current or previous medical condition puts you at risk of internal bleeding ( such as an stomach ulcer ). you have ever had a blood disorder that makes you prone to internal bleeding , such as bleeding inside any tissues , organs or joints of your body .
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if your doctor has prescribed zylt for you because you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of zellt ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one 70 mg tablet , taken or twice daily as described above . you should take zyillt for as long as your physician continues to prescribe it . your doctor will tell you how long you should
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in some cases , red pinpoint dots and a feeling of confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the soil . this may be the signs of an allergic reaction . the most common side effects reported with zyllt are : very common side effect ( affects more than 1 user in 10 ): dizzi
what zyllt contains the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopdogrell ( as hydrogen sulphate ). the other ingredients are lactose ( see section 2 under ' zyllingt contains lactoses '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose , titanium dioxide ( e171 ), red iron oxide ( ED20 ), talc and propylene glycol in the film . what zellt looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 , 14 , 28 , 30 and 50 film - coated devices are available . not all pack sizes may be
what lamivudine teva is lamivine the active substance in lamivane is a drug . what lamemiviludinne to use is used to treat long term ( chronic ) hepatitis b infection in adults . lam mivudines tva is an antiviral medicine that works by blocking the hepatis - b virus . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis). hepitis ( b is  a virus that infects the liver ) can cause long term( chronic ] infection , causing liver damage . how lamijine has been prescribed lamisvudince t Eva can be used in adults only . in adults it can be given to
do not take lamivudine teva if you are allergic to lamivine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 talk to your doctor or pharmacist before taking lamivaudinne toeva . taking lamevudines t Eva with other similar medicines may cause serious side effects . you need to be aware of the extra risks : if your doctor determines that you have liver disease other than hepatitis c . if any of these apply to you , tell your doctor . do not use lamigaudin tva if : you are seriously overweight ( especially if this is a woman ) your doctor may ask you to have blood tests before you start taking your medication , and at least 4 weeks after starting lamisudinine tv . this
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take your doctor will tell you how many tablets of lamivudine teva to take . if your doctor thinks that you may have been ill with your hepatitis b infection , talk to your doctor about ways to treat your infection and how to prevent your illness . do not stop taking lamisvudines tva without your doctor' s advice . lamivaudinne is for oral use . swallow the tablets whole with water . you may need to take lamivine for several weeks before you start taking it . this will help to keep your kidneys working normally . when you take lamevudince , you may take another medicine containing lamimivudi
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects of lamivudine teva have been associated with other conditions including hepatitis b . for more information , see ' serious side effects during therapy with hepatis c '. for further information on the side effects listed in section 6 , ' what lamisvudines tva can cause during lamichivune clinical trials , please refer to the package leaflet of the medicines that are used in combination with lamavudite . tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort / pain , nausea , vomiting , diarrhoea , increases in liver enzymes . liver problems may be serious . a rare but serious allergic reaction has been reported
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . lamivudine teva should be used within six months of first opening the blister . this medicine does not require any special storage conditions . if you have any unwanted tablets , do not throw them away . ask your pharmacist how to throw away tablets you no longer use . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamichudinne ( 18f ). each film - coated tablet contains 100 mg of lamimivudines . - other ingredients are microcrystalline cellulose , sodium starch glycolate ( type a ), magnesium stearate . tablet film : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( azure ), iron oxide red ( b ). what lamevudinoine toeva looks like and contents of the pack orange , round , biconvex film , debossed with " lt " on one side and plain on the other side . lamivine tablet tva is available in aluminium blisters of 28 , 30 ,
nespo is an anti - anaemic . it is used to treat your anaemia . anamania occurs when your blood is overly stimulated with red blood cells . this causes the symptoms of fatigue , weakness and shortness of breath . nnesco works by mimicking the natural hormone erythropoietin . by mimicry , erythropoet in your kidneys , your bone marrow produces more red blood cells . darbepooetine alfa is used in adult patients with chronic renal failure , to treat symptomatic anaaemia associated with chronic kidney failure . kidney failure is a rare but serious complication of kidney failure in which the kidney does not produce enough of the natural hormonal erytropoiеtin to treat anaery .
do not use nespo - if you have high blood pressure - or if other medicines are used - are allergic to nnesco ( darbepoetin alfa ) or to r - hoepo , which are used to treat high blood temperature - have been taking medicines that may cause sickle cell anaemia - suffer from a history of epileptic fits ( seizures ) - experience convulsions ( fits ) in order to have fits - liver disease - take drugs that may increase the risk of anaeemia if your doctor suspects you have an allergy to latex - the needle on the pre - filled tiee is a derivative of latex and may cause symptoms such as unusual tiredness and lack of energy - this may be a sign of pure red cell aplasia - it is
your doctor will carry out blood tests before you start using nespo . your doctor may change your dose depending on your haemoglobin level . the usual dose is 10 micrograms / kg . a haemeglobin niveau of 10 microglobulins per kilogram of your body weight will be checked every 12 hours . how nnesco is given your doctor or nurse will inject naspo into a vein , preferably into : chronic renal failure . it is given as a single injection under the skin or into  a channel ( intravenous ) to treat your anaemia . dose the dose of n nspo you will receive is calculated based on your body weigh between 0 . 75 and 0. 45 ml . you will need to take regular blood samples to monitor your anemia , to monitor the levels of sugar
like all medicines , nespo can cause side effects , although not everybody gets them . the following side effects have been reported in patients treated with nnespor : common ( these may affect up to 10 in 100 patients ) high blood pressure ( hypertension ) with fluid retention ( oedema ). uncommon ( these might affect upto 1 in 100 people ) blood clots ( thrombosis ). pain in the area injected rash with redness on the skin rare ( these could affect up 1 in 10 , 000 patients ). serious allergic reactions . sudden life - threatening allergic reactions ( anaphylaxis ) including swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioedem ). not known ( frequency cannot be estimated from the available data ): - ana
keep out of the reach and sight of children . store in a refrigerator ( 2 - 8 ). do not freeze . keep the original package in order to protect from light . nespo can be taken out of its refrigerator for up to 30 days when stored in syringes , or in tamper proof containers . you may remove nnesco from the refrigerator and store it at room temperature ( not above 30 ) for up a single period of up to 7 days . do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what nespo contains the active substance is darbepoetin alfa . nnesco is supplied as a pre - filled syringe containing 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 iu ( international units ) of the active sublingual substance darbepepo tin all . the other ingredients are : naspo contains sodium phosphate monobasic , sodium phospho dibasic and sodium chloride , polysorbate 80 and water for injections . what ? n nspo looks like and contents of the pack nnemespo is a clear , colourless to slightly pearly liquid , cloudy and colourless solution . it is available in packs containing 1 or
what macugen is macuogen is a solution that is injected into the eye by a doctor . it contains the active substance pegaptanib . this medicine reduces the formation of new blood vessels in the eye . what macugagen is used for macuGEN is used in adults for the treatment of macular degeneration . patients with this disease may experience vision loss or damage to the part of the retina called the macula . the maculate is the part that surrounds the front part of your eye , called the macular . when the macua is opened , the maculara is the light - sensitive layer that surround the front of the eye in amd . abnormal blood vessels grow out of control and the maculation stops the growth of these new cells .
do not use macugen if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if there is an active or suspected infection in or around your eye . warnings and precautions talk to your doctor or pharmacist before using macuogen . if any of these apply to you , or if they happen to you ( or you are not sure ), talk to the doctor or nurse before using Macugen ( see section 4 ). bleeding in the eye has been reported during macu Gen injection . tell your doctor immediately if : you have any of or any combination of any of any or combination of the following symptoms : eye pain , increased discomfort , worsening eye redness , blurred or decreased vision , and increased sensitivity to light . you have small particles in your vision . these may happen more often in your eye after
macugen will be given to you by a doctor or nurse who is experienced in giving injections . macuogen must be given as a single injection into your eye , every 6 to 9 days . the injection will be done in the vitreous part of your eye or the other eye ( ocular ) to help protect you from macu Gen . you will be asked to use antibiotic eye drops to help prevent macuge getting into your eyes . your doctor may give you some local anaesthetic ( numbing medicine ) for any pain you may have with the injection . if you are allergic to antibiotic eye drops , your eye may not be injected if antibiotic treatment is not recommended , as it may cause eye infection .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) with angioedema of which symptoms include : breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting / rapid pulse , stomach cramps , nausea , vomiting and diarrhoea . the frequency of these side effects is not known ( frequency cannot be estimated from the available data ). an infection in the internal portion of the eye has been reported in patients receiving macugen treatment . these symptoms have been reported mostly in adults , adolescents and children . see also section 2 . if you experience any of these symptoms , contact your doctor immediately .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . if you have any suspension left in a bottle after opening , the medicine should be used immediately .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegaaptanid in 90 mg / ml solution . - other ingredients are sodium chloride , monobasic sodium phosphate monohydrate , dibasic salt phosphatahydrate ; sodium hydroxide ; hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugagen looks like and contents of the pack macuogen solution for injection is provided in a single dose pack in : a pouch in  a pre – filled  ssyne ( 0. 25 mL or 0, 27 mmol ). the spout is sealed with an elastomeric plunger stopper
kepivance contains the active substance palifermin ( inactivated ) in escherichia coli . paliferedmin belongs to a group of proteins called epithelial cells , which are found in the mouth and digestive tract ( tissues that contain food ) and the skin . when you are given palifERmin , kepepivaze is used to treat oral mucositis ( soreness , dryness ) or inflammation of the mouth . it is a common side effect that occurs when it is used with treatments to treat your blood cancer . if your blood tumor is not well controlled with chemotherapy or radiotherapy or autologous hematopoietic stem cell transplantation .
do not use kepivance - if you are allergic to palifermin or escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using kepepivace . children and adolescents do not give this medicine to children and teenagers below 18 years of age . other medicines and keping keparin tell your doctor or pharmacist if this applies to you . taking other medicines please tell your pharmacist or pharmacist before taking keepivaze if : you are taking heparin . you have recently taken hepivain , or you have previously taken , heparain ). pregnancy and breast - feeding kepitivance is not recommended if any of these apply to you ( or you are not sure ),
kepivance should only be given to you by a doctor experienced in cancer treatment . the recommended dose of kepepivace is 60 mg / kilogram body weight given once every three weeks by intravenous injection into a vein . if you have any questions about how kepativance will be given , ask your doctor . you will be provided with keepivaze for three days after chemotherapy and radiotherapy . it is usually given for three consecutive days after receiving chemotherapy and radiation . your doctor will tell you how long you will receive chemotherapy and how long your chemotherapy andradiotherapy will last . chemotherapy andresuming chemotherapy anddrotherapy should be given for 24 to 48 hours after the chemotherapy and if radiotherapy is given for two consecutive days , the chemotherapy will be administered for two successive days . depending on how you respond to the chemotherapy , your doctor may decide to
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ) side effects reported with kepivance include : skin rash , itching and redness ( pruritus ) and erythaema ( an increase in the thickness in the mouth or tongue , change in colour of the mouth and tongue ), generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ) or altered taste , lipase and amylase levels ( seen in blood tests ) uncommon ( may effect up to one in 100 people ). if you get any of these side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliformin - this is equivalent to 6 , 000 units . - - other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kespivaze looks like and contents of the pack kepepivace is a white powder for solution for injection . it is supplied in a carton containing 6 vials .
cinacalcet accordpharma contains the active ingredient cinakalcet , which helps to control the levels of parathyroid hormone ( pth ), calcium and phosphorous in the blood . it is used to treat problems with organs called parathormon glands . the paratrons are four small glands in the neck , near the thyroid gland , that produce parat hormone ( proline ). cina Calcet accord pharmaceutical is used : to treat secondary hyperparathyroidism in patients with serious kidney disease who need dialysis to clear their blood of waste products to reduce the amount of calcium in the body ( hypercalcaemia ) in patients suffering from parat thyroid cancer to reduce amount of caloric acid in the urine . in primary hyperparaathyroidismus it is removed by removal of the gland . cinaCalcet accordmedicine is indicated for use in children 3 to 18 years of
do not take cinacalcet accordpharma - if you are allergic to cinacacalcet or any of the other ingredients of this medicine ( listed in section 6 ). - when you have low levels of calcium in your blood . your doctor will check your blood calcium levels before you start taking cinacinacalce accordpharma ( see section " other medicines and cinaccet accord Pharma "). warnings and precautions talk to your doctor before taking cinecalcetaccordpharma : - in rare cases you may experience seizures ( convulsions ). these can be seizures . - during treatment with cinacalicet accord pharmacy , seizures may occur as a result of liver problems . in rare instances you may also experience seizures , which may be life threatening events and fatal outcomes . low calcium levels can lead to life -threatening events or fatal outcomes for patients with low calcium rates ( hypocalcaemia
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will tell you how much cinacalcet accordpharma you should take . cina Calcet accordhe will tell your doctor about how many tablets of cinakalcet accordha you should taking . the tablets must be taken whole and are not to be divided . you will need to take regular blood samples during treatment to monitor your progress and will adjust your dose if necessary . patients with secondary hyperparathyroidism the usual starting dose for cinaCALcet accord Pharma is 30 mg . children and adolescents ( 3 to 18 years of age ) the usual dose for adults is 0 . 20 mg cinacinacalcalcet acordpharma per kilogram body weight . adults the recommended starting dose of cinecalcetaccordpharma is 30 micrograms . this medicine may
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience numbness or tingling around the mouth , muscle aches or cramps and seizures ( these may be signs that your calcium levels are too low ( hypocalcaemia ). swelling of the face , lips , mouth - tongue or throat that may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ) nausea and vomiting . these side effects are very common . very common in children and adolescents . common in adolescents may be : common ( might affect up to 1 in10 people ). dizziness , headache , trembling , diarrhoea , constipation , dry mouth . not known ( frequency cannot be estimated from the available data ). uncommon
what cinacalcet accordpharma contains - the active substance is cinacacalcet . each film - coated tablet contains 30 mg , 60 mg or 90 mg of cinakalcet ( as hydrochloride ). - cellulose , microcrystalline - crspovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminium lake ( 6000 ), iron oxide yellow ( encoding ink ). what cinecalcet agreementpharma looks like and contents of the pack cinacalicalcetaccordpharma 30 mg film  film – coated tablets are light green colored , oval shaped tablets approximately 9 . 65 mm long by 6 . 00 mm in diameter , biconvex , film screened tablet . they are supplied in bottles containing
jentadueto contains two active substances called linagliptin and metformin . linagleptine belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4- inhibitors ). metformine belongs a group of medicines known as biguanides . they work together to control blood sugar levels in adult patients with a form of diabetes called ' type 2 diabetes mellitus '. this medicine can be used alone or in combination with insulin . this medicinal product can be given alone or with certain other medicines for diabetes ( such as sulphonylureas , empagliflozin ) that are used to treat type 2 diabetic patients .
do not take jentadueto - if you are allergic to linagliptin or metformin or any of the other ingredients of this medicine ( listed in section 6 ). - in patients with severely reduced kidney function - patients with uncontrolled diabetes , with , for example , severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , lactic acidosis ( see " risk of lactic acidsis " below ) or ketoacidosis . ketoacaidosis is a condition in which substances called ' ketone bodies ' accumulate in the blood and which can lead to diabetic pre -coma . symptoms include stomach pain , fast and deep breathing , sweating , excessive alcohol consumption , high blood sugar , fluid retention , or excessive
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of jentadueto is one tablet a day . you currently take metformin as separate tablets , or as individual tablets with linagliptin and metformine . your doctor may adjust your dose of this medicine based on your response to this medicine or on your general condition . taking this medicine to reduce the chance of an upset stomach , you should take 5 mg linaglept in a single day , i . e . 2 , 000 mg metforminer hydrochloride . take jenteduet once a week to control your blood sugar . this medicine can be taken with another oral anti - diabetic medicine such as insulin . remember to take all medicines as directed by
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms need immediate medical attention you should stop taking jentadueto and see a doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ) - trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion ( hypoglecaemia is a common side effect of jenteduet plus sulphonylurea ). this side effect is usually mild and usually disappears without any major change . - common : may affect up to 1 in 10 people a side effect with jantaduato plus aulphonilurean is essentially a synthetic version of the combination jenduevo plus insulin . this
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . blister : store in the original package in order to protect from moisture . bottle : do not take this medicine if the pack is damaged or shows signs of tampering .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . each jenteduet 2 . 5 mg / 850 mg film - coated tablet contains 2 , 5 mg of linaguipt in one tablet and 850 micrograms of metformine hydroch chloride - each jerks- jerky - jenceto 2  . 7 mg - 1 , 000 mg film- coated tablets contain 2 : 5 mg ( 3 mg ) linagipti and 1  , 1 mg of metforin hydrocholoride in the other ingredients : arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous , hypromellose ,
edurant contains the active substance rilpivirine , which is used to treat human immunodeficiency virus ( hiv ) infection . e cours is a combination of hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). it works by preventing hiv from entering the body via food and drink . it is used in combination with hiv medicine to treat adults and adolescents 12 years of age and older who are infected by hiv and who have not taken hiv before . you must continue to take hiv medications for as long as your doctor prescribes it for you .
do not take edurant - if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking e pendant . - you should not take the following medicines : carbamazepine , oxcarbazepine ( e . de ) phenobarbital , and phenytoin ( medicines to treat epilepsy and prevent seizures ) or rifampicin ( a medicine to treat depression and prevent fits ) and rfapentine ( medicines used to treat some bacterial infections such as tuberculosis )) omeprazole / esomeprazola , or lansoprazol , pantoprazole , but also rabeprazol
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . adults and adolescents ( 12 to less than 18 years of age ) the recommended doses of edurant are : 1 . rifabutin , a medicine used to treat some bacterial infections , may be more effective than e during treatment with riobutin alone . your doctor may decide to reduce your dose of risabutine , or may decide not to give e pendant . 2 . an antacid , usually a medicinal used to prevent diseases caused by the acid in the stomach , are aluminium / magnesium hydroxide or calcium carbonate . the antacillator is usually taken by mouth or by injection , 2 to 4 hours before or after food . 3 . use
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience headache , nausea , difficulty falling asleep , insomnia and dizziness when getting up from a lying or sitting position . your usual liver tests may also show a lowering of certain enzymes called transaminase , which is important for your body to keep producing its own protection ( amylase ). your doctor may also test your blood to check for these enzymes . abnormal dreams , rash and stomach pain ( signs of depression ), tiredness , vomiting , and drowsiness , decreased appetite , sleep disorders , stomach discomfort , depressed mood , feeling anxious , confusion , abnormal dreams and dizzy . if you experience any of these symptoms , talk to your doctor . side effects reported with edurant are : very common side effects
what edurant contains - the active substance is rilpivirine . each tablet contains rilspiviine hydrochloride equivalent to 25 mg ripiviline . - a portion of the film - coated tablet core contains lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . the film content contains lacttosе monohydrate and hypromellose 2910 ( 6 mpa . 1 mpeg .) titanium dioxide ( e171 ), macrogol 3000 and triacetin .
avandamet tablets contain two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes . people with type 2 disease either don ' t make enough insulin ( a hormone that controls blood sugar levels ), or don  't respond normally to the insulin their body makes . rosisglit azone or metformine help your body make better use of the insulin it produces , and this helps reduce your blood sugar . you should also be given avand a sulphonylurea ( if you don ’ t have diabetes ), either alone or together .
you should not be given avandamet if your diabetes gets worse . do not take avandalmet : if you are allergic ( hypersensitive ) to rosiglitazone or metformin or any of the other ingredients of avandemet ( listed in section 6 ) if : you have had a heart attack or severe angina if any of these apply to you , or if they have had heart failure or have had it in the past if: you suffer from severe breathing difficulties if or have liver disease if/ they have diabetic ketoacidosis ( a complication of diabetes causing rapid weight loss , nausea or vomiting ) you have kidney disease 107 you are very dehydrated if anything happens to you ( see section 4 ). you are taking medicines that suppress your immune system ( the body ' s natural defences ) or have
always take avandamet tablets exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is 2 tablets of rosiglitazone and 1000 mg of metformin taken once daily . this dose is taken 1 to 8 hours apart . the maximum dose is 4 tablets of either rosisglit azone or 1000 mg metformine taken once weekly . your doctor will tell you how many tablets to take . take the tablets around the same time each day . if this dose does not work for you , your doctor may reduce your dose to 2 tablets in a row . swallow the tablets whole with water . do not crush or chew the tablets . it is best to take your tablets with food . to help you remember to take it , take it at the same times every day , at the usual
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions may occur following administration of avand amet : - raised and itchy rash ( hives ) swelling , sometimes of the face or mouth ( angioedema ) and / or difficulty in breathing collapse . contact a doctor immediately if you experience any of these symptoms . stop taking avandatamet and see a physician immediately . - lactic acidosis : the amount of lactic acids in the blood is increased ( lactic acidosis ) this is a common side effect with metformin in patients with severe kidney disease . symptoms of laceacadiasis are rapid breathing , cold and rapid breathing with or without cold temperatures . these may be signs of a possible sign of fatty liver or a reduced
keep out of the sight and reach of children . do not use avandamet after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special storage conditions . if you have any unwanted tablets , don ' t put them in waste water or household rubbish . ask your pharmacist how to dispose of tablets you don ’ t need . these measures will help protect the environment .
what avandamet contains - the active substances are rosiglitazone and metformin . avand amet tablets come in different strengths . each tablet contains 1 mg rositazone , 500 mg metformine . the other ingredients are : tablet core : 2 mg : rosivitazon , 5 , 600 mg metFORMin , 2 mg tablet : 3 mg  Rosigliatazone, 500 Mg metformIN , 4 mg ; rosazone 1000 mg met Formin ; 4 mg tablet of rosisglit azone or 1000 mg meetformin the other ingredient is : sodium starch glycollate , hypromellose , microcrystalline cellulose , lactose monohydrate .
clopidogrel mylan contains clopizid and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). clodogrell mylan is taken by adults to prevent blood cluts ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosesis , with an increased risk of atherathrombotic events ( such as stroke , heart attack , or death ). you have been prescribed cloclopidegrel Mylan to help prevent blood
do not take clopidogrel mylan 31 if you are allergic to clopizide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking clonogrell mylan . if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . in case you suffer from severe liver disease , your doctor may want to monitor you more closely while you are taking octogrel . warnings and precautions talk to your doctor or pharmacist before taking the medicine : if any of these apply to you before taking your first dose of clodogrela mylan ( see section 4 ). you may be at increased risk of bleeding such if : you have a medicinal condition that puts you at risk of internal bleeding ( such as an stomach ulcer 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if your doctor has told your doctor that you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral myLAN ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one 70 mg tablet , taken or injected at the right time each night . you should take clopraglinic acid for as long as your physician continues to prescribe it 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in some cases , red pinpoint diamonds and a feeling of confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the soil . this may be the first sign of an allergic reaction . the signs may include reddening , unusually intense pain when applying clopidogrel mylan to your skin , as it may also
what clopidogrel mylan contains the active substance is clopizid . each film - coated tablet contains 75 mg of clodogrell ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ' cloned clots '), clomidogrep mylan contain hydrogenated castingor oil , polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( 6000), yellow iron oxide , the talc and macrogol 3000 . what clumps into the pack the film  coated tablets are light orange , capsule - shaped and have " gsi " marked on one side and " 
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . doptelt is used in adults with chronic liver disease associated with low platelet count ( thrombocytes ) which may be treated with a medical procedure to prevent bleeding in adults who are unable to make enough platelets . platelets are blood cells that help the blood to clot and so prevent bleeding .
do not take doptelet : - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking doptelt . blood clots can form in the veins or arteries , and this can increase the risk of blood clumps . tell your doctor before taking this medicine if any of these apply to you . if your doctor thinks blood coagulation is too strong or too weak , or if blood clits form in other places . your doctor may want to monitor you more closely if dop Telet has been used in cancer patients who are taking the contraceptive birth control pill or hormone replacement therapy . you have recently had surgery or are injured 23 you are overweight if a woman of childbea
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the usual dose is one 5 mg tablet per day . you should take the tablet at least 8 hours after your last meal . do not take more than one doptelet tablet per meal , preferably at the same time each day , for example , one tablet in the morning and one tablet at the evening . your doctor may adjust your dose based on your response to dopelet . when you are ready to take doptelt , your doctor will tell you how many tablets you should swallow . this will give your body a chance to increase your dose over a period of time . in some cases , you may need to take more tablets than you should . if possible , take your tablets with you and tell your doctor at once .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : common ( may affect up to 1 in 10 people ) feeling tired uncommon ( may effect up to1 in 100 people ), low red blood cell count ( anaemia ) or blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain or swelling bone pain muscle aches fever reporting of side effects get the scoop scoop . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine and the safety and efficacy of this product .
what doptelet contains - the active substance is avatrombopag . each film - coated tablet contains avaatrobiopag maleate equivalent to 20 mg of avatombopag ( as maleate ). - -the other ingredients are lactose monohydrate ( see section 2 ), microcrystalline cellulose , crospovidone type b [ e1201 ], silica , colloidal anhydrous , magnesium stearate , vinyl alcohol , and talc , macrogol 3350 , titanium dioxide , iron oxide yellow . what dopetelet looks like and contents of the pack dopelet 20 mg tablets are pale yellow , round and rounded , with " av2 " marked on one side and " 20 " on the other side . the tablets are provided in one aluminium blister 
rapiscan belongs to a group of medicines called ' coronary vasodilators '. these help to narrow the heart arteries and heart rate . they relax the muscles in your heart . rapican is used during a type of heart scan called  myocardial perfusion imaging ' in adults . the scan contains a radioactive substance called a ' radiopharmaceutical ' which helps to obtain these images . it helps to get pictures of the muscles around the heart faster . this can be done by using a treadmill to get inside the heart more easily . after a scan , you may get a small amount of radiopharmaceutic in your body or it can be seen through a vein .
do not use rapiscan - if you have slow heart rate or high degree heart block ( e . g . due to sinus node disease ). - when your doctor has prescribed a pacemaker to treat chest pain ( unstable angina ). warnings and precautions talk to your doctor before using rapican . before starting treatment , you should have low blood pressure ( hypotension ) or heart failure . you should not be given rapistcan if : - you are allergic to regadenoson or any of the other ingredients of rapissecan ( listed in section 6 ). do not take rapscan : while you are being treated with rapecan , if any of these apply to you . talk to a doctor or nurse before using the medicine if your doctor thinks you may have a recent serious heart problem such as 
rapiscan will be administered to you by a doctor or nurse . the doctor will calculate your heart rate , blood pressure and how often you will be given rapican . it will be injected into a vein by resolving the solution with 400 ml of solution the injection will take about 5 minutes . you will also be given 10 mg / m2 body surface ( based on your weight ). the recommended dose is an injection of sodium chloride 9 mg / min 9 mg per minute ( 0 . 9 %) solution for injection , i . e . 5 mg a radioactive substance ( radiopharmaceutical ) will be used . your doctor will decide how much rapistcan you will receive . this will depend on your heart speed , your heart pace and blood pressure . before the rapissecan injection a dose
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects caused by the rapican injection are usually mild to moderate and usually disappear within 30 minutes after any treatment . if you experience any of the following side effects you should contact your doctor immediately : sudden stopping of the heart ( which may be a sign of damage to the heart ), heart block or a disorder of the cardiac signal . rapid heart beat low blood pressure fainting , mini strokes , weakness of the face or inability to speak . you should not receive rapistcan if : you have had a stroke or cerebrovascular accident you have experienced an allergic reaction which may include rash , wheals / weals or hives . your doctor will decide if treatment with rapissecan is suitable for you . tell your doctor if any of these
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your peni when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . you should not take viagra for a treatment of erectile dysfunction , also known as impotence . this is when a man cannot get , or keep a hard , hard - to - comfortable , and ed penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). - are taking medicines called nitrates , as the combination may lead to a dangerous fall in your blood pressure . tell your doctor if any of these medicines are used to treat angina pectoris ( or " chest pain "). if the medicines are given to you by your doctor or if they are made from nitric oxide donors such as amyl nitărite (" poppers "), as the combined effect may also lead to such a drastic fall in votre blood pressure ( see section 4 ). take special care with viagra if : you are taking riociguat . this drug is used to reduce pulmonary arterial hypertension ( i . e ., high blood pressure in the lungs 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 50 mg twice a day . you should not take viagra more than once a week . if possible , you may take viagra film - coated tablets or viagra orodispersible tablets at the same time each day , preferably at the start of the day ; if necessary , your doctor may increase your dose . swallow viagra whole with water . viagra can be taken with or without food . it is best to take viagra at the beginning of the night . when taken with a meal , it will help you to get an erection if someone else takes it with viagra . men who take viagra will usually get an sexual er if they are sexually stimulated . your doctor will tell you how long you
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with the use of viagra are usually mild to moderate and of a short duration . if you experience any of the following side effects stop taking viagra and seek medical help immediately : an allergic reaction - this occurs uncommonly ( may affect up to 1 in 100 people ). symptoms include sudden wheeziness , difficulty in breathing , dizziness ; swelling of the eyelids , face , lips or throat ; chest pains - get in a semi - sitting position and try to relax . you may be given nitrates to treat your chest pain . prolonged and sometimes painful erections : this occurs rarely ( may effect up to1 in 1 , 000 people ) if a man gets an er ection , which last
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of silddenaf ( as the citrate salt ). - other ingredients are microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate , hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( k29 ). what viagra looks like and contents of the pack viagra film - coated tablets are blue , oval , with a rounded - diamond shape and marked " sl25 " on one side . the tablets are provided in blister packs containing 2 , 4 , 8 or 12 tablets . not all pack sizes may be marketed .
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists that stimulate dopama receptors in the brain . stimulation of the dopa receptor receptors triggers nerve impulses inthe brain that help to control body movements . sfrol is used to : - treat the symptoms of primary parkinson ' s disease in adults . it can be used alone or in combination with levodopa ( another medicine for parkinsons 's disease ). - help to relieve the symptoms in adults with moderate to severe primary restless legs syndrome in adults and children .
do not take sifrol - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking sfrol . tell your doctor if any of these applies to you . - you have any medical conditions or symptoms that you may have . these include : - kidney disease - hallucinations ( seeing , hearing or feeling things that are not there ). most hallucines are visual . dyskinesia ( e . all ) are abnormal , uncontrolled movements of the limbs . in patients with advanced parkinson ' s disease , levodopa may also cause dyskineia . your doctor may want to monitor you more closely while you are taking , or while you take , s 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . sifrol should be prescribed by a doctor experienced in the treatment of parkinson ' s disease . the recommended dose is 3 tablets per day . during the first week , the recommended starting dose is 1 tablet of sfrol 0 . 088 mg / 0. 264 mg . after the first weeks , your doctor may increase your dose to 1 tablet . this will be until your doctor tells you to take ssifroll 0 088 - 0 in 0 to 264 - mg daily . you should take a total of 1 tablet each day , i .e ., sn 0 8 -0 , 000 mg , or 0 ( 0 and 264 tablets )
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common may affect more than 1 in 10 people common may effect up to 1 in every 10 people uncommon may affect up to1 in 100 people rare may affect less than 1 , 000 people very rare may effect less than 10 ,000 people not known frequency cannot be estimated from the available data people with parkinson ' s disease have experienced the following side effects as well as the following effects : - dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ) - dizziness - nausea ( sickness ) common : an urge to behave in an unusual way - hallucinations ( seeing , hearing or feeling things that are not there ) confusion - tiredness , irri
what sifrol contains - the active substance is pramipexole . each tablet contains 0 . 088 mg , 0 18 mg / 0. 35 mg . one tablet contains 7 . 7 mg pramipeexol as 0
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . it is used in adults to treat allergic conditions that affect the eye during the allergic reaction . allergic conjonctivits may occur when some materials ( allergens ) are exposed to sunlight or in the sun . these reactions may include itching , redness and swelling of the surface of your eye , if you feel worse .
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine listed in section 6 . - children and adolescents do not give this medicine to children under the age of 3 years because the active substance is benzalkonium chloride . warnings and precautions talk to your doctor or pharmacist before using e madine . see section 6 for more information . in clinical trials and post - marketing experience with emine , there is limited experience with the use of emedicine in children and teenagers under the ages of 18 years . other medicines and emagine tell your doctor if your child is using , have recently used or might use any other medicines . talk to the doctor or nurse if they are using other eye drops . use in children edine is not recommended for children under 3 years of age 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 3 drops in each eye . you should only use this medicinal product in both eyes if your doctor has told your doctor that you need to use emadine . do not use more than the recommended dosage . use in children and adolescents do not give this medicine to children under the age of 18 years . for children aged 2 years and above , the recommended starting dose is 1 drop in each nostril . after 1 month , your doctor may advise you to use the e madine bottle . wash your hands . hold the bottle , swabs , and remove the cap . pull the bottle out . remove cap , snap collar , back of the bottle and continue to use it . press your thumb or finger down ,
like all medicines , this medicine can cause side effects , although not everybody gets them . you should stop using the drops and contact your doctor immediately if you notice any of the following : common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye , eye redness uncommon side effects may affect ( up to1 in 100 people ), effects in and around the eye: corneal disorder ( abnormal eye sensation ), increased tear production , tired eyes , increased tear producing , blurred vision , corneal staining , decreased vision . not known ( frequency cannot be estimated from the available data ) side effects in your eye - corneal swelling ( oedema ) uncommon side effect ( may effect up to 2 in 100 users ) effect in and outside the eye ( corneal abnormality ), abnormal eye vision - increased tear output
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special temperature storage conditions . e madine is used to prevent infections .
what emadine contains - the active substance is emanastine . each ml contains 0 . 5 mg of difumarate . - other ingredients are benzalkonium chloride , trometamol , sodium chloride ( see section 2 ), hypromellose , purified water , hydrochloric acid and sodium hydroxide to keep acidity levels ( ph levels ) normal . what hemadine looks like and contents of the pack e madine is a liquid ( a solution ) for injection in a 5 mml or 10 mlitre plastic ( drop - container ) bottle with a screw cap .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetistetam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilephritis , to treat a certain form of epilema . epilemy is a condition where the patients have repeated fits ( seizures ). in this type of epileptic condition , fits initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of the head ( partial onset seizure with or without secondary generalisation ). when levetiractam has been given to you by your doctor to reduce the number of fits . as an add - on to other antiepepilic medicines to treat partial initiation seizures with or immediately after myoclonic seizures ( fits ) leveti
do not take levetiracetam actavis - if you are allergic to levetiractam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking levetiratetam actingavis and if any of your medical conditions or kidney problems apply to you : - follow your doctor ' s instructions . - watch out for any slow down in the growth or unexpected puberty development of your child . in a small number of people being treated with anti - epileptics such as levetistetam affects people having thoughts of harming or killing themselves . you should immediately tell your doctor of any symptoms of depression and / or suicidal ideation . tell your physician if side effects occur , including abnormal thoughts , feeling irritable or
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . take levetiracetam actavis twice each day - once in the morning and once inthe evening . in the evening , take monotherapy dose in adults and adolescents ( from 16 years of age ) weighing between 1 , 000 mg and 3 , 500 mg levetiractam actingavis will be given to you once a day , once in each morning and twice in the afternoon . your doctor will prescribe you a lower dose ( 500 mg each day and in the middle of the day ): monotherapy dosage in adults ( 16 years ) and adolescents weighing from 1 - 8 years of height weighing at least 1 . 000 mg , you will receive 3 . 3 mg levvietam as 2 tablets of 1  
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately , or go to your nearest emergency department , if you experience weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ) flu - like symptoms and a rash on the face followed by an extended rash with a high temperature , increased levels of liver enzymes seen in blood tests and an increase in a type of white blood cell ( 56 ) eosinophilia ), and enlarged lymph nodes ( drug reaction with fever , joint pain and dizziness ). these may indicate that you are at high risk for developing severe side effects
what levetiracetam actavis contains - the active substance is called levetiractam . levetistetam actionavis 250 mg : each tablet contains 250 mg levetiratam - levetiretam the recommended dose of levetiragetam atavis 500 mg , each tablet delivers 500 mg levracetm . - each tablet of levragetamp actavid 750 mg ; each tablet provides 750 ml of leveracet am . the recommended dosage of leviraceta actavia 1 , 000 mg and 1  , 1000 mg leviractm is crospovidon , povidone , silica colloidal anhydrous , magnesium stearate . not all pack sizes may be marketed .
what incruse ellipta is this medicine contains the active substance umeclidinium bromide , which belongs to a group of medicines called bronchodilators . what increse
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , do not using this medicine and tell your doctor immediately . warnings and precautions talk to your doctor before using incruses ellippa : - patients with asthma should not use this medicine if any of these apply to you ( or you are not sure ). talk to a doctor before you use incluse incrused ellipinium : you have asthma . you have heart problems . - you have an eye problem called narrow - angle glaucoma . tell your physician if : your doctor thinks you have enlarged prostate , difficulty passing urine or a blockage in your bladder . your doctor may want to monitor you more closely
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . use incruse ellipta regularly it is very important that you use inclumps of incruses ellippa every day , as instructed by your doctor to use it . this will help to keep you free of symptoms throughout the day and night . if this is the case , you must use this product every day even when you are having a sudden attack of breathlessness or wheezing . in order to relieve this attack you must have a quick - acting reliever
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you get any of the following symptoms after using incruse ellipta stop using this medicine and tell your doctor straight away : itching skin rash ( hives ) or redness 29 other side effects may include : common ( may effect up to1 in 10 people ) faster heart beat painful and frequent urination ( may be signs of a urinary tract infection ) common cold infection of nose or throat cough feeling of pressure or pain in the cheeks and forehead ( may indicate inflammation of the lungs ) if any of these side effects causes you problems , tell your physician . common ( might affect upto 1 in 10 users ) slower heart beat pain and frequent urine ( may mean that you have a
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the inhaler in the sealed tray in order to protect from light . after first opening of the tray , the inhaled tray should be used within 6 months . once the tray is opened , use the inhaleser immediately . if the ink has been stored in the refrigerator , store at room temperature ( below 30 ). the inHALF - fill cartridge after you have used it , and keep it at room temp ( below 25 ). always keep the container in the outer carton in order for the inking to work properly . medicines should not be disposed of via wastewater or household waste 
what incruse ellipta contains - the active substance is umeclidinium bromide . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microgram of umecclidini bromida ). - - any other ingredient ( excipient ( s )) is lactose monohydrate ( see section 2 under ' incruses ellippa contains lactoses ') and magnesium stearate . what increse incrussanta looks like and contents of the pack incrusite ellipinta is an inhalations powder . the ellipe ellipata inhaler consists of a grey plastic body , a light green mouthpiece cover and a dose counter . it is packaged in 
nucala contains the active substance mepolizumab , a monoclonal antibody , which is a type of protein that helps to fight asthma . nucalala is used to treat adults with severe asthma that affects at least 6 people . severe asthma affects many eosinophils , another white blood cell that circulates in the lungs . eeo sinphilic asthma nucale is used in adults to prevent asthma attacks and helps to control asthma attacks . it is usually given with medicines called high dose inhalers . when your asthma is not controlled with these medicines , you may be given medicines called oral corticosteroids . how nucalla works nucalam helps control your asthma , especially when it is first given . mepolizamab works by blocking the action of interleukin - 5 , this protein helps to
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if : you have worsening asthma 58 you have asthma - related side effects , your doctor will monitor your asthma while you are using nucalala . your doctor may decide to reduce your dose of nucale if your asthma does not improve with nucalation . you are more likely to get your asthma worse during nucal , and your doctor might decide to stop nucalcala treatment . if any of these apply to you , tell your doctor . allergic injection site reactions medicines of this type ( monoclonal antibodies ) can cause severe allergic reactions when they are injected into the body . see section 4 for more details about side effects and how to treat them
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one injection under the skin ( subcutaneous injection ) every 12 hours . your doctor may increase the dose to 100 mg within 1 hour using the pre - filled pen . you can inject nucala yourself if your doctor decides that treatment with nucalala is too intense or too weak . if the treatment with nuclear medicine is not working , your doctor will monitor you and decide if it is safe for you to inject nukala . talk to your doctor and nurse , if necessary . nucale can be used at any time during the course of treatment . it is important that you continue to use nucal , as long as your asthma symptoms improve or get worse . when attacks occur , or when your asthma problems are controlled
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur ( very common , may affect more than 1 in 10 people ) where the injection is given . sometimes symptoms include symptoms such as chest tightness , cough , difficulty breathing fainting , dizziness / feeling lightheaded ( due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you have a reaction or a similar reaction to nucale . if this happens , you should stop using nucalala and talk to your doctor . you should not stop using this medicine without first talking to your physician . your doctor will decide if and when you should restart nucalo .
keep out of the sight and reach of children . do not use nucala after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the nucale pre - filled pen in the outer carton in order to protect from light . after first opening , use within 7 days . this 7 - day period should be a long one .
what nucala contains - the active substance is mepolizumab . 1 ml solution contains 100 mg of mepolizamab in 1 l . - other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate . polysorbate 80 , edta disodium dihydrate ; water for injections . what nukala looks like and contents of the pack nucale is presented as a clear and colourless solution . it is available in packs containing 1 vial , or in a pack containing 2 vials or in the pack forming a multipack containing 3 vial ( 1 via ) vial
what ninlaro is nninlanaro contains a cancer medicine called ixazomib , called a ' proteasome inhibitor '. what ? ninelaron is used to treat adults with a type of cancer of the bone marrow called multiple myeloma . ixizomibe is used for cell survival in adults . how n inlars works in myelosom , cells contain a lot of proteins called proteasoms that are involved in their growth and division . what is ' nlar' used for ninchlarou is used in combination with lenalidomide and dexamethasone , other medicines used to manage multiple myélomania , or to reduce the number of cells that have spread to other parts of the body .
do not take ninlaro - if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , do not use nnlar . warnings and precautions talk to your doctor or pharmacist before taking n inlars . ninelarre may cause bleeding , persistent nausea , vomiting or diarrhoea . nerve problems such as tingling , numbness , swelling or a persistent rash . liver or kidney problems if any of these apply to you during treatment with ninklara , tell your doctor before starting treatment . before starting and during treatment , your doctor may order blood tests to check that you have enough blood cells . children and adolescents ninninglaron is not recommended for children and teenagers
ninlaro should only be prescribed to you by a doctor with experience in treating multiple myeloma . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . nnlaron must be taken in combination with lenalidomide , a medicine that is similar to dexamethasone , an anti - inflammatory medicine . your doctor will tell you how many tablets of n inlararo to take in combinationwith lenaldomide and dex amethamethason , once a week for the first 4 - week period . you will normally take nlarco once , on the same day of the week . during the first 3 weeks , the first week of the first month and then onwards , your doctor may decide to give
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ) low platelet counts ( thrombocytopenia ) nose bleeds easily bruise nausea vomiting diarrhoea numbness , tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet , ( peripheral oedema ) skin rash , itchy all over the body rare side effects are ( may effect up to 1 in 1 , 000 people ). these are signs of low platelets . these are very rare but are very serious and are very common . if any of these occur , tell your doctor or nurse immediately . reporting of side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister or carton after exp . the expiration date refers to the last day of that month . store below 30 . keep the capsule in the outer carton in order to protect from light and moisture . this medicine does not require any special temperature storage conditions . tell your pharmacist if you notice any damage or signs of tampering to medicine packaging .
what ninlaro contains - the active substance is ixazomib . each capsule contains 2 . 3 mg of ixizomibe . - each capsule of 2 , 3 mg contains ixazamia citrate . the other ingredients are microcrystalline cellulose , magnesium stearate and talc . in addition , the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( er ) and shellac , propylene glycol , potassium hydroxide and black iron oxide . what ? nnlaron 3 mg hard capsules the active ingredient is : ixamid . one capsule contains 3 mg ixzazomimb , one capsule is a white to off - white capsule .
do not use palforzia - if you are allergic to peanuts , or to arachis hypogoea . warnings and precautions talk to your doctor or pharmacist before using palforzaa : children and adolescents ( aged 4 to 17 years ) do not give palforza to children and teenagers . children and infants do not breast - feed . during treatment your doctor will monitor you and decide if treatment should be continued . peanut allergy if peanut ( sensitisation ) is tolerated in children and young people . do not take palforziea if allergic reactions occur . palforzea should not be used in patients who are known to have food allergies . if any of the above applies to you , do not share palfor zia with others .
do not take palforzia - if you are allergic to severe asthma . - your asthma needs treatment . do not give palfor zia to anyone else . you have a problem swallowing . this is because you have long term problems with your digestive system such as a severe mast cell disorder or severe or life - potentially life threatening anaphylaxis . for 60 days after your last dose of treatment , your doctor may decide to stop your palforzaa . it is important that you take pal forzia every day until the symptoms go away . peanut allergy may occur when you start receiving palforza , but this is not meant to cause an allergic reaction . your doctor will monitor you closely during treatment if your pal forzaa is allergic to peanut allergy . allergic reactions may occur during treatment with palforziea if peanut allergy is suspected . these reactions may
do not use this medicine - if you have ever had allergy or allergic reactions ( anaphylaxis ) to any of the ingredients of palforzia ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking palforzaa . allergic reactions can occur within 3 months of starting treatment with palfor zia , and initial dose escalation can be started at a lower dose . during these treatment phases , the initial dose elevation and up - dosing phases can be continued during the initial dosertion and up to four phases of pal forzia ; you should continue to take palforizia for as long as your doctor tells you to . if initially dosers start to use palforzea : you may experience desensitisation , especially on the day you are feeling unwell , or if your asthma gets
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects of palforzia are severe allergic reactions . tell your doctor straight away if you have any of the following symptoms while taking palforzaa . they usually go away within a few days or weeks after the reaction . trouble breathing , throat tightness , feeling of fulness , trouble swallowing , speaking - changes in voice , dizziness / fainting - severe stomach cramps , pain , vomiting , or diarrhoea , severe flushing or itching of the skin palforizia can cause problems with the stomach and digestive system . it can also cause indigestion , heartburn or heartburn . if this happens , it is not known how often this happens to you . you may experience some or all of the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special temperature storage conditions . any hard lumps of powder should be thrown away .
what palforzia contains the active substance is : 0 . 5 mg / 1 ml oral powder in capsules 1 , 10 or 20 mg . the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , magnesium stearate palforza 100 mg : each single - dose blister contains oral powderin capsules with opening microcrystalline cell , coloidal anhydratous siLICA , and magnesium sterarate paulforzian 300 mg , each single dose blister delivers oral powder , microcrystalline capsule , co - sachet microcrystalline silice , sterile silic , or magnesium stye . - beige oral powder not all pack sizes may be marketed . initial dose escalation ( see section 3 ) for children and adolescents ( aged 13 years and above ) the
zerene belongs to the class of substances called benzodiazepine - related medicinal products , which contain hypnotic actions . zere is used to relieve sleeping problems in adults . it is used at the end of treatment . the endocrinologist will decide on the type of treatment that is right for you . do not stop taking zer unless your doctor tells you to . you should contact your doctor if you have problems sleeping .
do not take zerene - if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zere . zerenede sleep apnoea syndrome may occur during short periods . you must tell your doctor if this happens . your doctor will decide how many treatments you need . have severe kidney or liver problems . myasthenia gravis : you must have very weak or tired muscles . do not exercise or exercise more than usual , or have severe breathing or chest problems if any of these apply to you . children and adolescents do not give this medicine to children and teenagers under 18 years of age . the use of zeene has not been studied in this age group . it is not known whether zerennegene causes undesirable effects . tell your physician if your child is taking any medicine ,
always take zerene exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is 10 mg once a day , with no possibility of difficulty falling asleep . do not take zene more than once  a night . if your doctor advises you to take a different dose , you may need a lower dose . it is best to take the capsule at bedtime , preferably at bed time . elderly ( over 65 years old ): if a person with mild to moderate liver problems is taking the medicine , take the first 5 capsules as soon as you notice that the capsule is cloudy , or if the person taking it turns into a coma , contact your doctor immediately . take the next capsules at the same time , at the usual time ; if an over
like all medicines , zerene can cause side effects , although not everybody gets them . if you notice any other changes in your health , tell your doctor or pharmacist as soon as possible . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon (affecting less than 1 to 1 user per 10 , 000 ) rare ( affecting 1 to 8 users in 10 000 ). very rare (affecting more than1 user in10 ,000 ) very rare . not known ( frequency cannot be estimated from the available data ). as with all medicines the following side effects may occur with any other change in your healthcare . tell your healthcare professional if any of the side effects gets serious or if there are any side effects not listed in this leaflet . you can also report
what zerene contains - the active substance is zaleplon 5 mg . - each capsule contains microcrystalline cellulose , pregelatinised starch , silicon dioxide , sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine ( e132 ), titanium dioxide ( s - 1310 ), gelatin , titanium dioxide . the printing ink contains red iron oxide ( i ) and yellow iron oxide , black iron oxide [ e 172 ), sodium laurryl , and silicon dioxide ( ( u - 13050 )). the printing imprint contains shellac , lecithin , simethicone , yellow ironoxide . what zeene looks like and contents of the pack zerène is a white , capsule
